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ABSTRACT 
Cell migration is important in animal development, tissue repair, the functioning of 
the immune system and for tissue homeostasis in general. Impairments in cell 
migration are associated with various developmental abnormalities and pathologies. 
In Drosophila development, cell migration is instrumental during metamorphosis, in 
the process of thoracic closure. The most studied mammalian model of cell 
migration at the cellular level is the scratch or wound-healing assay, in which a linear 
scratch is made in a confluent monolayer of cells, which then migrate to close the 
gap.  
The work presented in this thesis aims to understand how signaling associated 
with the mitochondrial respiratory chain affects cell migration in different models. 
As a tool to investigate this relationship, I used model organisms transgenically 
expressing the alternative oxidase, AOX, from a primitive marine animal, the 
tunicate Ciona intestinalis. AOX is an accessory component of the mitochondrial 
respiratory chain, which is found in microbes, plants, and some metazoan phyla, but 
not in vertebrates or insects. AOX directly oxidizes ubiquinol by molecular oxygen 
in a non-proton motive reaction, by-passing respiratory chain complexes III and IV. 
Utilizing AOX from Ciona intestinalis, I perturbed the mitochondrial respiratory chain 
and investigated the effect on developmental signaling affecting cell migration in the 
Drosophila and mammalian cell models. To create a control for these studies and test 
whether the ability of AOX to alleviate tested phenotypes depends on its enzymatic 
activity, I engineered a mutated variant of AOX in such a way as to abolish this 
activity. 
I observed that co-expression of AOX from Ciona intestinalis was able to alleviate 
cleft thorax and other dysmorphic phenotypes in Drosophila, brought about by 
activated GeneSwitch transcription factor, which I hypothesize to interfere in some 
way with nuclear receptor signaling during development. Using the mutant AOX 
control, I was able to show that AOX enzymatic activity is instrumental in rescuing 
developmental lethality or locomotor dysfunction, resulting from cytochrome 
oxidase deficiency. I proceeded to use mutant AOX to show that the same is true 
for the rescue of the dysmorphic phenotypes induced by GeneSwitch. 
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AOX expression also alleviated the cleft thorax phenotype induced by genetic 
manipulations of the JNK signaling pathway, which regulates the formation of the 
dorsal thoracic epithelium and governs the migratory behavior of the cell sheets 
everting from the wing imaginal discs during metamorphosis.  
Midline closure defects similar to cleft thorax in the fly are also seen in mammals, 
for example, in spina bifida, cleft lip and palate and cleft sternum. Considering the 
well conserved biology between fly and human and the highly conserved JNK 
signaling pathway, it was possible to use a mammalian cell-culture model to test the 
generality of the findings from Drosophila, as well as explore the molecular 
mechanisms underlying the influence of AOX on cell migration. I thus used the 
mammalian wound-healing model to confirm that AOX expression promotes 
migration in immortalized (but not primary) mouse embryonic fibroblasts, and 
rescues pharmacologically induced migration deficiencies through a mechanism 
involving JNK signaling. Reporter assays showed that AP-1 and its transcriptional 
activity are not a direct target of AOX. However the data suggest a possible direct 
involvement of JNK, acting through other targets. 
Despite the lack of knowledge on how AOX is regulated in animals, the use of 
various inhibitors showed that the effect of AOX on cell migration is most likely due 
to a specific effect on metabolism, possibly due to its thermogenic activity. A full 
elucidation of the processes that link mitochondrial perturbations with cell migration 
should be of considerable medical importance and might even enable the design of 
new and more effective treatments, e.g., for metastatic tumors, tissue injuries, and 
congenital midline closure defects. A better understanding of the role mitochondria 
play in mediating cellular signaling is still needed, and will be instrumental to fully 
understand many fundamental biological processes, causes of disease and enable the 
design of precision treatments.  
Results from this thesis provide us with a new paradigm linking mitochondrial 
function with developmental cell signaling. They also highlight what can be learned 
by combining tools and findings from different model organisms. In this case, the 
tunicate Ciona intestinalis provided a tool to better understand complex 
developmental processes in Drosophila melanogaster, which was then followed up in 
mammalian cells with potential relevance to human diseases. 
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TIIVISTELMÄ 
Solujen liikkumisella eli migraatiolla on tärkeä rooli yksilönkehityksessä, 
kudosvaurioiden korjaamisessa, immuunijärjestelmässä sekä yleisesti kudosten 
toiminnassa. Solumigraation ongelmat liittyvät moninaisiin kehityshäiriöihin ja 
sairauksiin. Drosophila melanogaster -banaanikärpäsellä puutteellinen solujen migraatio 
yksilönkehityksen aikana näkyy muun muassa halkiona kärpäsen keskiruumiissa. 
Solumigraation tutkituimmassa solutason nisäkäsmallissa yksikerroksiseen 
solupeitteeseen tehdään lineaarinen viilto, joka umpeutuu solumigraation 
seurauksena.  
Väitöskirjatyöni tavoitteena oli tutkia, miten mitokondrioiden soluhengitykseen 
liittyvä signalointi vaikuttaa solumigraatioon erilaisissa tutkimusmalleissa. 
Tutkimuksessani hyödynsin mallieläintä, joka oli geneettisesti muokattu tuottamaan 
alkukantaisesta Ciona intestinalis -vaippaeläimestä eristettyä vaihtoehtoista oksidaasia 
(alternative oxidase, AOX). AOX-entsyymiä ei esiinny selkärankaisilla eikä 
hyönteisillä, mutta muun muassa mikrobeilla, kasveilla ja joillakin monisoluisilla 
eläimillä se toimii osana mitokondrion hengitysketjua hapettamalla ubikinolin 
suoraan käyttäen molekulaarista happea. AOX ohittaa entsyymikompleksit III ja IV 
ilman protonien kuljetusta. Tutkimuksessani muokkasin mitokondrioiden luontaisen 
hengitysketjun toimintaa hyödyntäen AOX:ia sekä banaanikärpäs- että 
nisäkässolumallissa, ja tutkin tämän vaikutuksia yksilönkehityksen aikaiseen 
signalointiin ja solujen migraatioon. Kokeiden kontrolliksi ja testatakseni johtuuko 
fenotyypin oireiden lieventyminen AOX:n entsymaattisesta aktiivisuudesta, 
muokkasin AOX:stä mutaation avulla entsymaattisesti toimimattoman version.  
Havaitsin, että Ciona intestinalisista saadun AOX:n lisääminen kärpäsmalliin 
lievensi aktivoidun GeneSwitch transkriptiofaktorin aiheuttamaa 
keskiruumishalkiota ja muita kehityshäiriöitä. Hypoteesinani on, että aktiivinen 
GeneSwitch häiritsee jollakin mekanismilla tumareseptorien viestintää kehityksen 
aikana. Käyttämällä mutatoitua AOX-kontrollia osoitin, että sytokromioksidaasin 
vajeesta johtuvia letaaleja kehityshäiriöitä ja liikuntakyvyn ongelmia lieventävä 
vaikutus perustuu AOX:n entsymaattiseen aktiivisuuteen. Jatkoin käyttämällä 
mutatoitua AOX:ää osoittaakseni saman pätevän myös GeneSwitchin tuottamiin 
kehityshäiriöihin. AOX:n ilmentäminen lievensi lisäksi keskiruumishalkiota, joka 
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aiheutui JNK-signalointireitin geneettisestä manipuloinnista. JNK-signalointireitti 
säätelee keskiruumiin dorsaalisen epiteelin muodostumista ja ohjaa siipiaihioiden 
solukerrosten migraatiota kärpäsen muodonmuutoksen aikana.  
Nisäkkäillä on banaaninkärpäsen keskiruumishalkion kaltaisia keskilinjan 
kehityshäiriöitä, kuten selkäranka-, huuli-, suulaki- sekä rintalastahalkioita. Monet 
biologiset toiminnot ja varsinkin JNK-solusignalointireitti ovat säilyneet 
samankaltaisina ihmisellä ja banaanikärpäsellä, mikä mahdollistaa nisäkässolumallien 
käytön kärpäsillä saatujen tulosten yleispätevyyden kokeilemiseen sekä AOX:n 
vaikutusten taustalla olevien molekulaaristen mekanismien tutkimiseen. Näin ollen 
pystyin hyödyntämään nisäkässoluviljelmään tehtyä lineaarista viiltoa menetelmänä 
osoittaakseni, että AOX:n ilmentäminen edesauttaa solumigraatiota 
immortalisoiduissa (mutta ei primaarisissa) hiiren alkion sidekudossoluissa ja korjaa 
JNK-reitin manipulaation aiheuttamia häiriöitä solujen migraatiossa. 
Reportterimenetelmät paljastivat, että transkriptiotekijä AP-1 ja sen aktiivisuus eivät 
ole AOX:n suora kohde, vaan AOX:lla on mahdollisesti suora yhteys JNK-reitin 
toimintaan jotakin muuta kautta.  
Huolimatta siitä, että tietous AOX:n säätelymekanismeista eläimillä on 
puutteellista, kokeet useilla eri inhibiittoreilla viittasivat siihen, että AOX:n vaikutus 
solujen migraatioon todennäköisimmin selittyy spesifillä vaikutuksella 
aineenvaihduntaan; mahdollisesti entsyymin termogeenisellä toiminnalla. Kattavan 
kokonaiskuvan saaminen prosesseista, joiden kautta mitokondriaaliset häiriöt 
liittyvät solumigraatioon, tarjoaisi merkittävää lääketieteellistä tietoutta ja saattaisi 
jopa auttaa muun muassa syövän etäpesäkkeiden, kudosvaurioiden ja synnynnäisten 
keskilinjan kehityshäiriöiden hoitomuotojen kehittämisessä. Tarvitaan kuitenkin 
parempaa käsitystä mitokondrioiden osuudesta solusignaloinnissa, ja tämä on 
olennaista monien biologisten prosessien, sairauksien syiden ymmärtämisen ja 
kohdennettujen hoitojen suunnittelun kannalta. 
Väitöskirjassani esitetyt tutkimustulokset tarjoavat uuden mallin, joka liittää 
mitokondrioiden toiminnan yksilönkehityksen aikaiseen solusignalointiin. 
Tuloksissani korostuu myös se, mitä voidaan oppia yhdistelemällä erilaisten mallien 
tarjoamaa tutkimustietoa ja -menetelmiä. Tässä tapauksessa Ciona intestinalis -
vaippaeläimen käyttö auttoi ymmärtämään paremmin Drosophila melanogasterin 
monimutkaista yksilönkehitystä. Näiden tulosten pohjalta pystyin jatkamaan 
tutkimusta mitokondrioiden roolista solujen migraatiossa nisäkässolumallissa, millä 
on potentiaalisesti merkitystä ihmisen sairauksien tutkimisessa.  
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1 INTRODUCTION 
Regulation of epithelial sheet migration is a critical component of animal 
development. For example, dysregulation of epithelial gap closure results in birth 
defects including spina bifida and cleft palate. Incorrectly regulated cell migration 
can also lead to impaired wound healing and to metastasis in cancer. The signaling 
pathways which regulate cell migration are incompletely understood. Previous work 
by other groups has suggested a role for mitochondrial metabolism in this process. 
The goal of this research was to identify mitochondria-related targets for 
manipulating cell migration and epithelial morphogenesis, which may enable future 
treatments of birth defects and other disorders.  
In this work, I applied a genetic approach in the model fruit fly Drosophila 
melanogaster to dissect the signaling pathways regulating epithelial morphogenesis and 
explore the effects of altering mitochondrial metabolism. In both humans and fruit 
flies, the migration of cell sheets is known to be regulated by the JNK signaling 
pathway. Thorax closure depends upon morphogenetic movements during 
Drosophila development where migrating epithelial sheets everting from the wing 
imaginal discs join together to form the dorsal thoracic epithelium. Defects in cell 
signaling impair this process and produce a cleft thorax phenotype in flies, roughly 
analogous to spina bifida or cleft palate in humans. 
Alternative respiratory pathways are present in many eukaryotic organisms 
including some arthropods; but are not present in insects or vertebrates. Their roles 
include (1) to promote thermogenesis, (2) to prevent accumulation of reducing 
equivalents, and (3) to act as antioxidants and provide resistance to metabolic 
poisons. One of these alternative pathway enzymes is the alternative oxidase (AOX), 
which bypasses complexes III and IV of the mitochondrial respiratory chain.  
Here, I expressed the AOX gene from the tunicate Ciona intestinalis in flies that 
had been genetically modified to exhibit cleft thorax. I selected two such models. In 
the first of these I made use of the steroid-dependent GeneSwitch transcriptional 
activator, which I observed to induce cleft thorax and other dysmorphic adult 
phenotypes in the presence of the inducing drug RU486. The project was initiated 
by the chance observation that AOX expression was able to reverse these effects. In 
 20 
the second model, I generated cleft thorax by specifically downregulating 
components of the JNK pathway. 
To enable these studies, I began by creating an important control for these and 
all studies involving the expression of an exogenously derived AOX. I engineered 
mutant AOX lacking enzymatic activity to test if the phenotypic effects of AOX 
expression are due to enzymatic activity or some other property conferred by AOX. 
The identification of effectors that rescue cleft thorax in Drosophila may eventually 
translate to humans. Therefore, to build upon the Drosophila findings, I also explored 
the effect of AOX expression on JNK-dependent transcription and wound healing 
in cultured mammalian cells.  
The finding that AOX can influence cell sheet movements in different organisms 
implies that a general relationship exists between mitochondrial respiratory function 
and cell migration that might one day find applications in medicine. 
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2 REVIEW OF THE LITERATURE 
2.1 Mitochondria 
The mitochondrion is an organelle present in most cells of most eukaryotes. The 
only exceptions are some species of fungi (Margulis, 1981), and some anaerobic 
microbial eukaryotes, such as Pelomyxa palustris (Brandt & Pappas, 1959) or the 
oxymonad Monocercomonoides (Karnkowska et al., 2016). In mammals mitochondria 
are not found in differentiated erythrocytes. Mitochondria were first described as 
elementary organisms living inside the cell by Altman (1890), who called them 
bioblasts. The term 'mitochondrion' was first used by Benda (1897), who detailed 
their unique shape. According to the endosymbiotic theory, eukaryotes evolved from 
free living oxygen-metabolizing α-protobacteria, which were engulfed by a pre-
eukaryotic scavenger cell some 1.6 billion years ago (Zimorski et al., 2014). However, 
the pre-eukaryotic cell did not digest the α-protobacteria, but rather provided it 
shelter and nourishment, establishing symbiosis (Margulis, 1981; Lane & Martin, 
2010). 
2.1.1 Mitochondria: structure and function 
The number of mitochondria per cell varies between different cell types and 
organisms. Kinetoplastida, and some apicomplexans, such as Toxoplasma, have a 
single mitochondrion, while the oocytes of most animals, as well as the giant amoeba 
Chaos chaos contain thousands (Bereiter-Hahn & Voth, 1994). In a typical human cell 
there are 100-1000 mitochondria, depending on cell-type and its metabolic status. 
Each cell contains about 1000 nucleoids, which are supramolecular assemblies of 
mitochondrial DNA (mtDNA) compacted by mitochondrial transcription factor A 
(TFAM) (Brown et al., 2011; Kukat et al., 2015) and associated with other proteins. 
Mammalian mtDNA encodes only 13 polypeptides, each of which contribute to the 
oxidative phosphorylation (OXPHOS) complexes.  
Each mitochondrion has four interconnected compartments: two membranes, 
the outer (OMM) and inner (IMM) mitochondrial membranes; the intermembrane 
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space between them and the mitochondrial matrix (MM). The OMM and IMM differ 
in their composition and permeability (Daum &Vance, 1997; de Kroon et al., 1997; 
Mejia & Hatch, 2016). The IMM contains the mitochondrial respiratory chain (RC) 
which is composed of five enzyme complexes.  
The OMM includes the following proteins: enzymes involved in the metabolism 
of amino acids and fatty acids, receptor complexes for protein import (Lill & 
Neupert, 1996), pore forming proteins (Benz, 1994), proteins controlling 
mitochondrial morphology (Sogo & Yaffe, 1994), signal transduction components 
(deKroon et al., 1997), the machinery for the import and export of lipids part of 
which remains unknown (deKroon et al., 1997), and monoamine oxidases A and B 
(Schnaitman et al., 1967; Edmondson et al., 2009). In eukaryotes, cardiolipin is the 
only lipid that is fully synthesized in the mitochondrion. The IMM has several 
invaginations called cristae. Cristae are dynamic and their number and structure may 
have functional consequences (Bereiter-Hahn & Jendrach, 2010).  
Many mitochondrial enzymes which are involved in the above-mentioned 
pathways are localized in the matrix but some of them are tightly connected with the 
IMM, e.g., succinate dehydrogenase, a component of the tricarboxylic acid cycle 
(TCA cycle), dihydroorotate dehydrogenase, which functions in the pyrimidine 
nucleotide biosynthesis pathway, and choline dehydrogenase). TCA cycle enzymes 
are bound to each other and to the IMM forming a supramolecular complex called 
the metabolon (D’Souza & Srere, 1983; Velot et al., 1997). It was proposed that the 
organization of these enzymes into such a metabolon allows efficient intermediate 
transport between active sites. The first structural evidence of substrate channeling 
in the TCA cycle metabolon was shown by Wu & Minteer (2015). Only part of the 
energy released by the oxidation of respiratory substrates is used to produce 
adenosine triphosphate (ATP) and to transport metabolites, while the rest is released 
as heat. Mitochondria serve as heat generators in brown fat tissue which is found in 
all mammals (Smith, 1964; Cannon & Nedergaard, 2004). Mitochondria themselves 
function at temperatures at least 6 to 10 °C higher than the rest of the cell (Chrétien 
et al., 2018).  
Mitochondria are not stationary organelles. They are able to change structurally 
as well as move to sites of high adenosine triphosphate (ATP) demand to meet the 
energy requirements of the cell. Locomotion of the mitochondria and changes in 
their shape reflect the locations of energy consumption in the cell (reviewed by 
Bereiter-Hahn & Voth, 1994). 
Mitochondria have a set of well-defined functions. These differ according to cell 
type and are performed by mitochondria being able to change their number, 
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localization, shape and molecular components. Mitochondria generate energy in the 
form of ATP, using a so-called proton-motive force formed by three of the RC 
complexes (described in the next section).  
Mitochondria are responsible for regulating cell death and survival (Tournier et 
al., 2000; Schell et al., 2014; Morita et al., 2017) and also play vital roles in calcium 
homeostasis (Rasola et al., 2010; Lim et al., 2008) and steroid synthesis (Miller et al., 
2013). There are several important metabolic processes (or parts thereof) localized 
in the mitochondria including: the TCA, urea cycle, beta-oxidation of fatty acids 
(though not in all eukaryotes), haem synthesis, glycine cleavage and folic acid 
metabolism. The generation of iron-sulfur clusters is catalyzed by mitochondrial 
scaffold proteins and enzymes (Rouault & Tong, 2005). Six classes of steroid 
hormones (calciferols (Vitamin D), glucocorticoids, mineralocorticoids, estrogens, 
progestins and androgens), are made from cholesterol in mammalian mitochondria 
by mitochondrial P450 enzymes (Miller, 2013). Mitochondria achieve all of this by 
communicating with many different cell organelles including the endoplasmic 
reticulum and sarcoplasmatic reticulum in tight connection with the cytoskeleton, 
which is crucial for mitochondrial localization and translocation to the site of action. 
Mechanobiologists have furthermore proposed that the extracellular matrix 
mechanics also influence mitochondrial function (Bartolák-Suki et al., 2017; Lyra-
Leite et al., 2017). In fat-oxidizing tissues mitochondria associate with lipid droplets 
as peridroplet mitochondria (PDM). The function of PDMs is still largely unknown. 
Oocyte mitochondria in many species are organized together with Golgi bodies, 
endoplasmic reticulum and other organelles into a Balbiani body (Raven, 1961).  
Rapid transport of the mitochondria has been shown to occur along neuronal 
axon microtubules (Boldogh & Pon, 2007). Animal mitochondria rely primarily on 
microtubules for their transport, although there is evidence that actin filaments are 
also involved in their motility (Ligon & Steward, 2000). Mitochondrial movement in 
budding yeast is dependent on the actin cytoskeleton, not microtubules (Boldogh & 
Pon, 2007). Plants and other fungi also rely on actin filaments for mitochondrial 
transport. Mitochondrial localization inside the cell is not random and is important 
in physiology and disease (Campello & Scorrano, 2010). For example, in cell 
migration, anterior localization of mitochondria is necessary for the cells to migrate 
faster with greater persistence (Desai et al., 2013). Interestingly, perturbing 
mitochondrial localization within cells by mutating mitochondrial fusion and fission 
proteins impacts the distribution of mitochondria, decreases the number of cells with 
anterior-localized mitochondria and slows cell migration (Desai et al., 2013). 
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In most tissues mitochondria appear to be a dynamic network which can change 
their shape and location in the cell (Bereiter-Hahn & Voth, 1994). Mitochondrial 
movement is coordinated with changes in their shape, as shape has to be compatible 
with their movement (de Vos et al., 2005). Their shape depends on their function, 
cell-cycle stage, fusion and fragmentation. Mitochondria can change shape from 
elipsoid to interconnected tubular organelles. Continuously ongoing fusion and 
fission processes are instrumental in determining mitochondrial shape (Campello & 
Scorrano, 2010). Mislocalization of the mitochondria is important in a number of 
neurodegenerative diseases (Ferreirinha, 2004; Baloh, 2007) and it can affect lifespan. 
For example, decreasing mitochondrial fission has been shown to increase lifespan 
and fitness of Podospora anserina and Saccharomyces cerevisiae (Scheckhuber et al., 2007). 
The morphology of mitochondria is important for their function. For example, 
malformed, 'donut-shaped' mitochondria, a hallmark of the mitochondrial stress (Liu 
& Hajnóczky, 2011), are associated with abnormally small synaptic contacts, 
affecting the working memory in rhesus monkeys (Hara et al., 2014). 
Mitochondria are crucial to the functions of many differentiated cells in animals 
and have tissue specific functions. For example mitochondria are involved in 
regulation of synaptic transmission, brain function and cognition in aging (Sharpley 
et al., 2012; Hara et al., 2014). Sperm cell metabolism is also highly dependent on 
mitochondria. Although paternal mitochondria are degraded inside the fertilized egg, 
sperm mitochondria are critical for fertilization and sperm function (Koppers et al., 
2008). Sperm cells are vulnerable to oxidative stress (Mueller & Robaire, 1996; 
Aitken et al., 2012; Selvaratnam & Robair, 2016) and a correct mitochondrial redox 
homeostasis balance is crucial for normal sperm motility (Amaral et al., 2013). 
Moreover, sperm mitochondria in humans are protected in a keratinous structure, 
the mitochondrial capsule, formed by disulfide bonds between cysteine- and proline-
rich selenoproteins, including the sperm-specific phospholipid hydroperoxidase 
glutathione peroxidase (Ursini et al., 1999; Amaral et al., 2013). Mitochondria are also 
major components in the glucose-sensing mechanism controlling insulin secretion 
by pancreatic β-cells (Lowell & Shulman, 2005; Maassen et al., 2004; Maechler & 
Wollheim, 2001). Another example of a tissue specific function is the production of 
ketone bodies, as important energetic substrates, occurring exclusively in mammalian 
liver mitochondria. Finally, mitochondria serve as critical regulators of autophagy via 
their role in redox and metabolic homeostasis (Engel & Evans, 2006; Scherz-Shouval 
et al., 2007; Chen et al., 2007; Azad et al., 2009). 
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2.1.2 The mitochondrial respiratory chain 
Biochemical energy from nutrients is converted into ATP by glycolysis and the 
reactions of cellular respiration, combined with ATP synthase, later two making up 
the system of OXPHOS. OXPHOS is a key functional unit in the mitochondria. 
Respiration is performed by RC, which comprises NADH:ubiquinone 
oxidoreductase (complex I), succinate:ubiquione oxidoreductase, often described 
more simply as succinate dehydrogenase (complex II), ubiquinol:cytochrome c 
oxidoreductase (bc1 complex; complex III), cytochrome c (Cyt c), and cytochrome c 
oxidase (CcO; complex IV). In most tissues, the majority of electrons transferred by 
the RC are derived from NADH and enter the chain via complex I. Electrons 
derived from FADH2 in complex II feed directly into the ubiquinone (Q) pool. Q is 
lipid soluble and freely moves through the hydrophobic core of the membrane. Once 
reduced, (QH2), ubiquinone delivers its electrons to the next complex in the electron 
transport chain. Electrons are transferred through the RC to oxygen, while the 
mitochondrial membrane potential is generated by pumping of protons across the 
IMM. In the final step, ATP synthase (complex V) utilizes the proton gradient to 
energize the production of ATP from ADP and Pi. Importantly, the respiratory 
chain also sustains the TCA cycle by re-oxidizing NADH and FADH2. 
2.1.3 Mitochondrial dysfunction and disease 
The term 'mitochondrial disorders' is used for a collection of clinical syndromes 
characterized by faulty OXPHOS. The first mitochondrial disorder was described 
by Luft et al., (1962). He reported a case of a 35 year-old woman with general 
weakness, excess perspiration, high skin temperature, and inability to gain weight. 
Mitochondria of the patient exhibited defects in mitochondrial enzyme organization 
and had densely packed cristae with tubular inner structures (Luft et al., 1962). 
Mitochondrial disorders can result from deficiency or dysfunction of any OXPHOS 
component. Over 200 different genes are involved in assembling the OXPHOS 
complexes (Smeitink et al., 2001), and loss or functional inhibition of any of them 
can inhibit OXPHOS. Respiratory chain complexes can also be inhibited by various 
toxins that target the complexes directly, e.g., I (rotenone, Lindahl & Öberg, 1961), 
III (antimycin, Slater, 1973), IV (cyanide, Van Heyningen, 1935), or V (oligomycin, 
Bruni & Luciani, 1962). 
The incidence and prevalence of mitochondrial disorders is difficult to estimate 
because of their clinical and genetic variability and the limitations of current 
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diagnostic techniques (Skadal et al., 2003). Mitochondrial disorders manifest as a 
heterogeneous clinical presentation, from single tissue disorders such as specific 
neuropathies and myopathies, to multi-system disorders. The onset of the disease 
can occur at any life stage from neonatal to late adult (Zeviani & Di Donato, 2004). 
It is estimated that mitochondrial disorders occur with a frequency of 1/5,000 to 
1/10,000 births (Smeitink et al., 1998). Mutation analysis is complicated by the 
complexity of the mitochondrial respiratory chain, which is composed of 13 subunits 
encoded by mtDNA and over 70 subunits encoded by nuclear DNA. There are over 
300 mtDNA mutations associated with mitochondrial disorders (Govindaraj et al., 
2011). Mutations of mtDNA can be large-scale rearrangements, partial deletions or 
duplications, but are usually sporadic, inherited point mutations (Zeviani & Di 
Donato, 2004). A large number of other nuclear genes are required for mitochondrial 
protein import and assembly, as well as regulation of mtDNA replication and 
expression (Shoubridge, 2001). In all, some 1,500 nuclear genes code for 
mitochondrial proteins (Chinnery & Hudson, 2013), any of which is potentially 
involved in mitochondrial disease. Thus, mitochondrial disease can be caused by 
mutations in either the nuclear or mitochondrial genome and can be inherited as 
autosomal dominant/recessive, X-linked or maternally. Use of next generation 
sequencing has made the diagnosis and understanding of mitochondrial diseases 
better, which will lead to treatments (Nightingale, 2013). However, in approximately 
50% of adult patients with biochemical and morphological evidence of a 
mitochondrial disorder, the affected gene remains unidentified (Zeviani & Di 
Donato, 2004). Even the same mitochondrial disease, such as Leigh syndrome, can 
be genetically heterogeneous. In some cases it is caused by mtDNA mutations in 
ATP synthase subunit 6 (Makino et al., 2000) or NADH dehydrogenase subunit 4 
(Hadzsiev et al., 2010). In others it is due to autosomal recessive nuclear gene 
mutations in SURF1, LRPPRC (a mitochondrial mRNA-binding protein), complex 
I subunits NDUFS7 or NDUFS8 or complex II subunit SDHA (Zeviani & Di 
Donato, 2004). 
Tissues which require energy the most, such as the visual and auditory systems, 
the CNS and PNS, the heart, muscle, endocrine pancreas, kidney and liver are most 
sensitive to OXPHOS failure (Zeviani & Di Donato, 2004), and are most commonly 
affected in mitochondrial disease. 
Mitochondria and mtDNA are maternally inherited in all mammals (Hutchinson 
et al., 1974; Sato & Sato, 2013) and does not undergo germline recombination 
(Hällberg & Larsson, 2014). However, paternal mitochondria carried by sperm do 
enter the egg during fertilization (Schwartz & Vissing, 2002). During mammalian 
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zygote formation, sperm mitochondria are removed by either ubiquitination post 
fertilization (Sutovsky et al., 1996; Sato & Sato, 2013) or potentially during transport 
through the male reproductive tract (Sutovsky, 2003). However, two reports of 
paternal transmission of mitochondria, suggest that paternal mtDNA could be 
passed to the offspring in specific cases (Schwartz & Vissing, 2002; Luo et al., 2018). 
Mitochondria and their genomes are believed to be randomly distributed to daughter 
cells during cell division (Jenuth et al., 1996). However, stem-like cells have been 
observed to distribute mitochondria unequally, based on the age of the mitochondria 
(Katajisto et al., 2015). This was only observed within the stem-like cells in the culture 
and it is unknown if this phenomenon occurs in vivo (Sun et al., 2016). However, there 
is evidence of a corresponding asymmetric inheritance of both mitochondria in 
asymmetric division in yeast (McFaline-Figueroa et al., 2011). 
A repair system not as efficient as that in the nucleus, the proximity of the 
mtDNA to reactive oxygen species (ROS) production sites and the fact that mtDNA 
packing by TFAM is not as protective as the nuclear DNA by the histones 
associations, have been proposed to cause a higher rate of mutation in mtDNA 
compared to nuclear DNA (LeDoux et al., 2007; Alexeyev et al., 2013). This causes 
heteroplasmy, where, in a single cell or mitochondrion, wild-type and mutated 
mtDNA can coexist. Heteroplasmic mutations will not always manifest clinically. 
Only when mutated gene copies accumulate over a certain threshold, will the effects 
of the mutation no longer be masked by the co-existing wild-type mtDNA, and 
disease symptoms will become apparent (Thorbum & Dahl, 2001). However, the 
critical threshold differs depending on the exact mutation site, tissue, increasing over 
time in post-mitotic tissues and decreasing in mitotic tissues such as blood. mtDNA 
deletions give rise to a lower heteroplasmic threshold (~50%) for the appearance of 
disease symptoms (Rossignol et al., 2003). For many common point mutations, a 
level of 80-90% mutant mtDNA needs to be reached before symptoms manifest 
(Chinnery et al., 1997).  
Mitochondrial disorders currently have no cure. Mostly they are progressive, 
leaving the patient with severe disability and shortened lifespan. However, disease 
progression can also halt and symptoms may stay stable for decades. The complexity 
of mitochondrial diseases and the fact that they are still incurable necessitates 
different approaches to treatment. A hallmark of mitochondrial diseases is decreased 
ATP synthesis. Therefore, some therapeutic interventions aim at increasing the levels 
of ATP (Viscomi et al., 2015). Antioxidant treatments are also employed with the 
goal of protecting cells from increased oxidative damage caused by mitochondrial 
dysfunction (Ni et al., 2016; He et al., 2014). Endurance exercise and small molecule 
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compounds such as vitamins and cofactors have also been used to improve cellular 
energy metabolism or enhance it indirectly by inducing mitochondrial biogenesis 
(Reznick & Shulman, 2006; Jager et al., 2007; Holloway, 2009). Exercise improves 
endurance and muscle function and can also increase the percentage of healthy, non-
mutated mtDNA as well as trigger mitochondrial biogenesis (Viscomi et al., 2016). 
Nutritional therapy, with focus on implementing a ketogenic diet (KD) might be 
beneficial for mitochondrial function and alleviate mitochondrial disorders (Kerr, 
2010; Pfeffer et al., 2013; Peralta et al., 2015). KD is based on high fat, moderate 
protein and low carbohydrates. Ketone bodies produced from the oxidation of fat 
are the main source of energy (de Lima et al., 2014). On KD, cells are forced to 
bypass glycolysis and use oxidative phosphorylation. Preclinical research shows that 
KD induces mitochondrial biogenesis slowing down disease progression in the 
Deletor mouse, which has a mutant form of the mitochondrial helicase TWINKLE, 
which causes progressive external ophthalmoplegia (Ahola‐Erkkila et al., 2010). 
Ketogenic medium has been shown to kill cybrid cell lines, which carry 100% deleted 
mtDNA (Santra et al., 2004).  
Furthermore, the idea that increasing the amount and/or function of 
mitochondria could be beneficial to treat mitochondrial disease, has been tested in 
several ways. Treating fibroblasts from patients with different mitochondrial diseases 
with a pan-PPAR agonist, bezafibrate (Bastin et al., 2008), corrected respiratory 
complex deficiency in patient cells (Bastin et al., 2008). Replacing damaged 
mitochondria with autologous respiration-competent mitochondria has been 
reported to recover myocardial dysfunction (Emmani & McCully, 2018). In some 
patients with sparing myopathies, the pathogenic mtDNA is surprisingly absent in 
terminally fated myogenic precursor cells named satellite cells (Smith et al., 2004). 
Therefore, myotoxins have been used to destroy mature muscle myofibres harboring 
the mtDNA mutation, which leads to repopulation of the muscle by satellite cells 
(Clark et al., 1997). For diseases caused by heteroplasmic mtDNA mutations, one 
approach seeks to increase the proportion of wild-type mtDNA, using gene therapy 
to eliminate mutated mtDNA and propagate the wild-type mtDNA (Taylor et al., 
2000). Examples of such an approach include the use of a mitochondrially targeted 
restriction endonuclease designed to preferentially eliminate mutated mtDNA 
(Bacman et al., 2012). Another version uses sequence-specific nucleic acids which 
selectively bind and induce mutant mtDNA degradation (Mukherjee et al., 2008). 
However, despite many ingenious strategies to transfect DNA or RNA into 
mitochondria (Seibel et al., 1995), none has been shown to work routinely in vivo. 
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Genetic counseling in a family with a history of mitochondrial diseases is 
important, given the severity of the mitochondrial diseases. However, the inheritance 
of mutant mtDNA cannot be reliably predicted because of the germ cell bottleneck 
effect, wherein a limited number of mtDNA molecules are transferred into each 
oocyte during primary oocyte generation. That means that mothers with pathogenic 
mtDNA mutations will have offspring with variable levels of mutated mtDNA 
which cannot be predicted in advance (Chinnery, 2000). However, this can be 
evaluated using in vitro fertilization followed by preimplantation genetic diagnosis 
(Herbert & Turnbull, 2018). Women affected with high levels of heteroplasmy or 
homoplasmy, where nearly all mtDNA is mutated, could in the future undertake a 
form of germline therapy, mitochondrial replacement therapy, which would greatly 
decrease the risk of transmitting disease. Mitochondrial replacement therapy requires 
that an enucleated egg from an unaffected donor to be transplanted with the nuclear 
genome from the mother affected with the mitochondrial disease (Herbert & 
Turnbull, 2018). Environmental factors can also trigger or aggravate mitochondrial 
diseases (Wallace, 2010; Cheng et al., 2010), which adds additional complexity to 
treatment.  
Among these are pharmaceuticals (Wallace, 2010; Stumpf & Copeland, 2014), as 
well as exposure to environmental chemicals, such as rotenone, cyanide and other 
RC inhibitors which can interact with the genetic risk factors and trigger or aggravate 
the disease. 
Mitochondrial dysfunction has been implicated in several psychiatric diseases 
including autism spectrum disorders (Prabakaran et al. 2004; Rossignol & Frye, 2012), 
and neurological disorders such as Rett syndrome (Dotti et al., 1992). Five percent 
of children with autism spectrum disorder meet mitochondrial disease criteria 
(Rossignol & Frye, 2012). Such associations are extremely important as patients may 
benefit from treatments focused on addressing mitochondrial functionality. 
Mitochondrial dysfunction has also been linked with infertility (reviewed in Wallace, 
1999). mtDNA mutations are found in a wide spectrum of cancers (Polak et al., 1998; 
Ishikawa et al., 2001; Copeland et al., 2002; Tan et al., 2002), but it remains unclear if 
the mtDNA mutations influence carcinogenesis and if mtDNA plays a crucial role 
in the development of cancer. More work is needed to understand the significance 
of specific mitochondrial mutations in cancer and disease progression. (Ishikawa et 
al., 2001; Chatterjee et al., 2006). Acquired mtDNA mutations and mitochondrial 
dysfunction are also proposed to be involved in aging and age-related diseases such 
as diabetes (Mootha et al., 2003). Mitochondrial dysfunction is also observed in 
chronic periodontitis (Govindaraj et al., 2001; Pallavi et al., 2016).  
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2.1.4 mtROS and their role in cell signaling 
Oxygen and any other compound potentially capable of accepting electrons is 
described as a pro-oxidant. In biological systems the most important pro-oxidants 
are ROS. ROS are byproducts of aerobic life (Davies, 2000) and can be split into two 
groups of compounds, radicals and nonradicals. Radicals include the nitric oxide 
(NO), superoxide ion (O•−), hydroxyl (OH•), peroxyl (ROO•) and alkoxyl radicals 
(RO•). The group of nonradical compounds considered as ROS include 
hypochlorous acid (HClO), hydrogen peroxide (H2O2), organic peroxides, 
aldehydes, ozone (O3), and O2 itself (Kohen & Nyska, 2002). Low amounts of ROS 
are necessary to maintain different cell signaling systems (Schieber & Chandel, 2014; 
Mittler, 2017). In the 1980s, Sies (1985, 1986, 1991) proposed the oxidative stress 
concept. He described it as an imbalance between oxidants and antioxidants in favor 
of the former. The high reactivity of ROS makes them perfect signaling molecules 
(reviewed by D'Autréaux & Toledano, 2007), influencing many biological processes, 
such as proliferation (Szatrowski & Nathan, 1991; Preston et al., 2001), apoptosis, 
immunity, defense against microorganisms and autophagy (reviewed by Scherz-
Shouval & Elazar, 2007). 
ROS produced by mitochondria are termed mtROS. They act as signaling 
molecules in both normal physiology and in disease etiology (Cadenas & Davies, 
2000; Finkel & Holbrook, 2000; Schieber & Chandel 2014; Mittler, 2017).  
There are many oxidative stress-responsive transcription factors and genes and 
some of these have been implicated in influencing the aging processes. The effect of 
ROS on expression and activity of transcription factors is complex and occurs at 
multiple levels. For example, although ROS generally cause an increase in AP-1 and 
NF-κB levels (Pinkus et al., 1996), oxidative stress can at the same time decrease the 
transcriptional activity of these molecules through the direct oxidation of critical 
cysteine residues contained within the DNA-binding domain (Schenk et al., 1994; 
Meyer et al., 2015). The concentration of ambient oxygen influences embryonic 
development (Allen, 1991) as well as ROS generation (Turrens et al., 1992). 
Superoxide dismutase (SOD) activity increases during human fetal development in 
liver, blood and placenta, and during differentiation of monocytes (Allen, 1998). 
Macrophages and neutrophils create ROS which serve as bactericidal, anti-viral, and 
anti-tumor agents (Lander, 1997). Autophagy also depends on ROS (reviewed in 
Scherz-Shouval & Elazar, 2007; Moore, 2008; Azad et al., 2009) and, in turn, serves 
to decrease oxidative damage (Wu et al., 2009; Yang et al., 2014). 
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The RC is the major source and paradoxically the major target of ROS. Even 
though the RC is considered to be very efficient in passing electrons, several iron-
sulfur clusters within the respiratory chain are exposed and vulnerable to toxic, side 
reactions with oxygen and can produce superoxide (O2•−) (reviewed by Cadenas & 
Davies, 2000). As a by-product of normal RC activity, the RC is able to participate 
in one-electron reduction of oxygen leading to the formation of superoxide anion-
radical. As mentioned, the most susceptible sites for ROS damage are thiol groups 
and iron-sulfur clusters. The latter are specifically damaged by superoxide anion-
radicals, which are mainly produced at complex I, which contains ROS-sensitive 
thiols and many iron-sulfur clusters (Turrens et al., 1980) as well as complex III, 
which also contains iron-sulfur clusters (Finkel & Holbrook, 2000). Similar damage 
can also affect complex II (Quinlan et al., 2012; Moreno-Sánchez et al., 2013) and 
other sites in the mitochondrion. The α-ketoglutarate dehydrogenase enzyme 
complex (KGDHC) in brain mitochondria produces ROS in the mitochondrial 
matrix when the NADPH/NADP+ ratio there is elevated (Starkov et al., 2004). 
Complexes IV and V do not contain flavins or iron-sulfur clusters and thus are not 
sites of ROS production.  
ROS need to be well regulated in order to prevent oxidative damage in the cell. 
As signaling molecules, ROS can oxidize factors in a variety of pathways that lead to 
growth and survival, by altering enzyme activity, cellular localization, and protein-
protein interactions (reviewed by Schieber & Chandel, 2014). This involves different 
molecular targets, including protein kinases (Nogueira et al., and phosphatases 
(Hecht & Zick, 1992; Hamanaka & Chandel, 2010), transcription factors 
(Kohlgrüber et al., 2017), e.g., nuclear factor kappa B (NF-κB) (Flohé et al., 1997; 
Pateras  et al., 2014), NF-E2-related factor 2 (NRF2) (Mimura & Itoh, 2015), 
activator protein 1 (AP-1) (Abate et al.,1990; Amstad  et al., 1992), E26 avian 
erythroblastosis virus transcription factor-1 (ETS-1) (Shiu et al., 2018), Sister-of-
Mammalian Grainyhead (SOM) involved in neural tube closure, wound healing, and 
epithelial cell migration, cell-cycle regulators and membrane lipids (Gustavsson et al., 
2007; Caddy et al., 2010) and many others.  
Redox changes work through oxidation or reduction of protein sulfhydryls which 
induces conformational changes. In turn this alters the properties of proteins, such 
as DNA binding activity (Abate et al., 1990, Hecht & Zick, 1992), interactions with 
regulatory subunits, or the formation of protein complexes, which may be necessary 
for signal transduction or transcription to proceed.  
The mitochondrial RC controls a number of physiological and pathological 
cellular responses in part by producing mtROS. Much of this superoxide is rapidly 
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converted to H2O2 by mitochondrial superoxide dismutase (SOD2) as well as by 
cytoplasmic superoxide dismutase (SOD1). H2O2 is able to oxidize cysteine residues 
in proteins to cysteine sulfenic acid or to form disulfide bonds within or between 
proteins (Schieber & Chandel, 2014). This can upregulate cell signals generated, for 
example, by growth factors and hormones such as insulin (Cheng et al., 2010; Loh et 
al., 2009). Oxidative deactivation of catalytic cysteines in the active sites of protein 
tyrosine phosphatases like the tumor suppressor PTEN influences cell migration, 
growth, and survival (Lee et al., 2002; Hopkins et al., 2014).  
2.1.4.1 ROS-induced molecular damage 
Accumulation of ROS leads to oxidative stress where cellular constituents, including 
proteins, DNA and lipids are oxidized and suffer damage. The protonated form of 
the superoxide anion and the hydroxyl radical commonly initiate the process of 
autocatalytic lipid peroxidation. ROS react with the acyl moiety of lipid molecules. 
Polyunsaturated fatty acids are more susceptible to ROS attack, since the 
hydroperoxyl radical reacts more readily with acyl chains compared to a carbon-
carbon double bond. 4-hydroxy-2-nonenals (4-HNE) is considered a biomarker for 
oxidative stress and mediates a number of signaling pathways (Zhong & Yin, 2015). 
The net result of lipid peroxidation is conversion of unsaturated lipids into polar 
lipid hydroperoxides, which causes increased membrane fluidity, efflux of cytosolic 
solutes and loss of membrane-protein activities (Avery, 2011). Brain mitochondria 
have a higher concentration of lipids with polyunsaturated acyls, which are therefore 
more sensitive to free radical oxidation than any other lipids (Bolanos et al., 1997).  
Oxidation of the mitochondrial phospholipid cardiolipin leads to formation of 4-
HNE and other oxidation products (Yin & Zhu, 2012; Zhong et al., 2014). Oxidation 
of cardiolipin in turn has diverse consequences: it regulates apoptosis (Kagan et al., 
2005), leads to mitochondrial dysfunction, mitophagy (Chu et al., 2013) and human 
diseases (Paradies et al., 2009).  
Ribo- and deoxyribonucleic acids are also subjected to oxidative damage. DNA 
damage can be grouped into: strand breaks (single and double), sister chromatid 
exchange, DNA-DNA and DNA-protein cross-links, and base modifcations. All 
four bases can be altered which may lead to apurinic/apyrimidinic (AP) sites. ROS-
mediated DNA sugar and phosphate damage creates strand breaks (reviewed in 
Davies, 2000). DNA damage itself can result in elevated ROS generation (Hamanaka 
& Chandel, 2010; Kang et al., 2012). Direct oxidation of side chains of cysteine, 
tyrosine, histidine, arginine, and lysine residues, which are among the most 
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susceptible to ROS damage, results in the addition of reactive carbonyl functional 
groups on proteins, of which aldehydes are the most reactive (Suzuki et al., 2010). 
Oxidation of enzymes often leads to their inactivation. However, not all enzymes are 
equally susceptible to oxidation. For instance, glucose 6-phosphate dehydrogenase 
is considered to be among the most susceptible (Lushchak & Gospodaryov, 2005).  
2.1.4.2 ROS defense mechanisms in the cell 
ROS production is a by-product of oxidative metabolism. Therefore, all aerobes 
have had to develop defenses to resist or repair the damaging effects of ROS over 
the course of the 1.5 billion years of obligate endosymbiotic co-evolution. During 
this time mitochondria have developed a defense system to deal with oxidative stress 
similar to that of their cellular host (Zhong & Yin, 2015). However, excessive 
antioxidant defense when aerobes emerged would have limited subsequent evolution 
by protecting their DNA from mutations (Harman, 1981). There are four subclasses 
of antioxidant defense systems: (i) primary antioxidant defense (deals directly with 
ROS): superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione 
reductase (GR) and catalase (CAT), (ii) additional defenses that support primary 
antioxidant defense, including metal/protein complexes such as ferritin, transferrin, 
ceruloplasmin, metallothionein and low molecular weight antioxidants such as 
ascorbate, melanin, melatonin and uric acid, (iii) nonenzymatic dietary antioxidants 
such as vitamin E, carotenoids and plant polyphenols and (iv) enzymes that repair 
biomolecules damaged by ROS (Storey, 2004). For example, there are three major 
detoxification pathways to convert the lipid peroxidation (LPO) product, 4-HNE to 
less reactive chemical species: aldo-keto reductases (AKRs) or alcohol 
dehydrogenases (ADH) and aldehyde dehydrogenase (ALDH). AKRs and ADH are 
present in mitochondria. ALDH2, one member of the ALDH family, is exclusively 
located in mitochondria. (Zhong & Yin, 2015). Manganese-dependent superoxide 
dismutase (MnSOD, SOD2) converts superoxide anion into H2O2. This itself can 
lead to the generation of reactive species which can be damaging to lipids, DNA and 
proteins. Glutathione (GSH) serves as a buffer to minimize creation of harmful 
molecules and is one of the most important hydrophilic antioxidants in mitochondria 
(Hosamani & Muralidhara, 2013; Zhong & Yin, 2015). Glutathionylation has a key 
role in detoxifying mitochondria from the H2O2 produced by the RC under 
conditions where complex III is interrupted, thus protecting against the generation 
of oxidative stress (Garcia-Ruiz et al., 1995). One frequently employed mechanism 
to decrease mtROS production is to increase the rate of metabolic uncoupling. The 
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uncoupler-like proteins UCP2 and UCP3, located in the IMM, have been found to 
serve as proton channels through which protons pass from the intermembrane space 
to the mitochondrial matrix. This results in dissipation of the proton gradient across 
the membrane, and partial conversion of the membrane potential into heat. 
Uncoupling proteins (UCPs), notably the canonical UCP1, become abundant in 
mitochondria of animal tissues during prolonged cold periods, and are also present 
in heat-producing mitochondria of brown fat. UCP2 and UCP3 are proposed to 
decrease ROS emission from mitochondria (Guzman et al., 2010; Toime & Brand, 
2010; Mailloux et al., 2011).  
ROS defense can be compromised by either genetic mutations which impair the 
activity of the antioxidants, e.g., familial cases of amyotrophic lateral sclerosis (ALS) 
with a mutation in CuZn SOD (SOD1, Mariani et al., 2005), or by increased radical 
production (Trushina & McMurray, 2007). In both cases oxidative stress will damage 
cellular function (Hamran, 1956). Such damage is also associated with a number of 
age-related diseases, including atherosclerosis, arthritis, muscular dystrophy, macular 
degeneration, insulin resistance associated with type 2 diabetes, pulmonary 
dysfunction, various neurological disorders, different types of cancers, 
cardiovascular diseases, and psychiatric diseases, including depression, autism and 
schizophrenia (Brieger et al., 2012). Under pathophysiological conditions mtROS can 
initiate and promote cancer but can also serve as an Achilles’ heel in tumor therapies 
(Sabharwal & Schumacker, 2014). mtROS can also initiate the production of Aβ (the 
beta amyloid peptide implicated in Alzheimer’s disease) in vitro and in vivo (Leuner et 
al., 2012) and aging itself is associated with long term exposure to oxidative stress 
(Harman, 1956). However, there are reports that oppose the association between 
increased ROS and aging and this seems paradoxical. A lifespan-promoting role of 
ROS has been termed as mitohormesis and is believed to be behind increased 
lifespan mediated by caloric restriction (Ristow & Zarse, 2010). Hormesis is a 
“process in which a low dose of a chemical agent or environmental factor that is 
damaging at higher doses induces an adaptive beneficial effect on the cell or 
organism” (Mattson et al., 2008). The generation of ROS also occurs through 
exposure to numerous exogenous agents and biological events including ionizing 
radiation, UV, cytokines, growth factors, chemotherapeutic drugs, environmental 
toxins and hyperthermia (Salmon et al., 2007).  
Changes in the cellular redox equilibrium may also influence developmental 
pathways in a variety of tissues from phylogenetically diverse organisms (Sohal et al., 
1996). Increased ROS generation plays a role in cell differentiation (and a decrease 
in protein glutathionylation) (Sohal & Allen, 1986; Sohal et al., 1996). SOD activity 
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increases during metamorphosis of the fruit fly Ceradtitis capitatae (Fernandez-Souza 
& Michelson, 1976). MnSOD activity increases during neonatal rat brain 
development (Mavelli et al., 1982) and during monocyte transformation into 
macrophages in humans (Nakagawara et al., 1981). ROS can act as secondary 
messengers in cellular pathways which protect against, or repair damage (Ristow & 
Schmeisser, 2011, Yee et al., 2014). Increased mtROS in the cell is believed to induce 
an adaptive reaction, e.g., the mitochondrial unfolded protein response (UPRmt) 
which leads to resistance to stress and eventually decreases oxidative stress (Yoneda 
et al., 2004; Runkel et al., 2013; Nargund et al., 2015).  
Ferroptosis is a form of regulated cell death driven by iron-dependent lipid 
peroxidation with preferential oxidation of phosphatidylethanolamine (Kagan et al., 
2017). Loss of lipid repair enzyme, gluthatione peroxidase 4 (GPX4), which reduces 
hydroperoxides of polyunsaturated fatty acids (PUFA) and phospholipids (Imai & 
Nakagawa, 2003), leads to accumulation of lipid hydroperoxides and to fatty acid 
radical generation, causing plasma membrane damage and ferroptotic cell death 
(Yang et al., 2016; Agmon et al., 2018). Where and how fatty acid radicals are 
generated is not known (Friedmann Angeli et al., 2014; Gao et al., 2018), but 
accumulation of lipid hydroperoxides is iron-dependent. Iron chelators are found to 
block ferroptosis (Dixon et al., 2012), explaining the term chosen for this type of cell 
death. 
It is not known if mitochondria are involved in ferroptosis. What we know is that 
cells undergoing ferroptosis exibit electron-dense mitochondria and OMM rupture. 
Both morphological and chemical changes occur in mitochondria and contribute to 
ferroptosis (Friedmann Angeli et al., 2014). Mitochondrial permeabilization in 
ferroptosis is not dependent on BAX/BAK and BCL2 which are involved in 
apoptotic cell death (Dixon et al., 2012). However, when mitochondria are depleted 
via mitophagy, cells become more resistant to ferroptosis (Gao et al., 2019), 
demonstrating that the mitochondrion is a crucial player in ferroptosis. 
Given that the role of ROS in the cell is complex, the redox effects of cellular 
manipulations are context- and organism-dependent. 
2.2 Drosophila development and its regulation 
Metazoan development involves the coordinated activity of signaling pathways to 
regulate gene expression. This controls and executes the program of cell division, 
differentiation and cell deaths that shape the animal and its component parts, as it 
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matures. Drosophila is one of the classic model organisms in which this process has 
been studied. 
The Drosophila life cycle comprises embryogenesis, three larval stages, a pupal 
stage, and the adult stage. Embryogenesis occurs during the first day of the life cycle 
(after egg laying), and it involves segmentation, gastrulation and organogenesis. 
During development, a majority of animals first develop small versions of their adult 
body structures, followed by size increase. The development of Drosophila and of 
many insects as a whole differs. Embryogenesis gives rise to the larva, which 
represents a highly modified and typically simplified version of the adult body plan. 
During the larval stages, precursor structures are set aside as imaginal discs, that will 
develop later into the adult body components. Clusters of imaginal disc precursor 
cells invaginate from the embryonic epithelium and form these structures during 
larval development. The embryonic imaginal-disc precursor cells are in a G0-like 
quiescent state, but start dividing rapidly during larval growth (Duronio, 1999). 
Larvae feed and increase cell mass to the point where this triggers reactivation of the 
cell cycle (Edgar & Lehner, 1996). These precursors give rise to the imaginal discs, 
which are protected in the larva but do not develop further until the pupal stage, 
when they do not simply grow, but will be greatly transformed during 
metamorphosis. Imaginal discs consist of a single-layered epithelium adjoining the 
epithelium of the larval epidermis (Poodry & Schneiderman, 1970). If imaginal discs 
are dissociated, the integrity of the epithelium is destroyed (Poodry et al., 1971). 
There are 20 imaginal discs which develop their internal pattern as the larva grows. 
At metamorphosis, they evert (turn inside out), extend, and differentiate to form the 
epidermal layer of the adult fly body, including its appendages (wings, legs, eyes, 
halteres, and genitals). To form the thorax of the adult, migrating cells from pairs of 
contralateral discs eventually meet and fuse, joining also to the adjacent ipsilateral 
discs to form a continuous epithelium (Poodry et al., 1971). Cell identity within 
imaginal discs is controlled by position along the major body axes, e.g., 
anterior/posterior. Decapentaplegic (Dpp) and Wingless (Wg) are morphogens that 
pattern cell types along the dorsal/ventral and anterior/posterior axes, respectively, 
and are involved in growth and proliferation of imaginal cells (Duronio, 1999). In 
addition to the discs, other imaginal structures include histoblast nests, which will 
form the abdominal epidermis, and small groups of cells that will give rise to the gut 
or salivary glands (Cohen et al., 1993). 
Postembryonic development is controlled by fluctuations in the level of the 
steroid hormone 20-hydroxyecdysone (20E), traditionally called ecdysone. These are 
known as ecdysone pulses. Each pulse causes different developmental events by 
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activating stage- and tissue-specific gene expression programs (Riddiford, 1993). 
During the early stages of metamorphosis, most of the larval tissues go through 
programmed cell death in a process termed histolysis. Histolysis is followed by 
developing new structures through morphogenesis and differentiation that will make 
an adult fly (Baehrecke, 1996). Post-embryonically, larvae mature and grow using 
two modes of cell-cycle progression: the canonical G1-S-G2-M cell division cycle 
and the endoreduplication, or 'endo', cycle. Larval tissues that will not contribute to 
adult structures typically grow via the 'endo', cycle where DNA is replicated 
repeatedly without nuclear or cell division (Duronio, 1999).  
2.2.1 Signaling pathways regulating growth and cell migration during 
development 
To shape the structures of the organism, different cells initiate or cease proliferation 
at defined times during development. Mechanisms that coordinate growth, 
patterning, and cell proliferation in developing tissues are evolutionarily conserved 
and regulated by many of the same signaling pathways in vertebrates and Drosophila 
(Edgar & Lehner,1996), e.g., during mid-embryogenesis. These signaling pathways 
are highly interconnected, creating a vast diversity of cellular responses that are 
executed by relatively few signaling pathways: NF-κB Wingless/Wnt, receptor 
tyrosine kinase/extracellular regulated kinase (RTK/ERK), Jak-STAT, Akt/Tor, 
Notch, TGF-β, G protein coupled receptors (GPCR), Hedgehog, Toll, and steroid 
hormone pathways (Friedman & Perrimon, 2007). Output from the downstream 
transduction network will depend on the context, and the intensity and duration of 
signaling (Housden & Perrimon, 2014). For simplicity, I will briefly introduce some 
of the developmental pathways of the fly, which is the model organism used in most 
of my study, focusing on aspects that are important for the discussion of this thesis. 
I will also refer, in passing, to relevant studies on other organisms. 
Receptor tyrosine kinase (RTK) signaling has many functions during 
development. Particularly important are RTKs activated by fibroblast growth factors 
(FGFs), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), 
platelet-derived growth factor (PDGF), and glial cell line-derived growth factor 
(GDNF). Signaling malfunctions in these pathways causes a range of developmental 
disorders (Basson, 2012) in humans, including cancer. 
The mitogen-activated protein kinase (MAPK) cascades are central signaling 
pathways that regulate proliferation, differentiation, apoptosis, stress responses, cell 
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migration and survival.  Each cascade consists of three core protein kinases: MAP 
kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAPK, 
additionally accompanied by upstream MAP kinase kinase kinase kinase (MAP4K) 
and downstream MAP kinase-activated protein kinase (MAPKAPK) components. 
Within each of the cascades, the signal is propagated by phosphorylation and 
activation of the sequential kinases, eventually leading to the phosphorylation of 
target regulatory proteins by the MAPK and MAPKAPK components (Flores et al., 
2018). There are four different mammalian MAPK cascades named according to 
their MAPK components, as follows: extracellular signal-regulated kinase 1 and 2 
(ERK1/2), c-Jun N-terminal kinase (JNK), p38, and ERK5 (Kyriakis & Avruch, 
2001). After stimulation, the MAPK, as well as the MAPKAPK components 
phosphorylate different substrates in many cellular locations, and these are 
responsible for initiating diverse cellular processes, such as proliferation, 
differentiation, fate determination, neuronal plasticity, survival, and under some 
conditions stress responses and apoptosis (Yoon & Seger, 2006; Plotnikov et al., 
2011). The JNK subgroup of MAPKs have been implicated in morphogenetic events 
in both mouse and Drosophila (Pai et al., 2012) development. 
Steroid hormones work by binding to nuclear receptors, which activate 
transcription in a ligand-dependent manner (Bai et al., 2000). They have a role in 
stimulating invasive cell behavior, independent of effects on proliferation, as well as 
many other physiological and developmental processes. Dysregulation of steroid 
hormones or of nuclear receptor signaling in general, are major underlying factors in 
diseases such as metastasis of breast and ovarian cancer, because of effects on cell 
migration (Anzick et al., 1997; Bai et al., 2000). The maturation process in both insects 
and vertebrates is triggered by rises in hormone titres, and transduced by members 
of the nuclear-receptor superfamily. These functions are primarily controlled by 
thyroid hormone and sex steroids in vertebrates, whereas in holometabolous insects 
such as Drosophila melanogaster, genetic regulation of maturation occurs during 
metamorphosis and is triggered by rises in the ecdysone. (King-Jones & Thummel, 
2005). The ecdysone receptor is a heterodimer composed of Ultraspiracle (Usp) and 
the Ecdysone receptor (EcR). Usp is a member of the nuclear hormone receptor 
superfamily, considered as the fly retinoid X receptor (RXR) homolog. Amongst 
many roles, ecdysone regulates border cell migration. Border cells are groups of 
follicle cells in the Drosophila ovary and are a model system to the study cell motility 
(King, 1970; Montell, 1999). Border cells lacking Usp are unable to migrate (Oro et 
al., 1992) and defects in border cell migration lead to a failure of fertilization (Montell 
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et al. 1992). Recessive lethal usp mutations exhibit a heterozygous phenotype of cleft 
thorax (Henrich et al., 1994).  
Cleft thorax is a midline closure defect arising from a failure of cell migration, 
affecting the thorax and/or scutellum, the latter being a shield-like plate at the 
posterior of the mesothoracic tergum. Depending on its causes, the severity of 
clefting can range from mild to severe. The cleft may arise either from the improper 
fusion of the discs along the dorsal midline of the notum, or a mutant effect on cells 
lying along the midline of the mesothoracic disc. Affected flies also exhibit bent and 
misshapen sensory bristles and severely enlarged legs (Henrich, 1994). 
AMP-activated protein kinase (AMPK) is best known as a regulator of cell 
metabolism, maintaining the balance between ATP production and consumption in 
all eukaryotic cells because it senses cellular energy levels (Hardie, 2007). In addition, 
AMPK maintains polarity in epithelial cells (Hardie, 2007) and regulates cell 
migration by controlling microtubule (Nakano et al., 2010) and actin cytoskeleton 
dynamics and reorganization at the plasma membrane (Bae et al., 2011; 
Kondratowicz et al., 2013). AMPK activators are currently in clinical use to inhibit 
cell migration. However, the underlying mechanism is unknown (Yan et al., 2015). 
2.3 Cell migration 
Anthony van Leeuwenhoek was the first to observe and report cell movement in 
1674 (see Risler, 2009). Cell migration is necessary for the processes in animal 
development that create the 3D forms of tissues, organs and the whole body, 
described as morphogenesis. Many such processes take place during embryonic 
development, which shape the emerging organism (Stossel, 1993). Cell migration is 
also important in skin and intestine renewal and immune system function. Fibroblast 
and vascular endothelial cell migration is essential for wound healing (Lauffenburger 
& Horwitz, 1996; Montell, 1999). The ability of human spermatozoa to migrate is 
instrumental in fertility (Denissenko et al., 2012). After mammalian fertilization, 
selected cells of the developing embryo migrate to the uterine wall to establish the 
placenta (reviewed by Stossel, 1993). 
Misregulation of cell migration is implicated in diseases such as birth defects, 
cancer metastasis, mental retardation, atherosclerosis, osteoporosis and arthritis 
(Montell, 1999; Davis et al., 2003). It remains a major question in biology to fully 
understand how cells move, or to use Stossel’s (1993) terminology, how do cells 
crawl, when do they start their movement and what are the stop signals, once the 
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destination has been reached. To migrate, cells need to be able to polarize and extend 
two protrusive structures: membrane extensions on the leading edge of the cell called 
lamellipodia and actin-rich plasma-membrane microspikes that extend beyond the 
leading edge of lamellipodia in migrating cells and serve as antennae for cells to probe 
their environment, called filopodia (Ridley et al., 2003; reviewed in Mattila & 
Lappalainen, 2008). Protrusions are driven by actin polymerization, and adhere to 
the extracellular matrix or nearby cells via transmembrane receptors 
(Ananthakrishnan & Ehrlicher, 2007). By protruding in this way, the cell makes a 
traction site towards the migration point and releases the traction from the rear end. 
Protrusions are made by membrane movements which are believed to occur by an 
'elastic Brownian ratchet' mechanism, in which thermal energy bends the nascent 
short filaments, storing elastic energy (Mogilner & Oster, 1996; Mogilner & Oster, 
2003; Ananthakrishnan et al., 2007). At a point in time when the plasma membrane 
(PM) is most distant from the filament end, a new monomer of actin can be added. 
Consequently, the PM is no longer able to return to its former position since the 
filament is now longer. The filament cannot be pushed backwards by the returning 
PM as it is locked into the mass of the cell cortex by actin binding proteins. In this 
way, the PM is permitted to diffuse only in an outward direction (Ridley et al., 2003; 
Maciver, 2001). Cell migration is a cyclic process of protrusion, adhesion to the 
substrate, contraction of the cell body, and rear retraction (Abercrombie et al., 1971). 
Collective migration is defined as the ability of groups of cells to move together while 
tightly connected and influencing one another on their way (Rørth, 2012; Theveneau 
& Mayor, 2012). Both epithelial and mesenchymal cells can migrate collectively and 
interact with their extracellular environment during migration. Leader cells express 
different genes compared with internal and follower cells (Rørth, 2012). Epithelial 
cells maintain cell-cell adhesions. Leader cells form protrusions oriented in the 
direction of migration, whereas followers form smaller cryptic protrusions. 
Mesenchymal cells migrate directionally as a collective, but they form only transient 
cell-cell connections. Epiboly, neural tube closure and embryonic wound healing in 
vertebrates, ventral enclosure in Caenorhabditis elegans, and dorsal closure of the 
Drosophila embryo are morphogenetic movements that occur because of epithelial 
cell sheets being able to collectively migrate, spread and fuse (Bard, 1990). 
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2.3.1 Cell migration in Drosophila; single cell migration and epithelial sheet 
movement 
During embryogenesis of the fruit fly a complex cell migration takes place. In the 
embryo, migrating cells are: primordial germ cells (PGCs), cells of the tracheal 
system, hemocytes, the fly’s phagocytic cells (Montell, 1999), and border cells (King, 
1970). Border cell migration resembles the migratory behavior of human ovarian 
cancer cells, serving as a model to study molecules that promote spreading of human 
ovarian cancer (Yoshida et al., 2004). Neuronal and glial cells go through limited cell 
migration to establish axonal pathways (Klambt et al., 1991). Gastrulation involves 
massive cellular movements of the germ layers (Leptin, 2005), germ band retraction 
and dorsal closure, described in more detail in the next sub-section. The mechanisms 
that decide which cells become migratory and how cells physically move are poorly 
understood. 
2.4 Drosophila dorsal closure and thorax closure; JNK signaling 
role 
Dorsal closure (DC) is one of the most studied processes involving epithelial 
movement and fusion in metazoans, and has been employed as a model system to 
study wound healing (Harden, 2002) and movement of epithelial cell layers in general 
(Knust, 1997). 
DC begins in the middle of embryogenesis and lasts approximately two hours 
(Campos-Ortega & Hartenstein, 1985). The DC process goes through three phases 
(Noselli, 1998). First, dorsally located epidermal cells, leading-edge (LE) cells, 
elongate along the dorsoventral axis (Fig. 1 A). JNK signaling activation is restricted 
to LE cells during DC (Noselli, 1998). JNK activates the morphogen Dpp in the LE 
which controls the migration of the more lateral cells (Fig. 1 B). Third, LE cells from 
both sides meet on the dorsal surface and form the midline (Knust, 1996) (Fig. 1 C). 
DC relies exclusively on cell elongation. There is no cell proliferation or recruitment 
in this process (Young et al., 1993). 
DC is supported by apoptosis in the amnioserosa (Toyama et al., 2008). Apoptosis 
provides part of the force which drives DC (Toyama et al., 2008) and gives 
mechanical tension in wound healing which helps tissue reconstruction (Rosenblatt 
et al., 2011).  
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There are mutations which disturb different stages of DC (Knust, 1996). Mutants 
with defects in DC are described as 'dorsal open' because the mutant phenotype 
resembles a hole on the dorsal surface which reflects the failure of the movement of 
the lateral ectoderm. Mutations in core JNK signaling genes, DJNKK gene 
hemipterous (hep, JNKK, Glise et al. 1995) and DJNK basket (bsk, JNK, Riesgo-Escovar 
et al., 1996) disrupt DC because LE cells cannot form filopodial and lamellipodial 
protrusions. The core signaling module of JNK signaling consists of JNKK (Hep) 
which when activated phosphorylates JNK (Bsk) (Glise et al., 1995), which gets 
activated and phosphorylates Jun (Jra) (Riesgo-Escovar et al., 1996; Sluss et al., 1996) 
and Fos (Ciapponi et al., 2001). Jun (Jra), together with Fos (Kay) form the AP-1 
transcription factor which then activates JNK target genes and contributes to 
expression of TGF-β family protein Dpp in the leading edge of epithelial cells (Hou 
et al., 1997). Dpp then contributes to elongating the lateral edge of the embryo. 
During DC, the JNK signaling pathway is activated in the LE by an unknown signal. 
Another known target of JNK is Drosophila MAPK phosphatase Puc (Martín-Blanco 
et al., 1998). Puc controls JNK signaling in the LE (Martín-Blanco et al., 1998) by 
negative feedback, which is important to stop cell movement at the end of the 
process (Noselli & Agnès, 1999). In addition to specific mutants in JNK signaling 
that exhibit a dorsal-open phenotype and fail to complete embryogenesis, others do 
not complete disc eversion or are not able to fuse discs during metamorphosis 
(Pastor-Pareja et al., 2004).  
Apart from the JNK signaling pathway, there are other genes which can be 
mutated to generate the dorsal-open phenotype. These encode proteins involved in 
a variety of cellular processes, including components of the cytoskeleton (e.g., 
zipper), membrane proteins (coracle, yurt), cell adhesion proteins (shotgun, 
armadillo, myosheroid, scab) and extracellular matrix proteins such as pericardin 
(Simonova & Burdina, 2009). 
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Figure 1.  Dorsal and thorax closure in Drosophila. (A-C) Dorsal closure. (A) At embryonic stage 13, 
the epidermis covers the ventral and lateral sides of the embryo, while the amnioserosa 
(pink) covers the dorsal side. LE- leading edge (yellow). (A, B) Filopodial and lamellipodial 
protrusions on LE cells (yellow) during DC (Jacinto et al., 2000). (B) During the second 
stage, the epidermis moves dorsalward (dashed arrows), followed by elongation of the 
cells in the LE and lateral cells. (C) At the end of DC (embryonic stage 15), the two LE 
(yellow) meet at the dorsal midline and the cells fuse. (D-G) Dorsal thorax development. 
(D) The cells at the margin of the larval wing disc proper (red) will attach to other imaginal 
discs and form the continuous adult epidermis. (E-G). (D) In third instar larvae, the wing 
imaginal disc is attached to the larval body wall by the peripodial stalk (ps). During 
pupariation the disc epithelium everts through the widened peripodial stalk (upper arrow) 
and spreads inside the pupal case to replace the larval epidermis. At the same time, the 
wing blade develops through invagination of the disc epithelium (lower arrow). (E) At 6 
hours after puparation (AP), the dorsal parts approach each other (arrows) and attach to 
each other. The disc margin on the ventral side (dashed line) attaches to the leg discs to 
complete the ring-like structure of the thorax complex. (F) At around 8 hours AP, the 
anterior part of the future notum folds inside (arrow and dashed line), presumably to attach 
to the eye-antennal imaginal disc before it moves anteriorly. (G) At 9 hours AP, during 
head eversion (arrow), the wing imaginal disc is attached to all its neighbor imaginal discs: 
anteriorly to the eyeantennal disc (ea) and the dorsal prothoracic disc (dp), and posteriorly 
to the abdomen (a) and haltere disc (h). The border between them is marked in red. The 
final shape of the notum is obtained with further tissue movements. The scutellum (s) 
presumably forms by a dorsoposterior protrusion. Starting during pupariation dorsal parts 
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of two imaginal wing discs migrate until they finally attach to each other (black arrows). 
The expression domain of pannier (pnr, green) marks the dorsalmost stripe of the future 
adult epidermis. The pnrMD237 GAL4 driver used in the experimental work of this thesis has 
the same expression pattern. Modified from Zeitlinger & Bohmann (1999); Simonova & 
Burdina (2009). 
Along with JNK- and dpp-signaling, the Notch signaling pathway regulates DC. 
Notch mutants may partially restore the phenotype caused by the abnormalities of 
the JNK pathway (Zecchini et al., 1999). It is believed that the transmembrane 
receptor Notch negatively controls one of the probable alternative signaling 
pathways (probably, MAPK), which is able to partially compensate for the loss of 
JNK signal in relevant mutants. 
2.4.1 Differences between dorsal and thorax closure 
Thorax closure starts at the anterior end of the wing disc, proceeds through the most 
posterior region, and, finally, fills the gap (Martín-Blanco et al., 2000). JNK and dpp 
signaling mechanisms during thorax closure resemble those involved in DC, but with 
some differences (Zeitlinger & Bohmann, 1999; Martín-Blanco et al., 2000; Pastor-
Pareja et al., 2004). Imaginal cells are brought together by spreading over the larval 
epidermis in a process mediated by the extension of filopodia, which seem to pull 
the contralateral epithelial sheets toward the midline. JNK signaling is involved in 
both cell spreading and imaginal disc fusion (Martín -Blanco et al., 2000), while Dpp 
participates in the regulation of the actin cytoskeleton of cells at the imaginal LE and 
the maintenance of cell polarity (Ricos et al., 1999). However, there are some 
differences between dorsal and thorax closure illustrated in Fig. 2. During embryonic 
DC, the amnioserosa and the epidermal cells maintain their relative positions and, 
despite occasional delaminations, amnioserosa cells remain in place until the very 
end of the process. They detach from the overlying epidermis only when closure is 
completed, and undergo apoptosis. During disc spreading that leads to thoracic 
closure, imaginal cells crawl over the larval epidermis (Fig. 2). In this process, larval 
cells are left below and behind and eventually delaminate from the edges (Martín-
Blanco et al., 2000). 
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Figure 2.  Dorsal and thorax closure differences. Embryonic DC starts with the stretching of 
epidermal cells (green) and the simultaneous contraction of the apical ends of 
amnioserosa cells (pink). Amnioserosa and epidermis remain continuous during the whole 
process remaining in contact with the basal lamina (red). Once DC is finished, 
amnioserosa cells delaminate and undergo apoptosis (gray). During imaginal thorax 
closure, imaginal cells (blue) detach from the basal lamina (red) and using filopodia crawl 
over the larval cells (purple). Here, imaginal cells leave the larval cells behind and larval 
cells subsequently delaminate from the borders of the larval sheet and undergo apoptosis 
(gray). Modified from Martín-Blanco (2000). 
2.5 JNK signaling in mammals; parallels with the Drosophila  
MAPKs are crucial regulators of cell migration and the morphogenetic movement 
of epithelial sheets (Xia & Karin, 2004). JNK signaling pathway is evolutionary 
conserved and it is not surprising that apart from being involved in Drosophila dorsal 
and thorax closure it is also involved in mice in closure of the eyelid, neural tube 
(Sabapathy et al., 1999; Kuan et al., 1999) and optic fissure (Weston et al., 2003). 
Knockout mice for c-Jun have defects in eyelid closure and in fibroblast migration 
during wound healing (Grose, 2003; Javelaud et al., 2003; Li et al., 2003; Zenz et al., 
2003; Weston et al., 2004). c-Jun is essential for embryonic development, as fetuses 
lacking the protein die at mid-gestation with impaired hepatogenesis (Hilberg et al., 
1993). In rodent embryos, following cuts to the skin, c-fos and transforming growth factor 
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beta (TGFβ-1) which are homologs of Drosophila kayak and dpp are activated at the 
edge of the wound (Martin & Nobes, 1992).  
In vertebrates a phenomenon similar to DC occurs, described as embryonic 
wound healing. In contrast to mature individuals, this process does not result in scar 
formation (Martin et al., 1993; Martin, 1997). After a mouse or rat embryo’s skin is 
injured both c-Fos and TGFβ-1 are activated on the edge of the wound. They are 
the homologs of the D. melanogaster genes kayak and dpp, respectively (Martin & 
Nobes, 1992).  
Primary c-Jun-/- fibroblasts have a severe proliferation defect and undergo 
premature senescence in vitro (Johnson et al., 1993; MacLaren et al., 2004). The 
mammalian AP-1 transcription factor regulates the expression of many genes, such 
as those encoding matrix metalloproteinases (MMPs), integrins, cytokines, and 
growth factors (Angel et al., 2001, Yates & Rayner, 2002; Florin et al., 2004), which 
are involved in wound healing. The Scribble (Scrib) complex contributes to epithelial 
cell migration and fusion during both development and wound healing in mammals 
by recruiting the small GTPases Cdc42 and Rac and the serine/threonine kinase Pak 
to the LE of migrating cells (Murdoch et al., 2003; Zarbalis et al., 2004; Humbert et 
al., 2006; Dow et al., 2007; Bahri et al., 2010). The JNK-dependent network of 
transcriptional factors also contributes towards epithelial to mesenchymal transition 
(EMT), a biological process in which cells lose cell-cell adhesion and become 
migratory (Sahu et al., 2015). JNK and the Wnt pathway are main regulators of 
wound repair and tissue regeneration. In wound healing, the actin cytoskeleton (Hall, 
1998; Kaibuchi et al., 1999) is a major JNK target, as well as growth factors. 
Mechanical stretching of the wound-edge cells, loss of cell polarity or necrotic signals 
are reported to be upstream activators of this signaling pathway (Rämet et al., 2002; 
Nelson et al., 2005; Igaki et al., 2006). Expression of Wnt target genes is also 
stimulated by JNK activation to accelerate tumorigenesis (Sancho et al., 2009).  
Developmental morphogenesis, tissue injury, and oncogenic transformation can 
cause the detachment and elimination of epithelial cells by anoikis, a specialized form 
of apoptosis (Girnius & Davis, 2017). Loss of JNK function by epithelial cells may 
lead to survival of these cells in luminal spaces and if these cells accumulate 
additional mutations that may cause cancer. JNK deficiency accordingly enhances 
tumor formation in a model of breast cancer (She et al., 2002; Cellurale et al., 2012; 
Hübner et al., 2012). Two upstream components of the JNK pathway (MAP2K4 and 
MAP3K1) are frequently mutated in human cancer (Stephens et al., 2012, Nik-Zainal 
et al., 2016). However, an overactive JNK pathway also has been shown to cause 
cancer (Smeal et al., 1991; Hui et al., 2008; Barbarulo et al., 2013). This means that the 
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JNK pathway performs opposing functions in oncogenic signaling. Downregulation 
of JNK signaling leads to developmental defects, whilst an overactive JNK pathway 
can lead to cancers (Bubici & Papa, 2014). Abnormal JNK signaling contributes to 
many pathological conditions such as stroke (Wu et al., 2000; Borsello et al., 2003), 
obesity and insulin resistance (Hirosumi et al., 2002), and atherosclerosis (Ricci et al., 
2004). JNK activity has also been implicated in Parkinson’s and Alzheimer’s diseases 
(Zhu et al. 2001; Peng & Andersen, 2003), whilst JNK function is needed for brain 
development, memory and learning (Raivich & Behrens 2006; Waetzig et al. 2006). 
2.5.1 Interplay between JNK signaling and mitochondrial metabolism 
There is a multilayered link between JNK signaling and mitochondria. JNK is a major 
signaling pathway regulating both metabolic (Harris et al. 2002) and apoptotic 
(Kharbanda et al. 2000; Schroeter et al., 2003) functions in mitochondria, linking 
cytosolic and mitochondrial energy pathways. For example, it has been shown that, 
in primary cortical neurons, JNK-induced decline in pyruvate dehydrogenase (PDH) 
activity resulted in the decline of ATP levels and increased lactate concentration 
(Zhou et al., 2008). These observations suggest a shift from aerobic metabolism of 
pyruvate in mitochondria to its anaerobic reduction to lactate in the cytosol with 
concomitant NAD+ regeneration to support glycolysis. JNK may therefore serve as 
an important modulator of mitochondrial bioenergetics, anaerobic respiration and 
cellular ATP levels, regulating mitochondrial electron flow as well as the production 
of ROS from the RC (Zhou et al., 2008). JNK signaling is associated with the 
regulation of mitochondrial pathways of apoptosis following viral infection. After 
reovirus infection, MEKK1 activates JNK, which promotes the release of the 
proapoptotic factors Smac and cytochrome c (Cyt c) from mitochondria, both of 
which contribute to apoptosis (Clarke et al., 2004). Mitochondrial H2O2 has been 
shown to activate JNK in various cell lines upon inhibition of MAPK phosphatase 
or dissociation of the glutathione transferase-JNK complex (Nemoto et al., 2000; 
Chen et al., 2001; Foley et al., 2004). Prolonged JNK activation is believed to play a 
key role in cell injury. For example, apoptosis of auditory neurons as a consequence 
of oxidative damage has been shown to engage the major downstream target of the 
JNK signaling cascade, i.e., c-Jun (Scarpidis et al., 2003). This can be prevented by 
administration of an inhibitory peptide targeted against JNK (Eshraghi et al., 2006). 
Mitochondria produce H2O2 and NO (Cadenas & Davies, 2000; Poderoso et al., 
2000), which are involved in the regulation of redox-sensitive cell signaling through 
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the JNK pathway, thus coordinating functional responses between mitochondria 
and other cellular processes. For example, H2O2 activates JNK at multiple levels by 
mechanisms eliciting dissociation of inhibitory complexes (Saitoh et al., 1998) or 
suppression of phosphatases involved in kinase inactivation (Chen et al., 2001). Nitric 
oxide inhibits JNK activity by S-nitrosylation of a critical cysteine thiol (Park et al., 
2000). In contrast, JNK as a signaling molecule translocates to mitochondria under 
stress conditions (Kharbanda et al., 1997; Aoki et al., 2002) and has direct metabolic 
effects in mitochondria, through the activation of phosphorylation cascades (Zhou 
et al., 2008). This network thus connects cytosolic and mitochondrial processes that 
control energy levels and the redox environment throughout the cell (Zhou et al., 
2008).  
2.6 Alternative oxidase: proposed roles in living organisms 
The alternative mitochondrial respiratory chain contains the alternative NADH 
dehydrogenases (NDX) and quinone oxidases (AOX) (McDonald &Gospodaryov, 
2018). AOX, which is present in most organisms, is a non-proton motive ubiquinol 
oxidase (Berthold & Stenmark, 2003), i.e. it catalyzes the oxidation of ubiquinol and 
consequent reduction of oxygen to water (McDonald & Gospodaryov, 2018), and is 
a branch point in the respiratory electron transport chain, bypassing complexes III 
and IV (McDonald et al., 2009) (Fig. 4). By virtue of this property it dramatically 
decreases ATP production and released energy is dissipated as heat (Rhoads & 
Subbaiah, 2007). AOX is a membrane bound diiron carboxylate enzyme (Siedow et 
al., 1995). Depending on species it can occur as a monomer, homodimer or even 
multimer, with its iron atoms coordinated by glutamic acid residues (Berthold & 
Stenmark, 2003). AOX activity depends on the membrane-bound concentration and 
redox state of ubiquinone, as well as cellular oxygen concentration, and is regulated 
via gene expression or by post-translational modification. In the latter case, cellular 
redox status affects tertiary complex formation, whilst enzymatic activity is 
modulated by the action of allosteric effectors such as pyruvate or other metabolites. 
The ratio of oxidized to reduced protein varies considerably between species and 
tissues. In plant mitochondria, metabolites such as pyruvate, hydroxypyruvate and 
glyoxylate can activate AOX (Sluse & Jarmuszkiewicz, 1998).  
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Figure 3.  Mitochondrial respiratory electron transport chain showing AOX, which is a branch point at 
the level of ubiquinol. Electron flow from ubiquinol to complex IV (reducing O2 to H2O) is 
coupled to proton transport (at two sites) while electron flow from ubiquinol to AOX 
(reducing O2 to H2O) is not coupled to proton transport. Complexes I, III and IV pump  
protons (H+) across the IMM to the IMS, generating a proton gradient which is used by 
complex V to produce ATP. IMS, intermembrane space; IMM, inner mitochondrial 
membrane; M, mitochondrial matrix; cI-cV, complexes I-V; QH2, ubiquinol 
(dihydroxyquinone); Q, ubiquinone (quinone); Cyt c red, cytochrome c reduced; Cyt c ox, 
cytochrome c oxidized. 
The fungal AOX is stimulated by purine nucleotides, specifically ADP, AMP and 
GMP (Affourtit et al., 2002). However, any post-translational regulation as well as its 
activation and inhibition kinetics of AOX expressed in animals is unknown (Tward 
et al., 2019). In a number of organisms, the synthesis of AOX protein can be induced 
by superoxide anion (Minagawa et al., 1992). AOX mRNA and AOX activity can 
also be induced by H2O2 (Vanlerberghe & Mclntosh, 1996). All residues necessary 
for formation of the AOX’s active site and catalytic act are present in the coding 
sequence, therefore AOX may theoretically function as a monomer. Indeed, there 
are reports that AOX actually works as a monomer (Shiba et al., 2013) as well as a 
homodimer (Shiba et al., 2012). 
AOX activity is typically determined using tissue, cells, or isolated mitochondria 
in which oxygen consumption is measured in the presence/absence of AOX and 
COX inhibitors. Although this approach does not measure activity in vivo, it does 
indicate the capacity of the AOX pathway (Ribas-Carbo et al., 1995). However, 
oxygen isotope discrimination techniques can accurately measure AOX activity by 
measuring the flux of electrons through AOX in vivo (Robinson et al., 1995; Watling 
et al., 2006).  
The atmosphere of the early Earth is considered to be anaerobic. The first energy-
generating reactions presumably involved the breakdown of organic molecules in the 
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absence of oxygen. Since oxygen is a substrate in the formation of toxic reactive 
species, it is thought that changes in oxygen levels might have caused selective 
pressure for microorganisms to develop alternative respiratory proteins (McDonald 
& Gospodaryov, 2018) that are less vulnerable to ROS damage than other 
oxidoreductases. Many AOX-expressing organisms are subjected to regular changes 
in oxygen levels (anoxia/reoxygenation), e.g., plant roots that can be overwatered, 
causing anoxia (Veiga et al., 2000), or sea squirts that experience functional hypoxia 
(Torre et al., 2014). In addition, many of them are subjected to conditions which 
compromise synthesis of specific prosthetic groups of respiratory complexes, 
notably haem and iron-sulphur clusters, which are susceptible to damage by ROS. 
Since ROS, generated by NADPH oxidases, are frequently used by immune cells to 
attack pathogens, this may be one reason why many eukaryotic parasites have 
retained AOX over the course of their evolution whereas mammals developed 
different mechanisms to buffer such problems, and have lost the gene for AOX. 
AOX genes have so far been found only in slow-moving or sessile organisms 
(McDonald et al., 2009). However, there are sessile organisms which do not have 
AOX, suggesting that selective pressure to keep AOX is not only related to the 
sessile state and low ATP demand, but rather to conditions which compromise 
function of the respiratory chain. AOX is ubiquitously present in plants, where it is 
most extensively studied, as well as in many microorganisms, fungi and protists, 
including human/animal parasites such as Trypanosoma brucei, Cryptosporidium parvum, 
Blastocystis hominis, and Candida albicans (Young et al., 2014). In animals, AOX genes 
and AOX mRNA have so far been reported in: Placozoa, Porifera, Nematoda, 
Arthropoda, Mollusca, Annelida, Rotifera, Brachiopoda, Cnidaria, Echinodermata, 
Hermichordata and Chordata (McDonald et al., 2008; McDonald & Vanlerberghe, 
2004; McDonald & Gospodaryov, 2018). It is unclear as to whether the AOX gene 
is translated into protein in all of these animal species (McDonald et al., 2008). Since 
AOX is absent in humans and is essential for pathogenic fungi, human parasites and 
plant pathogenic Nematoda, there is an opportunity for developing species-specific 
AOX inhibitors which can be tested as potential therapeutics or fungicides (Young 
et al., 2014). In addition to protection against anoxia, one physiological role of AOX 
in plants is heat production (Meusse, 1975; Grant et al., 2008; Wang & Zhang, 2015). 
AOX also has a crucial role in chloroplast protection under extreme environments, 
such as high light (Xu et al., 2011), as well as tolerance to both biotic and abiotic 
stress (Saha et al., 2016) especially when resulting in decreased functioning of the 
cytochrome pathway. Crucially, AOX avoids the generation of excessive ROS 
resulting from an excess of reducing power accumulated in the ubiquinone pool 
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(Vanlerberghe, 2013). It therefore enables respiration to resist toxins such as NO, 
CO, CN-, etc., thus fine-tuning ATP production, and the maintenance of 
mitochondrial and cellular homeostasis (Moore et al., 2013). 
2.6.1 The role of AOX as gene therapy tool: potential and concerns 
RC dysfunction and ROS overproduction are proposed to be instrumental in cancer, 
aging, neurodegenerative and mitochondrially inherited diseases. By preventing RC 
blockade and excess ROS production, AOX has therapeutic potential (El-Khoury et 
al., 2013), and it has been shown that AOX from a tunicate, Ciona intestinalis, can be 
safely and ubiquitously expressed in mammalian cells (Hakkaart et al., 2006), flies 
(Fernandez-Ayala et al., 2009) and mice (El-Khoury et al., 2013). 
AOX could potentially be useful as a gene therapy for diseases caused by 
mutations in genes which encode subunits of complex III and IV of the respiratory 
chain and assembly factors for these proteins (Dassa et al., 2009; Kemppainen et al., 
2014). In the latter case, AOX would allow electron transfer from ubiquinol to the 
terminal acceptor (molecular oxygen). Without such transfer, mutant cells would not 
be able to completely oxidize respiratory substrates for several reasons: (1) product 
inhibition of upstream enzymes in a biochemical pathway - in effect, the entire 
pathway becomes blocked, (2) potential toxicity or signaling roles of intermediates 
within a biochemical pathway, (3) physical laws of membrane energetics - inhibition 
of the enzymes within the respiratory chain would lead to disturbance in membrane 
potential. In the case of complex III blockade, ubiquinol would accumulate in the 
membrane and cause overproduction of superoxide anion-radical by reverse electron 
transport through complex I. Superoxide anion-radical is able to damage other 
components of the respiratory chain and other macromolecules in its vicinity. In the 
case of complex IV blockade, both ubiquinol and reduced cytochrome c would 
accumulate in the respiratory chain. Reduced cytochrome c is also a signaling 
molecule which may exit the mitochondria and trigger apoptosis. If respiratory 
substrates accumulate (mostly organic acids formed in other catabolic processes, e.g., 
pyruvate from glycolysis, alpha-ketoglutarate and oxaloacetate - from amino acid 
transamination, fatty acids and acetyl-CoA from beta-oxidation) and reducing 
equivalents (NADH) are not oxidized completely, they become toxic to cells. The 
simplest mechanism of this toxicity is, for instance, lowering of pH, e.g., lactic 
acidosis. AOX thus has a potential use in diseases where mitochondrial dysfunction 
is an intermediate step in the pathological process, rather than the underlying cause. 
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For example, it was shown that expression of Ciona AOX mitigates symptoms of 
Parkinson’s and Alzheimer’s diseases in Drosophila models (Humphrey et al., 2012; 
El-Khoury et al., 2016), as well as a lethal inflammatory cascade in a mouse model of 
sepsis (Mills et al., 2016). Theoretically, it may also ameliorate the symptoms of 
diseases associated with impaired synthesis of prosthetic groups for respiratory chain 
complexes. Complexes III and IV, as well as cytochrome c, contain heme. Defects 
in heme synthesis, iron and copper acquisition would lead to a functional deficiency 
of complexes III and/or IV. 
It is difficult to predict which source of AOX enzyme would have the most 
benefits if used as a gene therapy tool in humans. AOX from Trypanosoma brucei 
(TAO) has been suggested to be the most appropriate to be used in human gene 
therapy (May et al., 2017). It functions at 37 °C within the human blood stream 
(Chaudhuri et al., 2006) and is the AOX protein that is the best structurally 
characterized (Shiba et al., 2013). It is also possible and desirable to engineer AOX 
proteins which can be specifically regulated for the purpose of gene therapy. This 
would potentially result in an AOX protein that could be turned 'on' and 'off' by 
cellular pyruvate levels or other effectors, and which could be beneficial under 
conditions of impaired ROS homeostasis (May et al., 2017). 
Constitutive and unregulated functioning of AOX in the whole organism might 
be problematic, as it would decrease the yield of ATP. However, due to a very low 
affinity for its substrate, ubiquinol, AOX does not efficiently compete with complex 
III (Bahr & Bonner, 1973) under standard physiological conditions. For this reason, 
it is believed that AOX, even if present ubiquitously, functions only when the 
cytochrome pathway does not. However, if constitutively activated, AOX could be 
triggered by local metabolic conditions in specific cells, and participate significantly 
in respiration, it could alter ATP production and other processes dependent on 
respiratory energy, such as the buffering of calcium. Moreover, an increased 
metabolic rate with concomitant heat production could be detrimental in some 
tissues. Saari et al. (2017) reported that Drosophila males expressing AOX had 
apparent retention of sperm within the testis, which might be attributable to 
thermogenesis. An interference with cell signaling may also involve ROS. AOX has 
been reported to decrease mitochondrial ROS production even under the conditions 
of normal oxidative phosphorylation activity (Fernandez-Ayala et al., 2009; Sanz et 
al., 2010). This could affect signaling events in which ROS participate. This is why it 
may be important for gene therapy purposes to engineer an AOX which can be 
turned 'on' and 'off' as desired. 
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To date, AOX proteins from two different sources have been successfully 
expressed in human cells, namely from C. intestinalis, expressed in a HEK293T cell 
derivative (Hakkaart et al., 2006) and from the thermogenic plant Arum concinnatum 
in HeLa cells (Kakizaki & Ito, 2013). Thus far, the C. intestinalis AOX is the most 
studied in terms of potential gene therapy applications.  
The immune response against transgene products is a critical issue for successful 
gene therapy. The bigger the phylogenetic distance between organisms, the greater 
the probability that the proteins of this organism would elicit an immune response. 
From this point of view, C. intestinalis AOX seems to be a better candidate for 
expression in humans than plant or trypanosomal AOX.  
Although the AOX family contains a highly conserved active site there are 
remarkable differences in ubiquinol oxidase activity between different AOXs (May 
et al., 2017). More detailed kinetic and biophysical characterization of different AOX 
proteins is needed to understand how differences in structure and sequence are 
related to differences in function. Once the properties of AOX are well established, 
the sequence of the polypeptide can potentially be manipulated by design to be 
highly active, have low immunogenicity, and be susceptible to external regulation. 
 
2.7 Drosophila genetic toolkit: The Gal4/UAS system for 
regulated transgene expression  
The Gal4/UAS system (Brand & Perrimon, 1993) is a binary expression system 
primarily used in Drosophila which makes it possible to study effects of the 
overexpression or downregulation of any gene in a selected tissue and developmental 
stage (Brand & Perrimon, 1993). In the driver line, a construct containing a cell-
specific promoter drives the expression of the gene encoding the yeast transcription 
factor Gal4 (Fig. 3 A). In the responder line, a transgene of interest is regulated by a 
promoter incorporating an upstream activation sequence (UAS). The Gal4 protein 
binds to the UAS sequence and drives expression of the transgene. Thus, the 
transgene should only be expressed in cells defined by the promoter regulating Gal4. 
Through their over-expression, misexpression or downregulation in a tissue- and 
time-specific manner, this allows different genes to be studied in an internally 
controlled manner. The two constructs are established in separate fly lines allowing 
for numerous combinatorial possibilities. The Gal4 protein has basal transcriptional 
activator activity at 18 °C, higher activity at 25 °C and even higher activity at 29 °C 
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(Busson & Pret, 2007). Temperature thus has a huge effect on the activity of Gal4 
and on the expression of transgenes that it controls. It is therefore important to 
control temperature when performing experiments using this system. However, the 
Gal4/UAS system is far from perfect. There is variability in Gal4-mediated 
transcription between cells which cannot be explained (Brand et al., 1994). Gal4 has 
dosage-dependent (Kramer & Staveley, 2003) biological effects, some of which are 
detrimental. Expression of high levels of Gal4 in Drosophila can modify the 
expression of many endogenous genes in a UAS-independent manner, among them 
components of important signaling pathways (Liu & Lehmann, 2008), even though 
there is no Gal4 ortholog nor UAS binding site in Drosophila. This potentially 
complicates the use of this system, since its original premise is that Gal4 is inactive 
in Drosophila. One of the mechanisms by which Gal4 might influence gene expression 
is via a selective block of protein transport into the cell nucleus (Uv et al., 2000). 
Most promoters and enhancers that drive Gal4 expression are active many times 
throughout development. That is why a modified Gal4/UAS system, the 
GeneSwitch System (GS), that utilizes a modified Gal4 protein was developed 
(Osterwalder et al., 2001). It requires antiprogestin, RU486, to activate it, in order to 
bind the DNA (Fig. 3 B). RU486 can be administered by either feeding or immersing 
the animals in a solution containing RU486. Reporter protein expression is 
dependent on the dose of the GeneSwitch activator drug RU486 (Osterwalder et al., 
2001). Again, the use of the GS system is justified under the assumption that GS is 
inert in the fly. However, GS is not completely inert in the absence of RU486, since 
it can still confer a significant decrease in target gene protein levels when RNA 
interference (RNAi) transgenes are used (Scialo et al., 2016). 
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Figure 4.  The Gal4/GeneSwitch-UAS expression systems in Drosophila. (A) GAL4 (yellow) binds at 
the UAS (dark grey triangles) which drives the tissue-specific expression/knockdown of the 
gene of interest. The GAL4-UAS system allows spatial control of gene expression. (B) 
GeneSwitch-UAS system allows temporal control of gene expression, in addition. In the 
absence of the activator RU486, the GeneSwitch (modified GAL4) protein is expressed in 
target tissues but is transcriptionally silent. Only when RU486 binds to the GeneSwitch 
protein, which is fused to the progesterone-binding domain, does it become 
transcriptionally active and thus able to drive the expression of UAS-linked genes. 
Modified from Nicholson et al., (2008) and Scialo et al., (2016). 
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3 AIMS OF THE STUDY 
The aim of this thesis work was to test whether transgenic expression of AOX from 
the urochordate Ciona intestinalis in model organisms is able to influence cell 
migration and other developmental processes. 
The more specific aims of this work were:  
1. To engineer a catalytically inactive variant of the AOX protein (mutAOX) using 
site-directed mutagenesis, thus establishing a control for the entire study (I) 
2. To create fly lines where AOX and mutAOX are inserted at the same integration 
site and thus serve as comparable controls for AOX activity in Drosophila using site-
specific transgene insertion, (I, II) 
3. To investigate the developmental effects of expressing the GeneSwitch 
transcription factor in Drosophila, and whether these are modified by concomitant 
AOX expression (II) 
4. To test whether tissue-specific knockdown of JNK cascade genes produces cell 
migration defects during Drosophila development, and whether these can be corrected 
by concomitant AOX expression (III) 
5. To test whether AOX expression influence mammalian cell migration, and if so 
under what conditions (III) 
6. To determine the mechanism behind any such effect (III) 
The starting point for the project was a preliminary observation made by my co-
author, K. Kemppainen, regarding the interaction between AOX expression and 
GeneSwitch in Drosophila. This motivated the detailed study (II) undertaken in regard 
to Aims 3-4, as well as the need for an appropriate control (Aims 1-2, I). The 
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outcome of these studies then justified the more extensive investigation of cell 
migration and the JNK pathway (Aims 5-7, III).  
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4 MATERIALS AND METHODS 
4.1 Drosophila stocks and maintenance (I-III) 
Drosophila strains, e.g., drivers, balancers, transgenic recipient, RNAi and various 
control fly lines and their sources are described in original communications. Flies 
were maintained in standard high-sugar medium (Fernandez-Ayala et al., 2009) on a 
12-h light/12-h dark cycle at 25 °C, except where indicated in the figure legends. 
Where indicated, medium was supplemented with RU486 (Mifepristone, Sigma) at 
the concentrations indicated in figures and legends.  
ΦC31 recombinase-mediated-site-directed transgenesis was used to generate 
transgenic fly lines (service provided by BestGene Inc, Chino Hills, CA), using 
recipient lines with the following integration sites: attP18 (chromosome X), attP40 
(chromosome 2) and attP2 (chromosome 3), according to Pfeiffer et al. (2010) 
employing the wild-type and mutated AOX constructs cloned in pUASTattB and 
pUASTattB itself as empty-vector control. Following characterization, transgenic 
lines were maintained over balancers appropriate for chromosome X, 2 or 3, bearing 
standard markers (FM7, CyO, TM3Sb, respectively). Transgenic lines UAS-AOXF24 
and UAS-AOXF6 were described previously (Fernandez-Ayala et al., 2009) and 
referred to in the thesis and in publications as 'high' expression or 'old' wt AOX 
lines. Other lines created in the study are described under Results. 
Crosses were implemented in triplicate, with flies being tipped into new vials on 
three successive days after mating. Nine vials per cross were analyzed in most 
experiments. Morphological abnormalities of the eclosed flies were scored as 
described in (II) and (III). 
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4.2 Cell culture 
4.2.1 Drosophila S2 cells 
Drosophila S2 cell line (Schneider, 1972), originally derived from late embryos, was 
cultured in Schneider's Medium (Sigma-Aldrich) at 25 °C. Cells were passaged every 
3-4 days. 
4.2.2 Mammalian cell lines  
Human embryonic kidney 293 (HEK 293) cells originally derived by treating a 
human embryonic kidney homogenate with sheared adenovirus DNA (Graham et 
al., 1997). This cell line has a highly aberrant karyotype and constitutively expresses 
Ad5 E1A/E1B proteins, which deregulate pRB/p53pathways (Stepanenko & 
Dmitrenko, 2015). HEK293T (293T, ATCC® CRL-3216™) cells used for the work 
in I, are the derivative of HEK 293 cells with the difference that they express the 
SV40 T-antigen. 
AOX-positive and -negative mouse embryonic fibroblasts (MEFs), sourced 
either from embryos transgenic for C. intestinalis AOX, inserted at the Rosa26 locus 
(Szibor et al., 2017), or from their nontransgenic littermates, were studied at passage 
6. MEFs, immortalized by retroviral transduction with HPV16 oncoproteins E6 and 
E7 (iMEFs) were supplied by P.K. Dhandapani, University of Tampere (III). 
The AP-1 reporter HEK293 recombinant cell line (JNK signaling pathway; BPS 
Bioscience), here abbreviated HEK-AP1, contains a firefly luciferase gene under the 
control of AP-1-responsive elements that are stably integrated into HEK293 cells 
(III).  
The BJ-5ta human fibroblasts (ATCC CRL-4001) has been immortalized with 
human telomerase reverse transcriptase (hTERT) (III). 
Mammalian cell lines were maintained at 37 °C in 5% CO2 and cultured as 
detailed in the original publications. 
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4.3 Molecular cloning 
The C. intestinalis AOX cDNA (Hakkaart et al., 2006) was recloned into suitable 
expression vectors for Drosophila (S2 cells and whole flies) and mammalian cells. For 
details see (I). In vitro mutagenesis of these constructs employed a PCR-based, site-
directed mutagenesis approach with customized oligonucleotides using Quick 
Change Site-Directed Mutagenesis Kit (Agilent Technologies) (I). All constructs 
were verified by sequencing prior to use. 
 
4.4 Gene expression assays 
4.4.1 RNA expression analysis by Quantitative Reverse Transcription-PCR 
(qRT-PCR) 
Extraction of RNA from 2-day old adult flies and S2 cells and measurements of 
transcript levels relative to an internal standard (RpL32 mRNA) were performed 
using standard methods (Fernandez-Ayala et al., 2009), as described in (I) and (III). 
4.4.2 Protein analysis by Western blotting 
To measure transgene expression at the protein level in the adult fly, total protein 
was extracted from 30 females or 40 males per sample (I, Fig. 2 D and E). Frozen 
fly samples were used for all experiments except for detecting mutant AOX in 
females, for which fresh samples were used (I, Fig. 2 D).  
For detecting phosphorylation at c-Jun, 300,000 MEFs or HEK-AP1 cells or 
250,000 BJ-5ta cells were plated on 6-well plates (CellStar; Greiner Bio-One, III, Fig. 
5). After 24 h, the medium was replaced with medium containing either 0.2% 
DMSO, 20 μM SP600125 in 0.2% DMSO, 20 μM JNK inhibitor V, 8 nM PMA, or 
no added drug and the plate was incubated for 2 h (or 40 min, in the case of PMA). 
Cells were carefully rinsed in ice-cold PBS and then scraped on ice using a CytOne 
cell scraper in resuspension buffer. 
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Primary antibody incubations were carried out overnight at 4 °C. Membranes 
were then washed 3 x 10 min in PBS-Tween and incubated with HRP-conjugated 
secondary antibody for 1 h at room temperature in PBS-Tween with 5% nonfat 
(w/v) milk. After this, the unbound secondary antibody was removed by three 
successive 10 min washes with PBS-Tween. Protein was detected and visualized 
using Immun-Star™ HRP Chemiluminescent Kit (Bio-Rad). The 
chemiluminescence of all blots was documented both with film and by using a Bio-
Rad ChemiDoc imager. 
Primary antibodies used were: customized rabbit anti-AOX (21st Century 
Biochemicals, 1:10,000, Dassa et al., 2009), rabbit anti-α-actinin C-20-R used as 
loading control (Santa Cruz Biotechnology, 1:5,000 (I) 1:7,000 (III), mouse anti-
ATP5α used as loading control (Abcam, 1:50,000(I)), phospho-c-Jun (Ser 73) rabbit 
monoclonal antibody (catalog number 3270; Cell Signaling Technology 1:1,000, III), 
and phospho-c-Jun (Ser 63) rabbit polyclonal antibody (catalog number 9261; Cell 
Signaling Technology, III). HRP-conjugated secondary antibodies were: peroxidase-
labeled Goat Anti-rabbit IgG (catalog number PI-1000) and Horse Anti-mouse IgG 
(catalog number PI-2000 (both from Vector Laboratories, 1:10,000 (I, III)). 
 
4.5 Transfection/transduction 
Transgenes were introduced into Drosophila and mammalian cell-lines, for various 
purposes, by plasmid DNA lipofection or by lentivector transduction, as detailed in 
(I) and (III). Briefly, to assess the expression and activity of AOX and a mutated 
variant (see Results and I, Fig. 2 A), plasmid DNA was transiently transfected into 
HEK293T cells using 60 μl Lipofectamine® 2000 (Invitrogen) under manufacturer’s 
recommended conditions (I). To assay the effects of transgene expression on AP-1 
directed transcription using a luciferase reporter approach, test plasmids and an 
appropriate cocktail of reporter-system plasmids (Chatterjee & Bohmann, 2012) 
were transiently transfected into Drosophila S2 cells (III, Fig. 7 A-D), using the 
FuGENE® HD transfection reagent (Promega) according to the manufacturer’s 
instructions. To conduct similar assays in mammalian cells, as well as for Western 
blotting to study c-Jun phosphorylation, transgenes were stably introduced into the 
HEK AP-1 reporter cell-line or into BJ-5ta cells by pWPI-based lentiviral 
transduction, followed by cell sorting and cloning at limiting dilution (III).   
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4.6 Migration assays 
4.6.1 Wound-healing assay  
For the wound-healing assay, samples of 90,000 cells were plated on 24-well plates 
(CellStar; Greiner Bio-One) as technical triplicates (3 wells per sample). After 24-48 
h, cells were treated with various drugs as detailed in (III), after which a linear scratch 
was made in the center of each well with a p10 (1 to 10 μl) pipette tip. The cells were 
then washed three times with medium to remove detached cells, and fresh medium 
containing the appropriate reagent was added to each well. 
 
4.6.2 Single-cell migration assay 
To measure single-cell migration, samples of 15,000 primary or immortalized MEFs 
(iMEFs) were plated on 6-well plates (CellStar; Greiner Bio-One) as technical 
triplicates (3 wells per sample). To minimize plate-specific effects, each plate 
contained all the genotypes used in a single experiment. Cells were imaged as 
described below, under section 4.7. 
 
4.7 Microscopy 
Light microscopy images of eclosed adult flies and their appendages were taken with 
a Nikon Digital DS-Fi1 High-Definition Color Camera, using the Nikon 
stereoscopic zoom microscope SMZ 745T run by NIS-Elements D 4.20 software. 
For live imaging of GFP fluorescence (III), anaesthetized adult flies or cleaned larvae 
were analyzed using a Zeiss Axio Imager2 microscope (50x magnification, producing 
Z projection images). Embryos collected from mating chambers or gently detached 
pupae were imaged in 35-mm glass-bottom microwell dishes filled with Halocarbon 
 64 
Oil 700 (Sigma-Aldrich), using an Andor spinning disc confocal microscope at 20x 
magnification.  
Wound closure time-lapse images were taken with a ChipMan Technologies Cell-
IQ controlled-environment observation incubator equipped with a Retiga EXi 1392 
charge-coupled-device camera, using a Nikon CFI Plan Fluorescence DL objective 
at 10x magnification until the wound closed (approximately 48 h) or for 24 h when 
metabolic inhibitor drugs were applied. Images were taken every 30 min. For further 
details, see (III). To generate images for measuring single-cell migration, cells were 
transferred 24 h after plating to a Nikon BioStation CT instrument equipped with a 
Nikon DS-1QM camera and imaged at 4x magnification every 6 min. Movement of 
living cells was analyzed using CellTracker image-processing software with semi-
automated migration detection.  
 
4.8 Luciferase assays  
4.8.1 Luciferase reporter assays in S2 cells 
The activities of cell-based reporters were measured by Dual Glo Luciferase Assay 
System kit (Promega). Transfected S2 cells (either untreated or treated with hep 
dsRNA to downregulate JNK pathway or pACT-Gal4 together with pUAST-Hepact 
for activated transcription) were transferred to wells of 96-well luciferase assay 
microplates (Lab Systems) and the luciferase assay was carried out in triplicate 
according to the manufacturer’s protocol. Luminescence was measured using a 
Thermo Labsystems Luminoskan Ascent plate reader (III, Fig. 7 A-D). 
 
4.8.2 Luciferase reporter assays in mammalian cells 
Firefly luciferase reporter assays were carried out in HEK-AP1 cells and in 
AOX/mutAOX-expressing clones derived from them using the Dual-Glo luciferase 
assay system (Promega), according to the manufacturer’s protocol. Luminescence 
was measured using a PerkinElmer UV/visible plate reader (III, Fig. 7 E). 
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4.9 Respirometry 
To test whether the mutAOX protein has enzymatic activity, oxygen consumption 
was measured on transiently transfected permeabilized HEK293T cells 48 h after 
transfection, in a Clark-type electrode (Hansatech Oxytherm system). Complex II-
driven respiration was measured in the presence of ADP and succinate. AOX-driven 
(antimycin-resistant) respiration was measured after the further addition of 
antimycin A, with subtraction of any residual oxygen consumption after adding 
AOX inhibitor, n-propyl gallate (for details, see I). Similarly, respirometry on S2 cells 
and homogenates from 1-4 day-old Drosophila males was conducted using the same 
system (I).  
 
4.10 Experimental methods conducted by co-authors 
In the published papers, molecular modelling (I, Fig. 1), Cox7a deficiency survival 
assay (I, Fig. 5 A), fly locomotor activity assay (I, Fig. 5 B), generation and 
respirometry of primary and iMEFs (III, Fig. 8 A and B), and wound-healing assays 
conducted in the presence of respiratory inhibitors (III, Fig. 8 C) were conducted by 
my co-authors. 
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5 RESULTS 
5.1 Structural modelling and mutagenesis of active site of Ciona 
intestinalis AOX (I) 
AOX is a diiron nonheme carboxylate protein which catalyzes four-electron 
oxidation of reduced ubiquinone (ubiquinol) reducing oxygen to water at the same 
time (Kern et al., 2007).  
Introduction of AOX from C. intestinalis (Tunicata: Ascidiacea) by transgenesis 
compensates many of the phenotypes resulting from complex III or IV deficiency 
in the fruitfly (Fernandez-Ayala et al., 2009; Kemppainen et al., 2014), cultured 
mammalian cells (Haakkart et al., 2006 Dassa et al., 2009) and in the mouse (El-
Khoury et al., 2013; Szibor et al., 2017). In order to understand whether the ability of 
AOX to rescue COX deficiency (Kemppainen et al., 2014), as well as cleft thorax and 
other developmental defects (see below; II, III), depends on its known enzymatic 
activity, we engineered a mutated variant of AOX (mutAOX) predicted to be 
disabled for enzymatic activity. We used findings from two previous studies to help 
us design mutAOX. In the first, AOX was shown to be phylogenetically well 
conserved and its active site residues have been characterized in a number of species 
(McDonald et al., 2009). In the second, the crystal structure of a representative AOX 
from Trypanosoma brucei, the parasite that causes African sleeping sickness, was 
resolved (Shiba et al., 2012).  
From these starting points we aligned the predicted Ciona AOX amino-acid 
sequence with T. brucei AOX, which revealed conservation of residues (I, Fig. S1 of 
the supplementary data). To engineer a fully catalytically inactive protein, we mutated 
four amino acids to alanine E239A, H242A, E344A, H347A (Fig. 5 B) (for details 
see I, Materials & Methods). Sequence alignment reveals that these four residues are 
fully conserved across the sequenced family of AOX from different species 
(McDonald et al., 2009). We substituted these amino acids with alanine, because 
alanine is a small and inert amino acid, a standard procedure in the field of 
mutagenesis. The mutations were predicted to disable AOX activity. The glutamate 
and histidine residues we mutated are directly involved in binding diiron moiety (Fig. 
5 A). We hypothesized that changing these residues would destabilize iron binding 
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and abolish enzymatic activity, leaving the protein still able to go to the mitochondria 
and fold correctly but unable to exhibit its normal enzymatic activity. We then tested 
to see if this was indeed the case. 
A 
B 
 
 
 
 
 
 
Figure 5.  Structural modelling and mutagenesis of active site of Ciona intestinalis AOX (CiAOX). (A) 
Conserved residues binding the diiron centre show an identical disposition in the Ciona 
model (CiAOX, green) as in the Trypanosoma brucei AOX (TbAOX, blue) (B) The residues 
selected for alanine-substitution mutagenesis in the CiAOX (here shown in blue), the 
resulting modelled structure (right) (Modified from I, Fig. 1). 
Selected residues in CiAOX for 
alanine substitution mutagenesis 
Modeled alanine substitutions in 
CiAOX structural model 
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5.2 MutAOX is stably expressed in mammalian cells and flies (I) 
To study the properties of mutAOX when expressed, I first verified the expression 
of the mutAOX construct by transient transfection into cultured HEK293T cells. 
Based on Western blotting (Fig. 6 A), mutAOX protein was the same size and 
expressed at comparable levels to wild-type (wt) AOX. Next, the mutAOX 
transgene, under the control of the GAL4-dependent UAS promoter, was 
introduced into the Drosophila genome by targeted insertion (for details see I, 
Materials & Methods). Control lines were created, containing wt AOX (described as 
'new' wt AOX line in I) and empty vector, inserted at the same site. Insertions were 
validated by PCR and sequencing. I then measured transgene expression directed by 
the ubiquitous daGAL4 driver, at both RNA and protein levels, using qRT-PCR (Fig. 
6 B, C) and Western blotting (Fig. 6 D, E). In both females (Fig. 6 B) and males (Fig. 
6 C), the expression of wt and mutAOX were similar at the RNA level, but 3-4 fold 
lower than AOX in the previously created transgenic lines, engineered by random P-
element insertion ('old' wild-type AOX lines, I). At the protein level, mutAOX has 
slightly lower expression than wild-type AOX in both sexes, and expression was 
again less than in the previously created 'old' wt lines. (Fig. 6 D, E).  
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Figure 6.  Expression of wt and mutAOX transgenes in mammalian cells and Drosophila. (A) 
Western blot of protein lysates of HEK293T cells transfected with wt, mutAOX or empty 
vector constructs (wt, mut, V), probed for AOX and for ATP synthase subunit α (ATP α) as 
loading control. (B, C) Relative RNA level of AOX expression, based on qRT-PCR (means 
± SD), in (B) females and (C) males of Drosophila lines transgenic for wtAOX, mutAOX, or 
empty vector. New wt and mutAOX lines were created by site-specific integration at 
defined chromosomal sites using the ΦC31 system; old wt AOX lines were UAS-AOXF6 
(chromosome 2) and UAS-AOXF24 (chromosome 3). For males, all values were 
significantly different from empty-vector lines; old wt AOX lines were significantly different 
from new wt AOX lines (p < 0.001, ANOVA followed by post-hoc Bonferoni-corrected t 
test). mutAOX and new wt AOX lines were not significantly different from each other. 
Statistical analysis for females gave similar results, although greater sample-to-sample 
variation for old wt AOX lines yielded only p < 0.05 comparing them with new wt or 
mutAOX lines. (D, E) Western blot of protein extracts from the same flies, probed for AOX 
or, as loading control, either ATP α or α-actinin (α Act). Unmodified from I, Fig. 2. 
MutAOX was stably expressed in cultured human cells and in transgenic flies, and it 
lacked enzymatic activity as expected (I, Fig. 4; enzymatic activity experiment 
conducted jointly with E. Dufour). Furthermore, mutAOX could not compensate 
pupal lethality caused by knockdown of cytochrome c oxidase subunit COX7a (I, 
Fig. 5 A), nor locomotor dysfunction resulting from neuronal specific knockdown 
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of COX7a (I, Fig. 5 B; experiment conducted by C. Yalgin), confirming that the 
observed rescue depends on the enzymatic activity of AOX. 
5.3 Expression of AOX rescues cleft thorax caused by 
tubGS/RU486 (II) 
The GeneSwitch (GS) system allows temporal control of gene expression thanks to 
a modified GAL4 protein that is active only when the synthetic progesterone 
analogue, RU486, binds to the fused progesterone steroid receptor. GeneSwitch 
adds temporal control to the GAL4/UAS system (Yamada et al., 2017). Transgene 
expression was induced during development by the GS, under the control of a 
ubiquitously active α-tubulin promoter (tubGS), by feeding RU486 to mothers while 
laying eggs, and to larvae until pupariation. For experiments involving RU486 we 
used a diet rich in nutrients (Fernandez-Ayala et al., 2009) because RU486 is not 
detrimental to fly lifespan on high nutrient food (Yamada et al., 2017).  
In the preliminary experiment it was observed that tubGS expression in the 
presence of RU486 causes cleft thorax which is rescued by AOX (Fig. 7 A). In a 
follow up study, I further observed, using the same system with induction by 10 μM 
RU486, extensive pupal lethality and a spectrum of additional malformations such 
as an enlarged tibia and femur, both fused together preventing movement of the fly 
in the majority of cases, bristle malformations, cleft abdomen, notches on anterior 
and posterior wing margins and externalized trachea (Fig. 8). These highly 
dysmorphic flies were alive nonetheless. For all the experiments throughout this 
thesis work, only vials with embryo numbers from 50-100 were analyzed to eliminate 
a crowded population which could affect resource availability during feeding, thus 
affecting the results. 
Coexpression of AOX rescued the phenotype substantially, with over 50% of the 
eclosing progeny now showing no cleft, and less than 20% having severe cleft. Ndi1 
targeted to mitochondria or GFP expressed in the cytoplasm did not rescue the 
phenotype. Nor did a single copy of AOX, when constitutively expressed under the 
α-tubulin promoter at a much lower level than when driven by tubGS. However, five 
doses of the tubAOX transgene gave rescue (II, Fig. 4 C) comparable with the UAS-
AOX lines (which express AOX at a higher level than tubAOX and UAS-AOX7.1 fly 
lines). To test if rescue is due to catalytic activity of AOX we tested mutAOX in the 
assay. The enzymatically inactivated variant of AOX did not rescue any of the 
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phenotypes implying that rescue was due to enzymatic activity of the AOX and that 
AOX operates in a dose dependent manner (Fig. 7 B). 
 
A 
 
 
 
 
B 
 
 
 
 
Figure 7.  (A) AOX partially rescues cleft thorax and developmental lethality caused by activated 
tubGS. Proportion of adult progeny exhibiting the indicated phenotypes, with hemizygous 
transgenes as indicated, cultured with or without 10 μM RU486. n ≥3 replicate vials for 
each studied genotype (except UAS-Ndi1, n = 2, hence no error bars shown). tubAOX 
transgenic lines had either a single hemizygous copy of AOX (tub-AOX) or five copies 
(5xtub-AOX). Asterisks indicates data classes significantly different from the equivalent 
class for control lacking any transgene additional to tubGS (Student’s t-test with Bonferroni 
correction, p<0.01). (B) AOX alleviates developmental abnormalities induced by activated 
tubGS. Proportion of progeny hemizygous for both tubGS and the indicated transgenes, 
which exhibited the indicated developmental abnormalities at 10 μM RU486. The total 
numbers of flies of each genotype analyzed, in a single large-scale experiment (n). 
Asterisks indicate significant differences (p <0.001) from the w1118 strain hemizygous for 
tubGS, based on chi-squared analysis for each phenotypic category or for the four thoracic 
phenotypes (normal thorax, malformed scutellum, mild cleft, and severe cleft) considered 
as a whole. Modified from II, Fig. 4 and 5. 
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Figure 8.  Examples of malformations caused by the tubGS driver in the presence of 10 μM RU486. 
(A-D) Thoracic abnormalities: (A) missing scutellar part, (B) mild cleft, (C) severe cleft, and 
(D) necrotic tissue, always localized at the scutellum or notum. (E, F) Wing abnormalities: 
(E) notched wings, with notches localized on the marginal anterior or posterior side or 
both, (F) noninflated wings. (G) Leg abnormalities, including overgrown and fused leg 
segments. (H) Externalized tracheal appendice, always in the ventral abdomen proximal to 
the posterior leg. (I) Abdominal cleft: midline splits between all dorsal tergite plates; 
laterotergites do not fuse at the dorsal midline and remain as hemitergites. tubGS; a-
tubulin-GeneSwitch. Unmodified from II, Fig. 5. 
5.4 AOX expression alleviates cleft thorax due to 
downregulation of JNK signaling (III) 
The findings presented in the foregoing section showed that a high dosage of C. 
intestinalis AOX expressed in Drosophila could alleviate developmental abnormalities 
caused by an engineered transcription factor from yeast. This prompted us to test if 
AOX could correct a well described Drosophila model of cleft thorax phenotype. 
Downregulation of JNK pathway genes, or misregulation of the transcription factors 
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encoded by pnr or usp, consistently leads to cleft thorax and was thus an obvious 
target. We first downregulated selected genes of the JNK signaling cascade in the 
mediodorsal region during Drosophila development using pnrMD237 GAL4 driver. This 
downregulation resulted in a cleft thorax phenotype as published previously. Using 
the GFP reporter already present in the pnrMD237 GAL4 fly line we verified the 
expression pattern of it (III, Fig. 1 B; see Table S1 in the supplemental material). We 
used pnrMD237 GAL4 to downregulate PDGF and VEGF receptor related (pvr; a receptor 
tyrosine kinase), misshapen (msn; JNKKKK) hep, bsk, Jun-related antigen (Jra; Drosophila 
fos) and kayak (kay; Drosophila jun) and to overexpress puckered (puc) (III, Table S2). 
These all produced a cleft thorax phenotype of various severities (Fig. 9) which was 
dependent on the tested construct/insertion and temperature. 
 
 
Figure 9.  Examples of thoracic phenotypes throughout the study scored as normal, mild, or severe. 
Arrows indicate the trend within each class toward more severe cleft thorax phenotypes. 
Modified from III, Fig. 1 C. 
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To attempt the rescue we combined these with expression constructs for AOX or 
for a control transgene, GFP. The mutAOX fly line (see above) was not available at 
the time of this study. 
For bsk and hep, I tested multiple RNAi lines (III, Table S1), each producing cleft 
thorax when combined with the pnrMD237 GAL4 driver. Expression of AOX (III Fig. 
2 A and Fig. 10 A, B) but not that of GFP (III, Fig. 2 B) alleviated the phenotype 
substantially. Using two different RNAi lines for each gene gave the same effect of 
AOX (Fig. 10 E-G). To exclude the promoter dilution effect we measured the 
amount of AOX RNA driven by pnrMD237 GAL4 in pupae with and without one of 
the double-stranded RNA (dsRNA) constructs for hep, which showed no significant 
difference (III, Fig. 2 D). Very few flies from the msn knockdown eclosed, while 
AOX or GFP expression gave no significant change in phenotype, despite a trend 
toward the wild-type for AOX (Fig. 10 C) and increased severity in the case of GFP 
(Fig. 10 F). A pvr knockdown was pupal semilethal when combined with the pnrMD237 
GAL4 driver, even when milder knockdown of the pvr was induced by growing the 
flies at 18 °C. Nevertheless, the number of eclosing progeny was not sufficient to 
enable a statistically meaningful analysis of the thoracic phenotype according to 
severity, but the mean proportion of progeny with cleft thorax was about 80% in 
this and parallel pvr knockdown experiments. Co-expression of AOX, but not GFP, 
significantly rescued semilethality (III, Fig. 2 C). AOX was not able to rescue kay and 
jra knockdown nor the lethality caused by overexpression of the AP-1 target Puc, 
which antagonizes Bsk by feedback mechanism (Martín-Blanco et al., 1998).  
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Figure 10.  AOX rescues cleft thorax induced by JNK signaling downregulation. Effects of co-
expressing (A) AOX or (B) GFP on the proportion of different phenotypic classes resulting 
from knockdown of bsk and hep, using the pnrMD237 GAL4 driver and RNAi lines KK 
104569 (bsk) and GD 47507 (hep). The data represent the means ± SEM for nine 
replicate vials in each experiment. n, the total number of flies analyzed. Statistically 
significant differences between the proportions of AOX or GFP expressing and 
nonexpressing flies of different phenotypic classes are shown. P values, as indicated, 
determined by Student’s t- test, two-tailed, paired, with the Bonferroni correction. (C) Effect 
of co-expressing AOX or GFP on pupal semilethality caused by knockdown of pvr (RNAi 
line KK 105353) using the pnrMD237 GAL4 driver. The data represent the means ± SEM for 
nine replicate vials in each experiment. n, the total number of flies analyzed in each case. 
Statistically significant differences between classes are indicated, with P values 
determined by ANOVA with the Tukey post hoc honestly significant difference test.  
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5.5 Is AP-1 the target of AOX? (III) 
5.5.1 AOX does not rescue cleft thorax caused by AP-1 transcriptional 
factor or manipulation of its downstream target Puc 
We next downregulated c-Jun or its dimerization partner, c-Fos, encoded in 
Drosophila by Jra and kay, respectively using the same pnrMD237 GAL4 driver. Co-
expression of AOX had only a slight effect on the severity of cleft thorax induced 
by knockdown of kay or Jra using the pnrMD237 GAL4 driver (Fig. 11 A and B). AOX 
was also unable to rescue the lethality caused by overexpression of the AP-1 target, 
Puc, which antagonizes the action of Bsk (Fig. 11 C). This result leaves open a 
possible direct involvement of AOX on AP-1 transcriptional factor. 
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Figure 11.  AOX does not rescue cleft thorax induced by altered expression of AP-1 or its target puc. 
(A, B) Effects of co-expressing AOX on phenotypic classes resulting from knockdown of 
kay (at 25 °C) and Jra (at 18 °C), using the pnrMD237 GAL4 driver and RNAi lines GD 6212 
(kay) and KK 107997 (Jra) (A) and alternate RNAi lines GD 19512 (kay) and GD 10835 
(Jra) (B). GD 10835 (Jra) construct is carried on chromosome X, two parallel crosses were 
required to test the effects of AOX expression in each sex, and statistical analysis was not 
meaningful in this case. The data represent the means ± SEM for 9 replicate vials in each 
experiment. n, total number of analyzed flies. Statistically significant differences between 
the proportions of AOX expressing and nonexpressing flies of different phenotypic classes 
are shown. P values determined by Student’s t-test, two-tailed, paired, with the Bonferroni 
correction. Jra knockdown using RNAi line KK 107997 was lethal at 25 °C and AOX did 
not rescue this lethality. (C) Effect of coexpressing AOX or GFP on pupal lethality caused 
by overexpression of puc driven by pnrMD237 GAL4 driver. All indicated progeny classes 
contained the overexpression construct, UAS-puc. The data represent the mean ±SEM for 
nine replicate vials in each experiment. n, the total number of analyzed flies. 
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5.5.2 AOX does not influence AP-1-dependent transcription in cultured 
cells  
In attempt to reveal the mechanism of the AOX-mediated rescue of cleft thorax, I 
tested whether AOX expression can change the transcriptional activity of AP-1 in 
the Drosophila and mammalian system. I set up luciferase reporter-based assays for 
both S2 and HEK293T cells. I tested whether AOX expression in Drosophila S2 cells 
was able to alter AP-1-dependent transcription under different conditions of JNK 
pathway activation, using the reporter system developed by Chatterjee & Bohmann 
(2012). AOX did not influence AP-1 transcription in the conditions of basal and 
activated JNK pathway. JNK pathway activation was achieved using the pUAST-
Hepact plasmid in combination with pAct-Gal4, which promotes pUAST-Hepact 
transcription of pUAST-Hepact by constitutive expression of Gal4. (Fig. 12 A-D). 
To conduct a similar experiment in mammalian cells, I made use of an AP-1 
Reporter HEK293 cell-line derivative (see III, Materials & Methods), here 
designated HEK AP-1. The cell line contains a stably integrated firefly luciferase 
gene under the control of AP-1-responsive elements. It was not possible to obtain 
consistent results with transiently transfected cells (data not presented). I therefore 
created stable AP-1 reporter cell lines, expressing AOX and mutAOX, using 
lentiviral constructs in which the transgene is co-expressed with GFP. Cells were 
cloned at limiting dilution. Different clones had highly variable degrees of AP-1 
transcriptional activity, most likely reflecting the diversity of copy number and 
integration sites, as well as possible karyotypic instability. This is a limitation of the 
system. 
However, I was able to replicate the findings from S2 cells in the mammalian 
model: AOX expressing clones showed no significant difference in AP-1 
transcriptional activity compared with mutAOX expressing clones or parental cells 
(Fig. 12 E). 
Using this model, I also tested the effects of inhibiting JNK pharmacologically 
with two inhibitors, SP600125 and AS601245 (JNK inhibitor V or inh V) (III). 
Whilst inh V decreased AP-1 transcription, SP600125 increased it, except when cells 
were pre-stimulated with PMA (Fig. 12 E), but again no differential effect was seen 
between AOX expressing, mutAOX expressing and control cells. 
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Figure 12.  AOX effect on AP-1-dependent transcription. (A-D) Firefly luciferase activity in S2 cell 
extracts co-transfected with (A) pMT-AOX (or empty vector) (B) pAC/AOX (or empty 
vector) (C) pUASTattBAOX (or pUASTattB-mutAOX), (A-C) and with pUAST-Hepact ± 
pAct-Gal4 to activate it or not (D) or following 5 days of dsRNA treatment (knockdown) for 
hep and with reporter constructs containing intact (TRE-fluc) or mutated (mRE-fluc), 
phorbol ester-response elements (RE), later serving as a background control and pAct-RL 
for normalization. All data were first normalized for transfection efficiency, using a 
cotransfected Renilla luciferase activity, and then renormalized against basal activity for 
the relevant controls: (A, B, D) the empty vector or (C) pUASTattB-mutAOX. AOX 
expressing and AOX nonexpressing cells were not significantly different from each other 
apart from one case in panel D (Student’s t-test, two-tailed, unpaired). Statistically 
significant differences between data classes were determined by one-way ANOVA with 
the Tukey post hoc honestly significant difference test. act, activated. (E) Firefly luciferase 
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activity in extracts of reporter cells and HEK AP-1 derived clones transduced with lentiviral 
constructs expressing AOX or mutAOX. Treatments: 0.2% DMSO, 20 μM SP600125 or 20 
μM inh V. Data normalized against the values for the corresponding non-treated cells 
(unstimulated) or for the corresponding cells treated with 8 nM PMA (stimulated). Box plots 
indicate the means and the 95% confidence intervals for each data set. Modified from III, 
Fig. 7. 
5.5.3 AOX expression does not affect c-Jun phosphorylation at Ser 63/Ser 
73 
JNK-mediated phosphorylation of c-Jun at Ser 63 and Ser 73 is critical for fibroblast 
migration (Javelaud et al., 2003). To understand if AOX modulates phosphorylation 
of c-Jun at Ser 63 and Ser 73, the same set of JNK modulators were tested for their 
effects on c-Jun phosphorylation at these sites. This was done in iMEFs (Fig. 13 A), 
as well as in two other cell lines, the HEK AP-1 line used for transcriptional assays 
(Fig. 13 B) and human fibroblast line BJ-5ta (Fig. 13 C). Only SP600125 decreased 
the amount of phosphorylated c-Jun, whereas JNK inhibitor V instead increased it, 
as did PMA. The presence of AOX did not influence c-Jun phosphorylation at these 
sites in iMEFs (Fig. 13 A), although it potentiated the effect of SP600125 and 
inhibitor V in an AOX-expressing BJ-5ta cell clone (III, Fig. 13 C).  
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Figure 13.  Phosphorylation status of c-Jun Ser 63 and Ser 73 residues. Western blots of cell lysates 
from (A) control and AOX expressing iMEFs (B) HEK AP-1 cells (C) control or AOX 
expressing human BJ-5ta fibroblasts. Untreated (untr) or treated with 0.2% DMSO, 20 μM 
SP600125 (SP) in 0.2% DMSO, 20 μM inh V, or 8 nM PMA. The molecular weights of the 
bands detected by each antibody were as expected: 100 kDa for α-actinin (α-act), 47 kDa 
for c-Jun phosphorylated at residues Ser 63 (pSer 63) or Ser 73 (pSer 73). Separate blots 
were probed for pSer 63 or pSer 73 and reprobed for α-act as a protein loading control. 
Unmodified from III, Fig. 5.  
5.6 AOX expression can influence mammalian cell migration 
(III) 
The failure of thoracic dorsal closure during Drosophila development is a defect in 
cell migration, which AOX expression was able to correct. To test the generality of 
this finding, I conducted cell migration assays in mammalian cells. MEFs were 
isolated from AOX hemizygous mice (Szibor et al., 2017) and wt littermates and 
immortalized using a standard retroviral transduction procedure with viruses 
encoding human papillomavirus 16 (HPV16) oncoproteins E6 and E7 (Lochmüller 
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et al., 1999; technical steps conducted by co-authors P.K. Dhandapani and L. 
Giordano). In these cells, AOX is expressed ubiquitously from an incorporated 
synthetic CAG promoter, the complete construct being targeted into the 
ubiquitously active Rosa26 locus (Szibor et al., 2017). 
The drugs SP600125 and AS601245 have both been shown to decrease cell 
migration (Jarvelud et al., 2003; Cerbone et al., 2012) and were used here for that 
purpose. Both drugs are potent, reversible, and an (which express AOX at higher 
level than tubAOX and UAS-AOX7.1 fly lines)ATP-competitive inhibitor of JNK.  
In iMEFs AOX increased the migration rate in all tested conditions in the wound 
healing essay, except when cells were treated with inh V. The scratch assay conducted 
on primary MEFs (at passage 6) revealed no difference in migration rate between 
AOX expressing and control MEFs (Fig. 14 B). All primary lines migrated much 
slower than iMEFs. Leading edge cells in AOX expressing fibroblasts were able to 
detach and scout the surface alone, making long protrusions. The wild-type iMEFs 
leading edge migrated as a whole (data not presented). 
To test if the effect of AOX is dependent on cell-cell contact, a single cell 
migration assay was conducted. The migration speed of single-cell migration of AOX 
expressing iMEFs was also significantly greater than that of control iMEFs in this 
assay (Fig. 14 C) indicating that faster cell migration is an intrinsic property of the 
AOX-expressing iMEFs. 
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Figure 14.  Effects of AOX on mammalian cell migration. (A, B) Wound closure rate of cultured (A) wt 
iMEFs (control) and AOX hemizygous iMEFs and (B) primary MEFs at passage six, either 
untreated (untr), or treated with: 0.2% DMSO, PMA (20 nM), SP600125 (20 μM in 0.2% 
DMSO), inh V (20 μM). Asterisks joining the bars denote statistically significant differences 
between the genotypes for a given treatment. Asterisks above the bars denote a 
statistically significant difference from untreated cells of the given genotype. (One-way 
ANOVA with the Tukey post hoc honestly significant difference test). Data represent three 
biological replicates, each analyzed in triplicate, except for DMSO, which used only two 
biological replicates. (B) The means ± SD are for pooled data from two cell lines of each 
genotype analyzed in triplicate at passage six. (C) Single cell migration rate of the iMEFs 
indicated genotypes. Asterisks denote statistical significance. (Student’s t-test, unpaired). 
n=31 for control iMEFs; n=21 for AOX expressing iMEFs. Unmodified from III, Fig. 4.  
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5.7 Antimycin A potentiates the migration of AOX-expressing 
cells (III) 
To be able to understand further how AOX influences the migration we tested 
various metabolic effectors in conjunction with AOX. From various OXPHOS 
inhibitors, antioxidants and uncouplers, tested, only antimycin A, which binds to 
quinone reduction site of the cytochrome bc1 complex (Huang et al., 2005), gave 
differential effect. Antimycin A stimulated the migration of the AOX iMEFs but 
suppressing the migration of the MEFs (III, Fig. 8 B). To understand these findings 
we checked respiration in the cell lines tested (III, Fig. 8 C) to observe the effects of 
AOX under antimycin A. AOX had no significant effect on whole-cell respiration 
or on permeabilized cell respiration on complex I-, II-, and  IV-linked substrates. 
However, in the presence of antimycin A, AOX enabled almost 80% of the 
uninhibited respiration rate in permeabilized cells, driven by succinate. This 
exceeded the measured rate of whole-cell respiration under uninhibited conditions. 
Capacity for AOX-mediated respiration was sufficient to maintain normal 
respiratory electron flow in iMEFs in the presence of antimycin A (Experiment 
conducted jointly with E. Dufour). 
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6 DISCUSSION 
6.1 Overview 
This work aimed to test whether transgenically expressed AOX can affect 
phenotypes related to the impairment of JNK signaling. We have found that 
expression of AOX was able to promote cell migration in three different models: in 
Drosophila, AOX expression corrected thorax defects caused by activated GS (II) and 
also when the JNK pathway was attenuated at several specific steps (III). It also 
promoted cell migration in AOX-expressing iMEFs (III). AOX was not able to 
correct migration defects when either of the Drosophila c-fos and c-jun homologues kay 
and Jra, respectively, were downregulated, as well as downstream targets of AP-1 
such as pnr and puc. AOX was also unable to enhance the migration of primary 
MEFs. AOX had no effect on AP-1-dependent transcription in proliferating 
Drosophila (S2) or mammalian (HEK293-derived) cells. The migration of AOX 
expressing iMEFs compared with that of control iMEFs was differentially stimulated 
by antimycin A but not by other compounds that affect the mitochondrial 
respiratory chain, membrane potential, production of ATP or generation of ROS. 
The summary of the main results from this thesis are illustrated in Figure 15. 
 
 
 88 
 
Figure 15.  Summary of AOX influences on cell phenotype. 
6.2 Use of the mutAOX control 
6.2.1 Validation of mutAOX 
To validate the use of the catalytically inactive mutated AOX, I first verified that it 
was targeted to the mitochondria and is compatible with life. I expressed the mutant 
AOX gene both in mammalian cells and Drosophila. Transiently expressed mutAOX 
in human cells was the same size as AOX (Fig. 6 A) and efficiently targeted to 
mitochondria of S2 cells (data not presented). MutAOX was shown to lack 
enzymatic activity using polarography (I, Fig. 4). In a functional assay carried out in 
Drosophila, expression of the mutated enzyme was unable to rescue the organismal 
phenotypes arising from engineered cytochrome c oxidase deficiency (I, Fig. 5).  
To create a catalytically inactive protein we chose to mutate four amino acids to 
alanine: E239A, H242A, E344A, H347A, even though in theory the mutagenesis of 
a single glutamate residue would be enough to destabilize the di-iron center. In 
parallel, a catalytically inactive mutant AOX has been engineered by introducing the 
mutation Y297F, targeting another conserved domain of the enzyme. However, 
when expressed in human cells the Y297F mutant AOX accumulated to much lower 
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levels than the wild-type protein, suggesting that this particular mutant protein is 
unstable and rapidly degraded (P.K. Dhandapani, personal communication). We 
showed that targeted mutagenesis described in I resulted in stable but catalytically 
inactive protein.  
6.2.2 Enzymatic activity of AOX is important for phenotypic rescue  
MutAOX was not able to rescue locomotor defects in the fly arising from engineered 
cytochrome oxidase deficiency. MutAOX and the low expression AOX line created 
in (I), showed that rescue of locomotor activity in the COX 7a knockdown fly is 
dependent on the enzymatic activity of AOX and is related to the amount of AOX 
expression/activity. The lower dose of AOX was not able to rescue lethality induced 
by ubiquitous COX knockdown (data not shown), but was able to rescue locomotor 
defects from neuronal-specific knockdown to a lesser extent than high doses of 
AOX (I, Fig. 5 B). This narrows down the mechanistic explanations for the rescue 
of the COX 7a knockdown phenotype (discussed later). This result also validates the 
usefulness of the fly lines expressing mutant AOX created in (I). 
In flies, the mutAOX transgene, introduced into the genome by targeted ΦC31 
insertion, showed 3-4 fold lower expression at the RNA level than the AOX 
transgenic lines previously engineered by P-element insertion (Fig. 6 B, C). Therefore 
mutAOX Drosophila lines generated by ΦC31 insertion are not suitable as controls 
for those expressing AOX at a high level, since different levels of expression may 
influence the observed phenotype. This is clearly illustrated in the AOX rescue of 
GS-induced developmental abnormalities (II, Fig. 5), where the mutAOX-
expressing flies were compared with transgenic flies generated in parallel, that 
expressed wild-type AOX from the same insertion site, i.e. at the same low level. In 
this case, as well as in the case of AOX rescue of locomotor deficit caused by 
cytochrome oxidase knockdown (I), lower expression of AOX gave an intermediate 
phenotype between that produced by wild-type AOX and that seen in non-
transgenic control flies. mutAOX gave no such rescue at all. Implementing this 
control was not possible in the case of JNK knockdown, where I found that low-
level AOX expression gave only a marginal or insignificant rescue of cleft thorax 
(unpublished data). It would thus be useful to create flies with high expression levels 
of mutAOX to test whether the observed rescue can truly be attributed to the 
catalytic function of the AOX enzyme. Nevertheless, the creation of ΦC31-
engineered fly lines containing: AOX, mutAOX and empty vector at the exact same 
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position in the genome allows, in principle, for a rigorous experimental setup to 
understand if AOX-related phenotypes arise from the catalytic action of AOX, or 
are simply a hormetic effect due to the presence of a xenotopically expressed protein 
in the IMM. My findings leave open the possibility that AOX has a yet to be defined 
function or mode of regulation. The Drosophila lines that were engineered for this 
work are currently being used by other researchers who are addressing the dose 
dependence of AOX in other studies. However, I was not able to use them for the 
JNK knockdown study for the reasons indicated above, given that all the rescue data 
were obtained using AOX lines exhibiting a higher level of transgene expression 
(III). 
6.2.3 Level of AOX activity is important for rescue of cleft thorax 
In a second example, a single copy of AOX, when constitutively expressed under 
the α-tubulin promoter at a much lower level than when driven by tubGS, could not 
rescue the GS-induced cleft thorax phenotype. However, five doses of the tubAOX 
transgene rescued (II, Fig. 4 C) comparable with the UAS-AOX lines (which express 
AOX at higher level than tubAOX and UAS-AOX7.1 fly lines). Once again, I 
conclude that AOX provides rescue in a dose-dependent manner. This result is 
consistent with work on mammalian respiratory membranes where, with increasing 
AOX supplementation to the membranes, the rate of NADH oxidation increases 
substantially (Fedor & Hirst, 2018). It would be interesting to test the limits of this 
effect, and whether too high an expression level of AOX is also detrimental to the 
rescue of cleft thorax. This would imply a 'Goldilocks' effect, perhaps by regulating 
ROS, which are also known to operate in such a way (Reczek & Chandel, 2017).  
As an alternative to the use of mutAOX as a control, it may be possible to use a 
small-molecule inhibitor of AOX in such studies. Such an inhibitor would have to 
be specific for the Ciona AOX and proven to be harmless to the model system(s) 
employed. Unfortunately, this is not the case for the known AOX inhibitors n-PG 
or SHAM. 
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6.3 tubGS induces developmental abnormalities in the fly  
Transcription factors act in a coordinated manner to direct cell division, growth, and 
cell death throughout life. During embryonic development, the coordinated action 
of transcription factors is also needed to drive cell migration and body plan. 
pnrMD237 GAL4 driven downregulation of JNK pathway components affects only 
the notum of the fly (Fig. 9), while GS under the control of the α-tubulin promoter 
is expressed ubiquitously in the fly. I found that it affects the development of various 
tissues and appendages, leading to cleft thorax, cleft abdomen, externalization of 
trachea, malformed bristles and notched wings (Fig. 8). A different GS driver, with 
a much lower and more restricted expression pattern (III, Fig. S2), affected bristle 
organization but only very subtly. The major dysmorphologies I observed with GS 
have been reported previously in a variety of mutants, often in combinations similar 
to this observation. Cleft thorax together with bent and misshaped sensory bristles 
and severely enlarged legs have been reported in Ultraspiracle mutants (Henrich et 
al., 1994), a dimerization partner of the ecdysone receptor and one of the key nuclear 
receptors which regulates fly development. GS is a steroid-activated chimeric GAL4 
protein (GAL4-progesterone-receptor fusion protein) (Fig. 3 B). Thus, it is not 
surprising that GS can affect so many tissues, given that Drosophila has such a 
complex development. Legs are derived from the same ancestor cells as the wing 
discs in early embryogenesis (Cohen et al., 1993). Tracheal placodes and leg primordia 
arise from a common pool of cells in Drosophila, with differences in their fate 
controlled by the activation state of the wingless signaling pathway (Franch-Marro, 
2006). Tracheal cells in Drosophila always arise in close proximity to the cells that are 
fated to give rise to the legs (Franch-Marro, 2006). The externalized trachea were 
always localized ventrally, close to posterior leg (Fig. 8 H). 
This all implies that GS might act already in early embryogenesis to produce the 
observed malformations, for example by interacting with ecdysone receptor 
signaling or other signaling pathways that impinge on JNK signaling in early 
development. Cleft thorax together with missing or extra bristles has also been 
reported in mutants of the GATA transcription factor pannier (Heitzler et al., 1996). 
Cleft thorax is observed when the nuclear transcription factor Y (dNF-Y) is 
downregulated. This is due to a decreased level of Bsk, as dNF-Y has been found to 
bind the bsk (JNK) gene promoter region, which contains a CCAAT box (Yoshioka 
et al., 2008). The pair-rule transcription factor gene odd regulates the segment polarity 
genes en and wg in the early embryo and also restricts JNK signaling to medial edge 
cells of the peripodial membrane for proper thorax closure. Misregulation of odd 
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leads to thorax closure defects (Tripura et al., 2011). Bristle abnormalities similar to 
those that we observed are also reported in mutants of the gene u-shaped, which is a 
dimerization partner of pannier (Cubadda et al., 1997). A completely different way in 
which GS may affect development is by proteotoxicity, as discussed in a later section 
(6.5.2). 
Whether and how the GS effect is related to JNK signaling still remains a puzzle 
and unraveling this relationship may shed light on the role of JNK signaling in 
Drosophila development more broadly. It could be that GS interacts with other 
transcriptional factors at the promoter regions of many developmental selector 
genes. A chromatin immunoprecipitation (ChIP) assay could be performed to 
understand whether GS binds in the Drosophila genome to the 5´ flanking regions of 
any of the genes known to influence development. 
6.4 Model systems: pros and cons 
6.4.1 Limitations of the fly model 
The majority of fundamental biological mechanisms and pathways that control 
development are conserved across evolution between species (Jennings, 2011). This 
allows the use of simple model organisms, like yeast, nematodes, Drosophila or the 
zebrafish, to study complex molecular processes that occur in the human body. It 
was Charles W. Woodworth, an American entomologist, who first proposed the use 
of Drosophila melanogaster as a genetic model organism (Sturtevant, 1959). Since 
Thomas Hunt Morgan’s pioneering work in the 1930s, Drosophila has been 
extensively used in the study of animal development and behavior, neurobiology, 
human genetic diseases and drug discovery. We can test the effects of novel therapies 
by exploiting genetic tools available in this model, one of which is RNA interference 
(RNAi) which I used (III) to downregulate the expression of genes involved in 
thorax formation, leading to defective midline closure. I also used another tool, 
UAS-GAL4, to overexpress the AOX enzyme from C. intestinalis, and observed that 
this was able to reverse the induced thoracic defect (II, III).  
However, Drosophila also has limitations. First, although the fly model helped me 
to understand which downregulated genes AOX can compensate for, and build a 
testable hypothesis, it was not possible to use it to elucidate the mechanism by which 
AOX provides this rescue. Techniques to isolate the specific cells where the JNK 
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pathway was downregulated and test my hypothesis are not currently available. This 
would require isolation of the limited cell population where JNK is active during the 
larval and pupal stage from the progeny containing all the needed transgenes for 
downregulation of the gene and rescue. There is currently no way to distinguish these 
larvae or pupae from controls, due to the specificity of the crosses and lack of 
markers. Validating my findings (III) in mammalian cells allowed me to test 
hypothetical AOX rescue mechanism(s) in a more experimentally malleable system 
that also has direct translational relevance to human disease. The fact that AOX was 
found to promote migration in both models, supports but does not prove that it acts 
by a common mechanism, whether by ROS dampening, heat production or 
something else.  
6.4.2 Developmental disturbance in Drosophila resulting from the GS 
system 
Drosophila is an invaluable model system in research because of its vast and easy to 
use genetic toolkit, providing over-expression, knockdown, and knockout of 
particular genes. Also, 75% of Drosophila genes have counterparts in the human 
genome (Pandey & Nichols, 2011). However, we are not always fully aware of the 
limitations of the tools available for research. To spatially and temporally control 
gene expression in a living organism is invaluable, but even an elegant system such 
as GeneSwitch in Drosophila has potential flaws that must be considered. 
The use of the GS system assumes that it is inert in the fly. However, the findings 
reported here suggest otherwise. I used tubGS and daGS drivers to ubiquitously drive 
the expression of AOX transgenes during development (II). I identified specific 
developmental abnormalities arising from the use of tubGS in combination with 
RU486, including substantial pupal lethality already at 2.5 μM RU486, and from 10 
μM dysmorphologies described above (Fig. 7 and 8). This suggests that the tubGS 
system itself induces such defects, by affecting transcription as hypothesized above. 
The chimeric GS protein should be inert, as there is no UAS sequence in the 
Drosophila genome to which it can bind. However, Liu & Lehmann (2008) showed 
that expression of high levels of the Gal4 protein in Drosophila can cause a genomic 
response, where modified expression was found, of many genes involved in 
development. Since GS is a modified Gal4 protein, it is perhaps unsurprising that it 
induces developmental defects (II), and conversely surprising that this has been 
previously ignored.  
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My work raises concerns about the use of the tubGS system. To avoid 
misinterpreting data it is advisable to use it in conjunction with control experiments 
that carefully monitor the effects of activated GS alone. We cannot rule out that 
there are other disturbances when using the system, even with other GS drivers and 
at lower RU486 concentrations than used here. Thus, all studies should control for 
the effect of the transcription factor plus RU486 alone, when drawing conclusions. 
There are many studies (e.g., Myllymäki & Rämet, 2013; Cho et al., 2014; Kim et al., 
2015) that may have reached misleading conclusions due to a lack of such controls. 
6.4.3 Limitations of the cell model 
One intriguing issue that arose was the difference in sensitivity to AOX between 
immortalized and primary MEFs (Fig. 14 A, B). In fact, it was difficult to perform 
wound healing assays on primary MEFs. Primary MEFs were extremely sensitive to 
JNK inhibitors, which iMEFs handled without observable problems. The use of 
human fibroblasts was set aside during the study, after it was discovered that the 
AOX-transduced BJ-5ta cell line exhibited structurally impaired mitochondria with 
decreased complex I activity (data not presented). Further investigation using other 
cell-lines would be needed, to confirm the generality of the effects of AOX on cell 
migration, and the relationship to immortalization or transformation.  
6.4.4 Limitations of the scratch-wounded confluent monolayer of fibroblasts  
During re-epithelialisation of the epidermis after injury, cells at the leading edge are 
able to undertake cytoskeletal changes; extending lamellipodia, filopodia and 
polarizing in the direction of migration (Wager et al., 2017). Individual cells can take 
on a leading role in collective migration, forming a cell group termed ‘leader cells’ 
that have a specific phenotype and profile of gene expression independent of other 
cells (Wager et al., 2017; Khalil & Friedl, 2010; Riahi et al., 2012). In a simple 2D 
system, a technique which recapitulates cutaneous wound re-epithelialisation (Wager 
et al., 2017), I observed that the AOX-expressing wound healing monolayer  has 
single 'leader cells', which were able to detach from other cells and explore the 
environment, making more protrusions than non-AOX control cells (data not 
presented). Computational methods could be applied to this data to extract different 
parameters than those used conventionally to describe collective cell migration. 2D 
and 3D environments are also different in terms of cell adhesion and migration 
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behaviors (Vu et al., 2015). In vivo, cells move in a complex environment defined by 
a combination of ECM proteins, proteoglycans, polysaccharides, growth factors, and 
signaling molecules (Frantz et al., 2010). Here, I tested the effect of AOX on the 
migration of cells in a purely 2D assay, stripped from any influence of the ECM. It 
would be interesting to test whether AOX can promote cell migration in models that 
better mimic the cellular environment in vivo, such as 3D scaffolds manufactured 
using biomaterials (Yang et al., 2017) or organoid models, e.g., the organotypic 
culture model of mammary branching morphogenesis (Ewald et al., 2008) before the 
wound healing is attempted in mice.  
6.4.5 Limitations of using GFP as a control 
Expression of an exogenous protein can perturb cell structure and function in 
unpredictable ways. This issue is inherent to any experiment, and is clearly 
demonstrated by my findings in the case of the GS system (II).  This was why I set 
out to create the catalytically inactive variant of AOX (I), which unfortunately was 
not available at the start of the JNK study, and anyway proved to be an insufficiently 
strong expressor. Instead, I initially used GFP expressed in the cytoplasm as a routine 
control in all AOX expression studies (II, III), which has its own limitations. GFP is 
a structurally and functionally distinct protein from AOX, thus having different 
properties when expressed as a foreign protein in cells. Even though it is considered 
an inert protein in model systems it has been shown that wild-type GFP from the 
jellyfish, Aequorea victoria, quenches O2•− and has SOD-like activity by competing 
with cytochrome c for O2•− (Bou-Abdallah & Chasteen, 2006). However, since GFP 
as used in my experiments resides in the cytosol, it should not have access to 
mitochondrially generated superoxide, nor should it interact with or compete with 
cytochrome c. On the other hand, the fact that it is expressed in a separate cellular 
compartment than AOX, which is an inner mitochondrial membrane protein, means 
that it may have different non-specific effects on cellular protein homeostasis. 
Nevertheless, by modulating ROS or interacting with cytochrome c, AOX could 
influence apoptosis during development, which could impact the mechanism behind 
any rescue. AOX acts by oxidizing quinol and preventing cytochrome c from 
reduction, while GFP may restrict cytochrome c oxidation.  Thus, they might be 
predicted to have opposite effects, which I indeed observed when attempting some 
instances of JNK-pathway rescue with AOX and GFP (III, Fig. 3 F). The JNK 
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signal-transduction pathway appears to be essential for the execution of apoptosis in 
response to several different stimuli (Davis et al., 2000). Apoptosis is needed in pupae 
where imaginal cells undergo apoptosis during thorax formation (Martín-Blanco et 
al., 2000 (Fig. 2). In the case of JNK knockdown AOX could be instrumental in 
'replacing' JNK by promoting apoptosis, for which GFP is not so much a control as 
a parallel experiment. 
6.5 Possible mechanisms of AOX rescue of cell migration 
defects  
6.5.1 AOX rescue depends on its enzymatic activation 
Based on my findings (I, II), the effects of AOX on Drosophila depend upon on its 
activation, at least in the case of locomotor impairment resulting from COX 7a 
knockdown (I) and the developmental abnormalities resulting from activated tubGS 
(Fig. 7). This is also most likely the case for rescue of JNK knockdown and 
promotion of cell migration in the wound-healing assay (III). Data obtained from 
many transgenic models, including human cells (Hakkaart et al., 2006; Dassa et al., 
2009), mice (El-Khoury et al., 2013) and flies (Fernandez-Ayala et al., 2009) indicate 
that the AOX from C. intestinalis becomes activated only when needed, i.e. when the 
cytochrome pathway is blocked, and there is resulting over-reduction of the quinone 
pool. This is consistent with previous studies in other organisms (Hoefnagel & 
Wiskich, 1998; Castro-Guerrero et al., 2004), which showed that AOX activation 
occurs when ubiquinol accumulates to substantial levels due to respiratory chain 
inhibition or overload. This would mean that AOX activation during development, 
when the JNK pathway is inhibited or if GS is active could be due to mimicking this 
condition. However, not much is known about the activation of AOX in metazoans, 
leaving open the possibility that the downregulation of JNK signaling or the presence 
of activated GS leads to the enzymatic activation of AOX by an as yet unknown 
metabolic mechanism. What we know is that AOX activity in plants increases with 
cold (Stewart et al., 1990) or oxidative stress (Wagner, 1995). This further implies that 
there might be disturbances in the redox state of the developing cells of the thoracic 
epithelium due to JNK downregulation or GS activation, or in a cell monolayer 
responding to wounding.  
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6.5.2 AOX decreases ROS  
It is known that AP-1 mobilizes oxidative defense and it is at the same time sensitive 
to oxidation and therefore protected by number of proteins. For example, redox 
factor 1 (Ref-1) is involved in reduction of the critical cysteine residues of Fos and 
Jun to maintain their DNA-binding activity following oxidative stress (Xanthoudakis 
& Curran, 1992). MBF1 also protects the critical cysteine residues from oxidation 
(Jindra et al., 2004) and stimulates AP-1 binding to DNA. AOX could be 
instrumental in protection of AP-1 from oxidation by generally decreasing mtROS 
when activated (Dogan et al., 2018). This, however needs to be tested by measuring 
ROS in the relevant cells, and assessing the status of the cysteine residues of AP-1 
by redox proteomics. However, I could not see any change in AP-1 transcriptional 
readout in AOX-expressing S2 cells, nor in mammalian cells when JNK was 
modulated. This implies that the mechanism of AOX action is not due to ROS. 
Furthermore, this conclusion is supported by the lack of any effect of ROS 
modulators on the AOX-dependent stimulation of migration in the wound-healing 
assay (III, Fig. 8). 
6.5.3 AOX is a thermogenic protein 
Temperature is what Richard Feynman called the 'jiggling' of atoms (Sengupta & 
Garrity, 2013). Thermosensors are molecules whose temperature sensitivity serves 
as information about the thermal environment and trigger an appropriate 
physiological or behavioral response (Sengupta & Garrity, 2013). What that means 
is that temperature alters the configuration of the atoms of biomolecules, affecting 
their activity. Environmental temperatures and their changes can be read by nucleic 
acids, lipids and proteins, acting as thermosensors, which then regulate cellular 
processes, including transcription, protein stability and signal transduction (Sengupta 
& Garrity, 2013). Such processes could underlie the effects of AOX. 
When AOX is active, electrons are passed to oxygen without proton pumping, 
so that the energy of the reaction is used to produce heat. It is well documented that 
AOX is thermogenic in plants under specific circumstances; for example in the 
flowers of Philodendron selloum and Symplocarpus foetidus, which can heat up to 35 °C 
above ambient temperature (Elthon & Mcintosh, 1987; Wagner et al., 2008; Seymour, 
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2000). We showed in a recent report that Ciona AOX expressed in Drosophila may be 
functionally thermogenic under specific physiological conditions, providing cold 
resistance to developing and adult flies (Saari et al., 2018). Consequently, if 
enzymatically active, AOX could increase the temperature of the developing thorax 
in Drosophila, which in turn may activate or by-pass JNK signaling by a variety of 
mechanisms, allowing migration to proceed. One such mechanism could simply be 
a thermogenic potentiation against oxidative stress, strengthening JNK signaling 
(Courtial et al., 2017). Increased phosphorylation of JNK was observed in human 
fibroblasts under thermal stress (Courtial et al., 2017). Another mechanism could 
involve heat-shock proteins. Heat shock protein 90 (Hsp90) has been reported to 
stabilize proapoptotic JNK signaling (Nieto-Miguel et al., 2007), whilst heat shock 
protein 70 (Hsp70) has been shown to promote cell migration by acting as a 
chaperone to deliver proteins to the leading edge (Boroughs et al., 2011). 
As discussed above, a likely way in which GS influences development in 
Drosophila is via transcription. However, an alternate mechanism could be its 
accumulation in the cell causing proteotoxicity. The latter hypothesis is tentatively 
supported by the fact that I observed the same developmental abnormality, cleft 
thorax, when the human huntingtin protein with an extended polyglutamine repeat 
of 93 residues (Httex1p Q93) was ubiquitously expressed in Drosophila (unpublished 
data). A proteotoxic effect could potentially be mitigated by the fact that AOX being 
thermogenic activates the heat-shock response, which is instrumental in decreasing 
misfolded proteins, thus providing the rescue. It would be interesting to attempt 
AOX rescue of the cleft thorax induced by Httex1p Q93.  
6.5.4 AOX affects ATP production 
AOX activation would mean decreased electron flow through complex III and 
cytochrome c oxidase and thus, decreased ATP production. This might be 
exacerbated by increased heat production. These changes could provide the initial 
stimulus for JNK activation as a stress response. However, treatments that limit 
mitochondrial ATP production (oligomycin, FCCP and rotenone) did not have 
differential effect on the migration of AOX-expressing cells in the wound healing 
assay (III, Fig. 8) showing that ATP modulation is most likely not behind the 
mechanism of AOX action in that context. In the fly, AOX rescued cleft thorax 
induced by JNK knockdown, and in iMEFS restored migration when JNK was 
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blocked by SP600125. However, despite their apparent similarity, these two effects 
of AOX could be via different mechanisms.  
6.5.5 Potential interplay between AOX and mitochondrially localized JNK 
JNK functions as a signal transducer that conveys cytosolic oxidative stress signals 
to both the nucleus and mitochondria. JNK phosphorylates c-Jun, p-53, Elk-1, ATF-
2 (Johnson & Nakamura, 2007; Weston & Davis, 2007) as well as Bax protein, 
promoting apoptosis (Bong-Jo et al., 2006). JNK translocates to mitochondria and, 
by facilitating cytochrome c and SMAC release from the intermembrane space, it can 
induce apoptosis (Aoki et al., 2002). JNK also phosphorylates pyruvate 
dehydrogenase (PDH). It has been proposed that JNK kinase may trigger either a 
phosphorylation cascade across mitochondrial membranes involving unidentified 
intermediates, or activate a second messenger, such as Ca2+, leading to the activation 
of PDH (Zhou et al., 2008). 
Mitochondria are sources of H2O2 and NO (Cadenas & Davies 2000; Poderoso 
et al. 2000). Antimycin A increases H2O2 production due to its action on complex 
III, which in turn results in the translocation of JNK into the mitochondria (Hanawa 
et al., 2008). The potentiation of cell migration in AOX-expressing iMEFs, but not 
in the control iMEFs suggests that proximity of JNK when complex III is blocked 
creates conditions for the AOX to promote cell migration. 
6.5.6 AOX and IMM shape 
The shape of the inner mitochondrial membrane influences mitochondrial function 
(Mannella, 2006).  For example ATP synthase contributes to the curving of the IMM 
as result of its oligomerization (Paumard et al., 2002; Strauss et al., 2008). Optic 
atrophy 1 (OPA1) protein is anchored to the IMM and is another protein involved 
in mitochondrial shape which affects its functions (Campello & Scorrano, 2010; 
Belenguer & Pellegrini, 2013). New mitochondria-shaping proteins influencing their 
function continue to be discovered. 
The presence in the IMM of the Ciona AOX protein, which presumably functions 
as a dimer, might affect inner membrane organization which could have various 
bioenergetic implications. Altered IMM topology might affect mitochondrial 
signaling leading to the activation of JNK or of a parallel pathway. However, whilst 
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this might be a plausible mechanism to account for the promotion of iMEF 
migration by AOX, it cannot explain why AOX corrects cleft thorax and other 
developmental abnormalities caused by tubGS plus RU486, since this requires the 
enzymatic activity of AOX, as shown by the mutAOX control (II). 
6.6 Potential use of AOX in therapy 
Despite sequence conservation, AOXs of different species exhibit considerable 
diversity in enzymatic properties (May et al., 2017). How Ciona AOX is regulated is 
still unclear, and there is insufficient data on animal AOX in general to address this 
issue (McDonald et al., 2009). AOX expressed in animals possess a unique C-terminal 
of unknown function (McDonald et al., 2009), but also lack an N-terminal cysteine 
residue which is important for enzyme regulation in plants (McDonald et al., 2009). 
In plants, AOX protein is stress-regulated (as well as being tissue-specific): for 
example, it is dramatically increased within 5 hours of addition of antimycin A in 
tobacco (Vanlerberghe & Mclntosh, 1992). Our own recent work shows that AOX 
is induced in Ciona by hypoxia and sulfide exposure (Saari et al., 2018). Obviously, 
such regulation is lost in transgenic models, unless it operates post-transcriptionally. 
Conversely, the inference that AOX is activated in specific contexts in Drosophila 
development and in migrating mammalian cells may provide a handle on 
understanding exactly how and by what the enzyme is activated metabolically, which 
could help assess better how to use or engineer it therapeutically. In this context, it 
would be illuminating to test AOXs from other organisms (e.g., plants, fungi or 
trypanosomes) in the same assays used here. 
A similar type of epithelial sheet movement to that seen in thoracic closure in 
Drosophila occurs in ventral closure in C. elegans, and in neural tube closure, embryonic 
wound healing and epiboly in vertebrates (Harden, 2002). In addition, key events in 
cancer progression show remarkable similarities with wound healing (Chang et al., 
2004), suggesting that cancer involves deregulation of normal wound healing 
processes (Dauer et al., 2005). DNA microarray analyses have shown that the gene 
expression pattern of healing skin resembles that of malignant tumors (Iyer et al., 
1999; Chang et al.,2004). Wounds which do not heal could be a risk factor for 
malignant transformation (Schäfer & Werner, 2008) due to specific changes in gene 
expression (Chang et al., 2004). This strengthens the idea proposed by Dvorak (1996) 
that “tumor stroma generation is wound healing gone awry.” Accelerated wound 
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healing is desirable, e.g., in victims of burns, and in people with slow-healing skin 
lesions as seen in diabetics (Greenhalgh, 2003) or following surgery, At the same 
time we do not want wound healing to go awry, promoting tumor formation.  
Once the mechanism is more clearly established, a follow-up study would be to 
test AOX in a mouse wound-healing model (Dunn et al., 2013), aiming eventually to 
apply the knowledge in human diseases such as chronic wounds, where the 
underlying biology is still not well understood (Nuutila et al., 2014). Translating 
between models is appropriate in this case because the molecular machinery and 
mechanisms driving wound healing resemble those found in tissue fusion events 
during animal development (Kurosaka & Kashina, 2008), including dorsal and 
thoracic closure in the Drosophila embryo. Based on my findings, AOX could also be 
applied therapeutically in humans to prevent developmental abnormalities; however, 
its use in any application could also promote tumor invasion. The outcome may 
depend on the specific context of where, when and how much AOX is being 
expressed. AOX may therefore prove most useful as a tool to elucidate the 
underlying processes and ensure a safe outcome in a wide variety of interventions. 
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7 CONCLUSIONS 
This is the first report that xenotopic expression of AOX remedies developmental 
abnormalities that occur without any documented mitochondrial respiratory chain 
defects. That itself raises the intriguing question of how alterations to nuclear-
receptor and JNK signaling may influence mitochondria and vice versa. Using data 
obtained from two tested models: thorax closure in Drosophila and wound healing in 
mammalian cells, I am able to propose that mitochondria impact collective cell 
migration, specifically involving the respiratory chain at the level of complex III 
and/or IV. Perturbation of the mitochondrial RC affects signaling pathways which 
control cell migration. The importance of this discovery which combines in vivo 
model organism experiments and in vitro cell culture should lead to further studies 
investigating the mechanism whereby mitochondrial respiratory function affects cell 
migration and other developmental programs. My observation that AOX influences 
the migration of iMEFs, which are highly dependent on glycolysis, but not that of 
primary MEFs, suggests a new dimension in considering the links between 
mitochondrial metabolism and cancer metastasis. Other important questions arising 
from my work concern the role of ROS and mitochondrial heat production in 
regulating the intracellular signals responsible for lamellipodia formation, actin 
cytoskeleton remodeling and focal adhesion turnover. AOX is believed to act, 
indirectly and perhaps also directly, as a scavenger of mitochondrially generated 
ROS; but it is also thermogenic. Although a unifying hypothesis would be attractive, 
there could be different modes of action of AOX affecting cell migration in these 
different models. A temperature effect could operate in one case, but ROS 
modulation in another. Using an omics approach could give insight into possible 
mechanisms of AOX action which can then be subjected to more rigorous 
experimental testing. Omics could also be used to probe how GS causes such a wide 
spectrum of malformations in Drosophila, and how this relates to interference with 
transcription, cell signaling or proteotoxic stress.  
The development of in vivo thermal probes for use in Drosophila would enable 
measuring the temperature in the pupa during thorax formation. Indirectly we could 
test expression of the heatshock proteins, some of which are known to promote cell 
migration, e.g., Hsp70 binds the protein cross-linking enzyme tissue 
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transglutaminase (tTG) localizing it to the leading edge in cancer cell migration. 
(Boroughs et al., 2011). To test the involvement of ROS, we could attempt the rescue 
of the cleft thorax with catalase or expose flies to agents such as mitoquinone 
mesylate (MitoQ) or N-acetyl cysteine (NAC).  
A full understanding of the mechanism whereby AOX impacts development can 
potentially enable the design of new treatments for tissue injuries, metastatic tumors 
and congenital midline closure defects, as well as more 'conventional' effects of 
mitochondrial dysfunction. 
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The mitochondrial alternative oxidase, AOX, carries out the non proton-motive re-oxidation of 
ǡǤƤ
of AOX from Ciona instestinalis, carrying mutations at conserved residues predicted to be required for 
ǤƤ
ƪǡƪ
for a subunit of cytochrome oxidase. The mutated AOX transgene is thus a potentially useful tool in 
ơǤ
The mitochondrial alternative oxidase, AOX, carries out the non proton-motive re-oxidation of ubiquinol by 
molecular oxygen. Terminal electron transfer by AOX constitutes a parallel system to that provided by OXPHOS 
complexes III and IV in plants, fungi, protists and many animal phyla1. AOX is believed to become activated under 
stress conditions, when the OXPHOS cytochrome chain is overloaded or unavailable.
In many organisms this is achieved, at least in part, via the regulated expression of the AOX gene, which is 
induced by a variety of stresses relevant to OXPHOS dysfunction2,3. The enzyme is also inherently responsive to 
the metabolic signature of such stresses in different organisms. Firstly, it is activated by high levels of its reduced 
substrate, ubiquinol4,5, which is assumed to reflect a lower affinity for the substrate than that exhibited by OXPHOS 
complex III, with which it competes. Thus, under normal physiological conditions, most of the electron flow 
from ubiquinol to oxygen is channelled through complexes III and IV, even if AOX is physically present. Only if 
ubiquinol levels increase, for example, if the enzymatic capacity of complexes III and IV becomes limiting, will 
AOX become functionally significant. In addition, AOX is allosterically activated in many organisms by metabo-
lites whose levels increase under conditions of OXPHOS insufficiency, for example pyruvate3, as well as by other 
metabolites indicative of cellular redox state.
Although the AOX gene has been lost, during the course of evolution, in the lineages leading to the most com-
plex and advanced metazoan groups, including mammals1, we reasoned that its reintroduction by transgenesis 
should enable such animals to buffer many of the pathological stresses resulting from OXPHOS dysfunction6. 
Thus AOX could become a therapeutic tool for treating mitochondrial diseases and other conditions mediated by 
OXPHOS dysfunction7. Preliminary tests in model organisms, including cultured human cells8,9, Drosophila10,11 
and the mouse12, support this concept. In particular, the expression of AOX from the tunicate Ciona intestinalis, was 
shown to compensate many of the phenotypes resulting from cytochrome oxidase (COX, complex IV) deficiency 
in Drosophila, including the knockdown of structurally essential subunits of the complex11. However, if AOX is to 
be of value in eventual therapy, the mechanism of this compensation needs to be established. The hypothesized 
ͷ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enzymatic by-pass is only one of several possible such mechanisms. Expression of an inert transgene, such as 
GFP, in place of AOX, was unable to rescue the phenotypes produced by engineered deficiency of cytochrome 
oxidase10,11. However, this control cannot be unambiguously interpreted, since the expressed GFP was not targeted 
to mitochondria, and even if it were, does not possess other structural features of AOX that enable it to insert into 
the inner mitochondrial membrane in a specific fashion and interact with other components thereof.
In order to provide a more applicable test of whether the ability of AOX to rescue COX deficiency depends 
on its primary enzymatic activity, we sought to engineer the AOX in such a way as to destroy this activity, whilst 
producing only a minimal effect on the overall structure, stability and expression of the protein. To do this, we took 
advantage of the fact that AOX is well conserved phylogenetically, that the residues contributing to its active site 
have been characterized in a number of species, and that the structure of a representative AOX, from the protistan 
parasite Trypanosoma brucei, has recently been published13. Using currently available bioinformatics tools, we 
modelled the structure of the Ciona intestinalis enzyme against this template, predicted amino-acids required for 
binding the catalytically essential diiron moiety at the active site, and proceeded via alanine-substitution mutagen-
esis to create an expressible version of the enzyme expected to lack enzymatic activity, despite being predicted to 
fold to a similar overall structure. In several different contexts (cultured human and Drosophila cells, as well as 
whole animals), we found that the mutated AOX was stably expressed but devoid of detectable enzymatic activity. 
Furthermore, expression of the transgene encoding the mutated AOX was unable to rescue engineered COX defi-
ciency in the fly, confirming that this rescue indeed depends on the enzymatic activity of AOX.
Materials and Methods
Sequence alignments and molecular modelling. The sequences of AOX homologues found by BlastP 
searching were aligned using the MUSCLE algorithm built into the software MEGA614, with default parameters. 
A homologous model of the structure of one subunit of the C. intestinalis AOX was generated using the software 
I-TASSER15, based on the crystal structure of the Trypanosoma brucei AOX (PDB 3VV9:A)13 as template and the 
multiple sequence alignment described above as input restraint. Other parameters were set as default. Selection 
of the model was based upon the best accuracy estimations provided by the C-scores, estimated TM-scores and 
RMSD values. Because the N-terminal region (M1-K103) of the C. intestinalis AOX structure could not be mod-
elled with high accuracy, this region was eliminated from the analysis. The dimeric model of C. intestinalis AOX 
and the positioning of the two diiron centres (one per subunit) were built by overlapping two copies of the model 
generated by I-TASSER into the crystal structure of the dimeric T. brucei AOX using Pymol (www.pymol.org). 
Pymol was also used to analyze all structure models and to produce the figures.
Cloning procedures and mutagenesis. For Drosophila expression, the C. intestinalis AOX coding sequence, 
including its natural stop codon, was recloned from the pMT/V5-His B vector (Invitrogen), in which it had been 
previously propagated, into the EcoRI site of pUASTattB16. Based on the multiple sequence alignment shown in 
Fig. S1, and the results of molecular modelling (see Results), PCR-based alanine substitution mutagenesis and 
recloning were carried out according to the scheme of Fig. S2. Mutations E239A, H242A, E344A and H347A were 
introduced, using the plasmid-borne AOX cDNA as template, Pfu DNA polymerase (Stratagene) and oligonucleo-
tides (all shown 5′ to 3′ ) as follows: GAAGCTGAAAATGcGAGAATGgcCTTAATGACTGCG and CGCAGTCA 
TTAAGgcCATTCTCgCATTTTCAGCTTC to create E239A/H242A, followed by ATCTGAGCTGAT 
GcAGCACATgcCAGATCAGTCAAC and GTTGACTGATCTGgcATGTGCTgCATCAGCTCGGAT to create 
E344A/H347A (lowercase letters indicate the sites of introduced mutations). For expression in S2 cells, constructs 
containing the original and mutated AOX cDNA inserts, again using the natural stop codon, were recloned into 
the EcoRI site of pAc5.1/V5-His B (Invitrogen, USA) to create pAC/AOX17 and pAC/mutAOX. For transient 
mammalian expression, the wild-type and mutated AOX coding sequences were recloned, respectively, into a 
pBR322-derived kanR plasmid containing the CAG promoter18 and bovine growth hormone poly(A) signal, together 
with other elements not relevant to the present study (copies of the tet operator, loxP sites, insulator elements and 
portions of the porcine Ggta1 gene), to create the expression constructs pCAG-AOX and pCAG-mutAOX. The 
nucleotide sequences of all clones were confirmed by Sanger sequencing using the Big Dye Terminator v3.1 kit 
(Life Technologies) and an ABI3130xl Genetic Analyzer, according to the manufacturer’s specifications.
Drosophila stocks and maintenance. Except where stated, flies were maintained and grown on standard 
medium at 25°C, using a 12 h light/dark cycle, as previously10,19. Balancers, recipient line w1118, the RNAi line for 
CG9603 (Vienna Drosophila RNAi Center line 106661), the ubiquitous da-GAL4 driver (Bloomington line 8641) 
and the driver line bearing elavC155-GAL4 on chromosome X and UAS-Dcr2 on chromosome 2 (Bloomington line 
25750), were obtained from stock centres. Φ C31 recombinase-mediated-site-directed transgenesis was used to 
generate transgenic fly lines (service provided by BestGene Inc, Chino Hills, CA), using recipient lines with the 
following integration sites: attP18 (chromosome X), attP40 (chromosome 2) and attP2 (chromosome 3), according 
to Pfeiffer et al.20, employing the wild-type and mutated AOX constructs cloned in pUASTattB and pUASTattB 
itself as empty-vector control. Following characterization, transgenic lines were maintained over balancers appro-
priate for chromosome X, 2 or 3, bearing standard markers (FM7, CyO, TM3Sb, respectively). Transgenic lines 
UAS-AOXF24 and UAS-AOXF6 were described previously10.
Cell culture and transfection. HEK293T cells were cultured as previously21. Plates of 3 × 106 cells were trans-
fected with 24 μ g of the pCAG-AOX or pCAG-mutAOX plasmids or, as control, empty vector (pWPI, Addgene), 
using 60 μ l Lipofectamine® 2000 (Invitrogen) under manufacturer’s recommended conditions. Drosophila S2 cells 
were grown and transfected with pAc5.1/V5-His B or derivatives as previously17.
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Expression assays. RNA extraction and QRTPCR to measure AOX transcript levels using RpL32 RNA as an 
internal normalization standard were as previously described10, using RNA from 2 day-old adult male and female 
flies. Protein extraction from 2 day-old Drosophila adults and Western blots were conducted essentially as by 
Fernandez-Ayala et al.10, with the following modifications: for females, 1% SDS was used for lysis instead of 1.5% 
Triton X-100, flies were processed in batches of 30 (females) or 40 (males), SDS-PAGE used Any kD™ Criterion™ 
TGX™ 18-well gels (Bio-Rad), Prestained Protein Ladder (Thermo-Scientific) and ProSieveTM EX Running and 
Transfer Buffers (Lonza), and membranes were treated in PBS-Tween® instead of TBS. Primary antibodies used 
were customized rabbit anti-AOX10 (21st Centrury Biochemicals, 1:10,000), rabbit anti-α -actininin C-20-R (Santa 
Cruz Biotechnology, 1:5,000) and mouse anti-ATP5A (Abcam, 1:50,000). Secondary antibodies were Peroxidase 
Goat Anti-rabbit IgG and Horse Anti-mouse IgG (both from Vector Laboratories, 1:10,000). Post-nuclear extracts 
(PN) from HEK293T cells were prepared according to Cannino et al.21. Protein concentrations were measured 
using the Bradford assay.
Respirometry. Oxygen consumption of 5 × 106 human cells was measured 48 h after transfection, follow-
ing permeabilization with 80 μ g/ml digitonin, in a Clark-type electrode (Hansatech Oxytherm system) using 
respiratory buffer A22 at 37 °C. Complex II-driven respiration was measured in the presence of 10 mM ADP and 
10 mM succinate. AOX-driven (antimycin-resistant) respiration was measured after the further addition of (60 ng/
ml) antimycin A, with subtraction of any residual oxygen consumption after adding 100 μ M n-propyl gallate. 
Respirometry on S2 cells was as described previously17 and was also conducted on homogenates from 1–4 day-old 
Drosophila males. Briefly, 25 males were gently homogenized in 0.8 ml ice-cold isolation buffer (250 mM sucrose, 
5 mM Tris-HCl, 2 mM EGTA, pH 7.4) and muslin-filtered. Respirometry was performed on 150 μ l aliquots of this 
homogenate, mixed with 500 μ l assay buffer (120 mM KCl, 5 mM KH2PO4, 3 mM HEPES-KOH, 1 mM EGTA, 
1 mM MgCl2, 0.2% BSA, pH 7.2), substrates (15 mM glycerol-3-phosphate and 5 mM ADP) and inhibitors as for 
permeabilized mammalian cells.
Behavioural assays. Time to eclosion following Drosophila crosses was measured as previously23. Eggs from 
parents crossed two days earlier were collected over three consecutive nights, and cultured at 25°C. Adults less 
than 24 h old were collected and sorted on ice, after which batches of 5 male flies were placed in each empty vial. 
After a 10 min waiting period, flies were tipped down and their subsequent behaviour recorded using a DFK 
21AF04 camera (The Imaging Source, Bremen, Germany) and Media Recorder 2 software (Noldus, Wageningen, 
Netherlands). The climbing index11 for each vial was manually calculated from recordings as the mean number 
of flies which climbed 6 cm in 10 s in three trials. Climbing indices from different genotypes were compared by 
one-way ANOVA with Bonferoni adjustment, using SPSS 12. The box plot was drawn with BoxPlotR (boxplot.
tyerslab.com), with Tukey style whiskers extending to the data point that is no more than 1.5 × IQR (interquartile 
range) from the edge of the box24.
Human subjects. The work reported here did not use human subjects or any materials derived from human 
subjects, other than the freely available cell-line HEK293T.
Results and Discussion
Modelling and creation of mutated AOX transgene. Alignment of the predicted Ciona intestinalis AOX 
amino-acid sequence with the corresponding protein from other taxa, including Trypanosoma brucei, revealed 
conservation of residues implicated in the organization of the diiron centre of the enzyme, as previously reported 
by Shiba et al.13. The four invariant glutamate residues and two histidines correspond in Ciona AOX with E200, 
E239, E290, E344, H242 and H347 (Fig. S1), numbered from the first methionine of the putative preprotein. In the 
Trypanosoma AOX structure, the conserved histidines participate in a hydrogen bond network that also includes 
a conserved tyrosine, Y297 in Ciona AOX (Fig. S1). Structural modelling (Fig. 1) showed that Ciona AOX can 
fold to an almost identical structure as its Trypanosoma counterpart, ignoring the poorly conserved N-terminal 
region (residues 1–103 of the Ciona protein, Fig. S1). Four alpha-helices enclose the diiron centre of each protomer 
of the homodimeric protein, with the conserved glutamate and histidine residues similarly juxtaposed as in the 
Trypanosoma protein (Fig. 1). Based on this structure, we tested the functional significance of the conserved 
residues at the predicted diiron centre, by mutating four of them to alanine (E239A, H242A, E344A, H347A), in 
appropriate transgenic constructs for expression in mammalian cells and Drosophila (Fig. S2). The mutations were 
predicted to destroy the binding of iron to the active site, whilst only minimally disturbing the overall structure 
of each subunit.
ƪǤ In order to test its functionality, 
the expression of the mutated AOX construct (mutAOX) was first verified, following transient transfection into 
cultured human cells. Based on Western blotting (Fig. 2A), the mutAOX protein was the same size and compa-
rably expressed as wild-type AOX. Next, the mutAOX transgene, under the control of the GAL4-dependent UAS 
promoter, was introduced into the Drosophila genome by targeted insertion at single sites on each chromosome. 
Parallel control lines were created, containing wild-type AOX and empty vector, inserted at the same sites. Following 
validation of the insertions by PCR and sequencing, we measured transgene expression directed by the ubiquitous 
da-GAL4 driver, at both RNA and protein levels, using QRTPCR (Fig. 2B, C) and Western blotting (Fig. 2D, E).
In both females (Fig. 2B) and males (Fig. 2C), the expression of wild-type and mutAOX were similar at the 
RNA level, but 3–4 fold less than AOX in the previously created transgenic lines, engineered by random P-element 
insertion. At the protein level, mutAOX showed slightly lower expression than wild-type AOX in both sexes, and 
expression was again less than in the previously created lines (Fig. 2D, E).
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When expressed ubiquitously using the da-GAL4 driver, the AOX and mutAOX transgenes produced only 
very small changes in developmental timing, most of them non-significant compared with the corresponding 
vector-only line (Fig. 3).
Mutated AOX lacks detectable enzymatic activity. The functionality of the expressed AOX vari-
ants was tested by polarography. Permeabilized HEK293T cells, following transient transfection with wild-type 
AOX, supported approximately 80% of the uninhibited oxygen consumption, in the presence of antimycin. 
Antimycin-resistant oxygen consumption was undetectable in permeabilized cells transiently transfected with the 
mutAOX construct or empty vector (Fig. 4A). A similar result was obtained after transfection of Drosophila S2 cells. 
After transfection with either of two different AOX-expressing constructs, whole-cell respiration in the presence 
of antimycin was 70–73% of the uninhibited rate, but was undetectable in control cells or cells transfected with the 
mutAOX construct (Table S1). Finally, in homogenates from male transgenic flies carrying targeted insertions at the 
same locus (on chromosome 2), induced to express the transgene ubiquitously using the da-GAL4 driver, wild-type 
AOX supported 14% of the uninhibited substrate oxidation rate in the presence of antimycin (Fig. 4B), whereas 
mitochondria from mutAOX- or empty vector-transgenic flies showed no antimycin-resistant substrate oxidation. 
In every polarography experiment, expression of the AOX transgene was verified by Western blotting as per Fig. 2.
ƪǤ The fact that the mutated AOX is devoid 
of detectable enzymatic activity allowed us to use the newly created transgenic lines to test whether the previously 
observed phenotypic rescue of flies knocked down for a subunit of cytochrome oxidase (Cox7a) was due to the 
enzymatic activity of AOX or some other property conferred by the AOX protein, when expressed in Drosophila. 
Moreover, the fact that the newly created transgenic lines express AOX at only about 30% of the level of the lines 
previously studied, allowed us to test whether phenotypic rescue was quantitatively dependent on AOX expres-
sion level. Ubiquitous knockdown of CG9603, the broadly expressed isogene for Cox7a, was previously shown to 
produce pupal lethality11, which was rescued by high-level expression of AOX.
To test the new transgenic lines, we first confirmed that the RNAi line used in the experiment was devoid of 
the additional insertion previously reported to confer pupal lethality unrelated to specific target knockdown25 
(Fig. S3). We then combined the CG9603 RNAi line with AOX and control transgenes, plus the da-GAL4 driver 
to induce simultaneous transgene expression and Cox7a knockdown. Wild-type AOX rescued the lethality, as 
previously (Fig. 5A), whereas mutAOX or the empty vector were unable to do so, confirming that AOX enzymatic 
activity is required for the rescue.
Next, we investigated the effects of CG9603 knockdown and its potential rescue by AOX, using the 
neuron-specific driver elavC155-GAL4. Previously, it was shown that this produces a locomotor defect in newly 
Figure 1. Structural modelling and mutagenesis of active site of Ciona intestinalis AOX. (A) Model of 
the active site of the Ciona (Ci) enzyme, green, compared with the structure of the Trypanosoma brucei (Tb) 
AOX, blue. In both cases, the diiron site (iron moieties in orange, hydroxyl in pink) is buried in a four alpha-
helix bundle. For clarity, only one protomer is shown. (B) Conserved residues binding the diiron centre show 
an identical arrangement in the Ci model (green) as in the Tb structure (blue). (C) The residues selected for 
alanine-substitution mutagenesis in the Ci enzyme (here shown in blue), alongside the resulting modelled 
structure.
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Figure 2. Expression of AOX transgenes in mammalian cells and Drosophila. (A) Western blot of protein 
extracts from HEK293T cells transfected with wild-type and mutated AOX constructs (wt, mut) or empty 
vector (V), probed for AOX and for ATP synthase subunit α as loading control. (B,C) Relative AOX expression 
at RNA level, based on QRTPCR, in (B) females and (C) males of different Drosophila lines transgenic for 
wild-type or mutated AOX, or empty vector, inserted on chromosomes X, 2 and 3, as shown, in combination 
with the ubiquitous da-GAL4 driver. New wt (wild-type) and mutAOX lines were those created by site-
specific integration at defined chromosomal sites using the Φ C31 system; old wt AOX lines were UAS-AOXF6 
(chromosome 2) and UAS-AOXF24 (chromosome 3). For males, all values were significantly different from 
empty-vector lines; old wt AOX lines were significantly different from new wt AOX lines (p < 0.001, ANOVA 
followed by post-hoc Bonferoni-corrected t test), but mutAOX and new wt AOX lines were not significantly 
different from each other. Statistical analysis for females gave similar results, although greater sample-to-sample 
variation for old wt AOX lines yielded only p < 0.05 comparing them with new wt or mutAOX lines. (D,E) 
Western blot of protein extracts from the same flies (amounts as shown), probed for AOX or, as loading control, 
either ATP synthase subunit α or α -actinin, as indicated.
Figure 3. Developmental time to eclosion of AOX transgenic flies. Eclosion day (mean +SD) for females and 
males of different Drosophila lines transgenic for wild-type (wt) or mutated (mut) AOX, or empty vector (v), 
inserted on chromosomes X, 2 and 3, as shown, in combination with the ubiquitous da-GAL4 driver. *denotes 
significant difference from flies of the same sex from the empty vector line on the same chromosome, p < 0.05 
(Student’s t test).
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eclosed flies11. To potentiate the phenotype, we included UAS-Dcr2 in the background, so as to increase the pene-
trance of RNAi. Without concomitant AOX rescue, the resulting flies showed a severe locomotor defect as measured 
by their inability to climb the walls of the vial, in a standard negative geotaxis assay (Fig. 5B). High-level expression 
of AOX produced, as before, a clear rescue, whilst lower-level expression using the newly created transgenic lines 
produced only a modest phenotypic improvement (wild-type AOX), or no improvement at all (mutAOX, Fig. 5B).
Structural conclusions. Alternative oxidases are members of a superfamily of metalloenzymes, characterized 
by a common catalytic function of activation of molecular oxygen, and by common structural elements defining 
the catalytic diiron centre, including the four-helix bundle fold and a motif comprising two histidine residues, 
four carboxylate groups, and a bridging carboxylate group across the diiron centre26–28. The crystal structure of 
the trypanosomal enzyme indicates that it is a homodimer with each monomer comprising six long and four 
short α -helices13. The subunits interact with each other via α -helices 2, 3 and 4, whereas the hydrophobic region 
formed by α -helices 1, 2, 4 and 5 is proposed to anchor the protein to the inner surface of the mitochondrial inner 
membrane. A series of conserved arginine residues, capable of interacting with phospholipid head-groups, may 
Figure 4. Respirometry of AOX-transfected cells and flies. Oxygen consumption (% resistant to antimycin, 
as defined in Materials and Methods) of (A) permeabilized, transiently transfected cells, and (B) homogenates 
from male transgenic flies induced for expression using da-GAL4 driver, expressing wild-type (wt) or mutated 
(mut) AOX or empty vector (v). The flies had transgenic insertions on chromosome 2. *denotes significant 
difference from vector-only flies.
Figure 5. AOX rescue of Cox7a deficiency. (A) Survival (%) from egg to eclosion of flies of the indicated 
genotypes, all bearing the da-GAL4 driver and the CG-9603 knockdown (RNAi) construct. Lines tested 
contained either no additional transgene (–), vector only (v), wild-type (wt) or mutated AOX (mut), in each case 
on chromosome 3. (B) Boxplot of climbing index of flies of the indicated genotypes. All flies carried the elavC155 
-GAL4 driver on chromosome X plus UAS-Dcr2 with or without the CG9603 knockdown (RNAi) construct on 
chromosome 2, and the indicated AOX transgene on chromosome 3 (AOX7.1 is the Φ C31-targeted insertion). 
Bars indicate medians, boxes show the first and third quartiles percentiles, whiskers are plotted according to 
the Tukey scheme (Krzywinski and Altman, 2014). Significant differences based on ANOVA are indicated by 
horizontal lines (black, red) denoting p < 0.05 and 0.001, respectively. A single outlier point is indicated by an 
open circle.
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assist inner membrane anchorage13. Our structure modelling of the C. intestinalis AOX suggests that the same 
structural elements are conserved in animal AOXs, and that the enzyme is also a homodimer inserted into the 
mitochondrial inner membrane.
In addition, the model predicts that the active site, and therefore the mechanism of oxygen activation, are also 
conserved in animal AOXs. The four-helix bundle, which acts as a structural platform for the binding of the two 
iron atoms, buries the active site deep in a hydrophobic environment. In T. brucei AOX, glutamate residues 123, 162, 
213 and 266, in addition to a hydroxo-bridge, are responsible for directly coordinating the diiron centre. The centre 
is further stabilized by a redox-active tyrosine residue29,30, Y220, and two histidine residues (H165 and H269), 
which are within hydrogen-bond distances of E123, E169 and E213. The C. intestinalis AOX model indicates that 
the homologous residues E200, E239, E290, E344, Y297, H242 and H347 organize the active site in the same way.
Functional conclusions. In theory, the mutagenesis of a single glutamate residue should be enough to dest-
abilize the diiron centre31. However, taking advantage of the proximity in the DNA sequence of the codons for 
E239 and H242 and of those for E344 and H347, we were able to create alanine substitutions for four important 
active site residues simultaneously. According to our model, these mutations should disrupt iron binding, thus 
generating a mutant devoid of catalytic activity, without any major disturbance to the overall protein structure. 
These predictions are supported by the fact that the mutant and wild-type proteins were expressed at comparable 
levels in mammalian cells and in flies, but that no enzymatic activity could be detected.
Importantly, the mutated enzyme was unable to rescue the organismal phenotypes arising from engineered 
cytochrome oxidase deficiency. In theory, the action of a foreign protein in attenuating such phenotypes could be 
due to any of several different mechanisms, of which the provision of an enzymatic by-pass for ubiquinol oxidation 
is only one. In previous work we found that Ciona AOX, when expressed in Drosophila mitochondria, decreased 
the net production of mitochondrial ROS even under non-inhibited conditions10,32. The mechanism of this remains 
unknown, but one possibility is that AOX is able to act directly or indirectly as an antioxidant, e.g. by binding and 
quenching quinone radicals via some other mechanism. Studies in various organisms have supported the idea 
that a hydrophobic pocket, located between α -helices 2 and 3, binds and channels ubiquinone to the active site33, 
which might be involved in such an activity.
A second possibility would be a hormetic response to disruption of the inner mitochondrial membrane or 
its protein complexes by the foreign protein. The induction of a variety of defence pathways to protect cells from 
increased ROS, disturbed protein, lipid or redox homeostasis, or altered mitochondrial turnover or dynamics, 
might equip the organism to cope with the additional but related stresses of respiratory insufficiency. Many stud-
ies in model organisms support this concept of ‘mitohormesis’34. Whilst we cannot rule out that such effects are 
material in other contexts, our findings do exclude them in regard to the developmental lethality produced by 
global cytochrome oxidase knockdown, or the locomotor dysfunction resulting from its knockdown specifically in 
neurons11. Based on our findings, that mutAOX cannot compensate these phenotypes, we infer that the rescue of 
these effects of cytochrome oxidase deficiency by AOX is almost certainly due to its enzymatic activity as a quinol 
oxidase, though formally we cannot exclude other, unknown effects of iron binding. A requirement for enzymatic 
activity might not be true of every phenotypic feature conferred by AOX in model organisms. Our findings indicate 
a robust way to test this in regard to all potential such phenotypes, allowing the mechanisms by which AOX acts 
to be probed, controlled or verified.
Several quantitative issues are also addressed by our findings. The first is that the extent of phenotypic rescue 
depends in some instances on the AOX expression level, but in other cases, such as the rescue of the developmental 
lethality caused by ubiquitous COX knockdown, is an all-or-none phenomenon. We suggest that this reflects a 
threshold effect wherein even the three-fold lower expression level of AOX, when integrated at specific sites by 
Φ C31-mediated recombination (in comparison with P element-mediated integrants created previously), exceeds 
a threshold value required to maintain metabolic homeostasis and complete development. In contrast, the lower 
expression level of the targeted integrants gave a clearly weaker rescue of locomotor dysfunction, when COX was 
knocked down only in neurons, roughly in proportion to the decreased expression level.
It may also be noted that the amount of antimycin-resistance conferred upon respiration in homogenates from 
the targeted integrants was still approximately 14%, compared with approximately 20% for the P element-mediated 
integrants, even though they are expressed at a much higher level. The level of respiratory antimycin-resistance in 
the fly may vary between tissues, and this 20% maximum may reflect only the properties of the predominant class 
of mitochondria. Most of the respiratory capacity in adult flies is vested in the flight muscles, where mitochondria 
make up almost one-third of the total tissue mass35. The apparent upper limit of how much electron flow can be 
diverted through AOX probably reflects specific features of this tissue and its energetic needs. The limit could be 
dictated by the constraints of membrane architecture, for example, if much of the ubiquinone pool is channelled 
directly from complex I to complex III via respiratory supercomplexes, such that it equilibrates only slowly with 
free ubiquinones available to AOX36. Most of the respiratory activity in adult Drosophila indeed resides in super-
complexes37. Such a phenomenon may account for the inferred threshold effect on the rescue of developmental 
lethality. Conversely, the organization of the respiratory chain may differ in other tissues, such as in neurons, where 
a more graded response to the AOX expression level is evident.
In conclusion, mutAOX offers a useful tool for future studies of the mechanism(s) whereby expression of 
Ciona AOX modifies the phenotypes of model organisms, potentially contributing the eventual development of 
AOX-based therapies.
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Aspergillus flavus       ---------------MASFF---LNITCPNRACLA--------------- 17
Arabidopsis thaliana       MMITRVEPRAQIAVSGGWTT---FVLDGPYVSSHE--------------- 32
Nicotiana tabacum       -----------------MWV---RHFPVMGP------------------- 11
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Tetrahymena thermophila       MRANLFKKCLQIHKNTNTLFSVSRRFKSDLQYTPE--------------- 35
Paramecium tetraurelia       --------------------------------------------------
Trypanosoma brucei       ---MFRNHASRITAAAAPWV---LRTACRQKSDAK--------------- 29
Ciona intestinalis       TVKRYLVGYSWSTQPHSRLLHSCQQLKIDDKNKSEHFKIETNDSTDEPNI 88
Strongylocentrotus purpuratus      ----------------------------LKHKHQEKLMVKKSQLLLHTSK 34
Crassostrea gigas       ---------------VSGIRTSNGLRNAGTKADVDENIKKFKEENFEKIP 68
Urechis unicinctus       -ALITSMPQVYAYSTQTRSLNNKAKESVNLGPHIQENLKKFREGSHENVS 83
Nematostella vectensis       --------------------------------------------------
Trichoplax adhaerens       --------------------------------------------------
Amphimedon queenslandica       ----------------------------------------VRAFSASSNE 40
Penicillium rubens       ---------------------------ATTLNSSCVVSKRTSAFSLTSKR 53
Aspergillus flavus       --------------------------------------AGNSAQLLGKHV 29
Arabidopsis thaliana       -----ALSRSHILKPGVTSAWIWTRAPTIGGMRFASTITLGEKTPMKEED 77
Nicotiana tabacum       ----------------------------------------RSASTVALND 21
Zea mays       ----------PLLALAGGGERGGALVWVRVRLLSTSAAEAKEEVAASKGN 71
Acanthamoeba castellanii       RHLSLRLAPTTMTSTTSRTSSATSTTMTTRGRWCQGGALAWSRANTTSAA 97
Gregarina niphandrodes       -----------------RILWTDFRMPSTAAQTRRLPQFTEQRRTVVFKK 62
Tetrahymena thermophila       ----------------------------------------NNFFQNTFNS 45
Paramecium tetraurelia       -----------------------------------------------MNR 3
Trypanosoma brucei       -------------------------------------TPVWGHTQLNRLS 42
Ciona intestinalis       EVENFPHFREAKKAKETQKGSSLAEAEEHPDVEEGRAMQDGGYRLPHPIW 138
Strongylocentrotus purpuratus      ESGKVDDHIQAAVEKPGSQ----------------------KYLLPHPIW 62
Crassostrea gigas       DPEQLDHFRKTQSTDQLVESMKN-------------PPPMGTHTLPHPIW 105
Urechis unicinctus       VPEELQHFRKSTEEGVKGNGPEEE------------KPPMGAVALPHPIW 121
Nematostella vectensis       --------------------------------------------------
Trichoplax adhaerens       --------------------------------------------------
Amphimedon queenslandica       PEEKAPHFKRSSVVHPLSAHIKM-------------VMQEKPYTLPHPIW 77
Penicillium rubens       PISSTPKSQTITDYFPAPETP---------------NVKEVQTAWVHPVY 88
Aspergillus flavus       IAGVSPRTVFTPGRRPQSTQSSL----------------VTKSSWTHPVY 63
Arabidopsis thaliana       ANQKKTENESTGGDAAGGNNKGDKGIASYWGVEPNKITKEDGSEWKWNCF 127
Nicotiana tabacum       KQHDKKVENGGAAASGGGDGGDEKSVVSYWGVPPSKVTKEDGTEWKWNCF 71
Zea mays       SGSTAAAKAEAVEAAKEGDGKRDKVVSSYWGVAPSKLMNKDGAEWRWSCF 121
Acanthamoeba castellanii       MTDGEPKQTQEEKKAAASNPSIAAQQTVERAQQQSGKSTRVAYTLPHPIW 147
Gregarina niphandrodes       EQGQPKHFNAKSNATASPSLLAESEEYEKN------WVSETRYTQPHPIW 106
Tetrahymena thermophila       ISQSQKQKEVKTQFQPNAVSTEE---------------KLGVYVLPHPIW 80
Paramecium tetraurelia       HLSKLLKKSFSLSTKPNQN-----------------------YTMPHPIW 30
Trypanosoma brucei       FLETVPVVPLRVSDESSED---------------------------RPTW 65
Ciona intestinalis       HKQELESVRIS-----HRPPVGKVDKLAYYSVQLLRTGFDVFSGYT---- 179
Strongylocentrotus purpuratus      SEEELDAVEVT-----HNPPKERVDKAAYFACKALRANFDFFSGFS---- 103
Crassostrea gigas       SEEELHSVKVT-----HKPPEGFVDKLAFRSVKLLRSTFDLLTGFN---- 146
Urechis unicinctus       SEEELHSVHVT-----HRNPEGIVDKIAYMGVKFTRGCYDFVSGYS---- 162
Nematostella vectensis       --------------------------------------------------
Trichoplax adhaerens       ---------------------------MYSICR----------------- 6
Amphimedon queenslandica       TESELNEVTIT-----HVKPSLFVDKAAYASVQTLRFFFDVFSGYY---- 118
Penicillium rubens       TEAQMQSIQIA-----HRQTANWSDWIALGTVRFFRWGMDTATGYK---- 129
Aspergillus flavus       TTSQLHSIQTA-----HRNAIDWSDRMALGTVRFLRWGMDLVTGYH---- 104
Arabidopsis thaliana       RPWETYKADITIDLKKHHVPTTFLDRIAYWTVKSLRWPTDLFFQRR---- 173
Nicotiana tabacum       RPWETYKADLSIDLTKHHAPTTFLDKFAYWTVKALRYPTDIFFQRR---- 117
Zea mays       RPWEAYKPDTTIDLNRHHEPKVLLDKIAYWTVKLLRVPTDIFFQRR---- 167
Acanthamoeba castellanii       QNEYVDAVEIN-----HTPPENLTDKLALNTVRLMRFNFDWMSGYS---- 188
Gregarina niphandrodes       NDEEVHAVQKT-----HFRPRGVSDRAALYLLRSIRGVFDVCTGYA---- 147
Tetrahymena thermophila       TKEDVENVQIT-----HFKPKNIGDRLSHYLIQSMRLGFDVMSGYKKVFP 125
Paramecium tetraurelia       NKPELEKVSLE-----HKTAITFGDHFAYYFIQSMRLGFDVMSGYK---- 71
Trypanosoma brucei       SLPDIENVAIT-----HKKPNGLVDTLAYRSVRTCRWLFDTFSLYR---- 106
$QGMHONRYLü HWDO)LJ6SDJH  RI
Ciona intestinalis       LGT------YTGRLDEKQWVKRIIFLETIAGVPGMVGAMVRHLVSLRRLK 223
Strongylocentrotus purpuratus      WGK----------RTERKWIYRIIFLETVAGVPGMVAAMSRHLRSLRRMQ 143
Crassostrea gigas       WGE----------RTEKKWVLRICFLETVAGVPGMVAAMTRHLHSLRRLK 186
Urechis unicinctus       RGR----------QDEKMWVSRLCFLETVAGVPGMVAAMVRHLTSLRKMR 202
Nematostella vectensis       ------------------------MLETVAGVPGMIGAMTRHFNSLRRLT 26
Trichoplax adhaerens       ---------------------RIIFLETVAGVPGMVAAMTRHLHSLRRMR 35
Amphimedon queenslandica       IGK------FRGTLNEKKWLTRIIFLETVAGVPGMIAAMLRHLRSLRYLQ 162
Penicillium rubens       HPKPGEQLPARFKMTEHKWLNRFVFLESIAGVPGMVGGMLRHLRSLRKMK 179
Aspergillus flavus       HSHPRDAHSPRFRMTEEKWITRFIFLESVAGVPGMVAAMLRHLKSLRRMR 154
Arabidopsis thaliana       YGC------------------RAMMLETVAAVPGMVGGMLLHCKSLRRFE 205
Nicotiana tabacum       YGC------------------RAMMLETVAAVPGMVGGMLLHCKSLRRFE 149
Zea mays       YGC------------------RAMMLETVAAVPGMVGGMLLHLRSLRRFE 199
Acanthamoeba castellanii       WGK----------LTEADWLRRIIFLETVAGVPGSVAAILRHLHSLRRLK 228
Gregarina niphandrodes       FGP----------LSAQGWINRVVLLETIAGVPGLVGAAFRHLRSLRRME 187
Tetrahymena thermophila       WQQ------KSGELTERGWLNRMVFLETVAGVPGFVAAMHRHLRSLRRME 169
Paramecium tetraurelia       KTL----PFQSELVSEKKWINRVLFLETVAGVPGFVAGMHRHLRSLRGMK 117
Trypanosoma brucei       FGS----------ITESKVISRCLFLETVAGVPGMVGGMLRHLSSLRYMT 146
                               **  * ***       *  ***
Ciona intestinalis       RDHGWIHTLLEEAENERMHLMTAMRIANPGIIMRTSIVVAQGIFVSGFSL 273
Strongylocentrotus purpuratus      RDHGWIHTLLEEAENERMHLMTALEIKQPSLFFRLMVLGAQGIFVNMFFI 193
Crassostrea gigas       RDHGWIHTLLEEAENERMHLMTALQLRQPSWLFRSGVIVSQGAFVTMFSI 236
Urechis unicinctus       RDHGWIHTLLEEAENERMHLMVMLQLKQPSLFFRLGVMVTQGVFVSGFSV 252
Nematostella vectensis       RDHGWIHTLLEEAENERMHLMTALELKRPGILFRGVILAAQGVFVNMFFI 76
Trichoplax adhaerens       RDYGWIHTLLEEAENERMHLLTALHLKRPGPFFRACVILGQGIFVNFFIL 85
Amphimedon queenslandica       RDHGWIHTLLEEAENERMHLLTALVLRKPGFLFRFAVIGAQGIFVTLFSA 212
Penicillium rubens       RDNGWIETLLEEAFNERMHLLTFLKLAEPGWFMRVMVIGAQGVFFNGFFL 229
Aspergillus flavus       RDYGWIETLLEEAYNERMHLLTFLKLSQPGPAMYFMVLAAQCVFFTGFSL 204
Arabidopsis thaliana       QSGGWIKALLEEAENERMHLMTFMEVAKPKWYERALVITVQGVFFNAYFL 255
Nicotiana tabacum       QSGGWIKALLEEAENERMHLMTFMEVAKPNWYERALVFAVQGVFINAYFV 199
Zea mays       HSGGWIRALLEEAENERMHLMTFMEVAKPKWYERALVLAVQGVFFNAYFL 249
Acanthamoeba castellanii       RDHGWIHTLLEEAENERMHLLTGLKLKQPGKIFRTAVWVTQGIFFNFFFA 278
Gregarina niphandrodes       RDYGWIHTLLEEAENERMHLMSALMIKNPGRVFRTFVIAGQLFFLPLYTG 237
Tetrahymena thermophila       RDYGWIHVLLEEAENERMHLLTFLKVQKPTLLFRLGVISAQFNYVLMFGL 219
Paramecium tetraurelia       RDQGWIHTLLEEAENERIHLLTFLNIKKPSLIFRTGVVLAQAWYVALFGV 167
Trypanosoma brucei       RDKGWINTLLVEAENERMHLMTFIELRQPGLPLRVSIIITQAIMYLFLLV 196
         ***  ** ** *** **        *           *
Ciona intestinalis       AYLISPRFCHRFVGYLEEEAVKTYTHCLEELDSGN--LKMWCRMKAPEIA 321
Strongylocentrotus purpuratus      SYLVSPRFCHRFVGYLEEEAVITYTKLLKDLRADA--LPKWKDRIAPEIS 241
Crassostrea gigas       AYMLSPRFCHRFVGYLEEEAVFTYSKCLKDIESGS--LKHWQTKAAPDVA 284
Urechis unicinctus       AYMLSPRLCHRFVGYLEEEAVITYTKLLKEIDSGA--MQHWNTLPGPDVA 300
Nematostella vectensis       AYLTSPRFCHRFVGYLEEEAVKTYTYCLECIDNGK--LPTWNTLKAPKIA 124
Trichoplax adhaerens       SYLISPRFCHRFVGYLEEEAVITYTKCLNQIDRGY--LPMWAKMDAPDIA 133
Amphimedon queenslandica       AYIISPKFCHRFVGYLEEEAVKTYTHCLECIDRGD--LKVWAKTAAPSIS 260
Penicillium rubens       SYLISPRICHRFVGYLEEEAVITYTRAIEELEAGN--LPEWKDLDAPEIA 277
Aspergillus flavus       AYLISPRICHRFVGYLEEEAVITYTKAIQELDKGN--LPLWSNMEAPAMA 252
Arabidopsis thaliana       GYLISPKFAHRMVGYLEEEAIHSYTEFLKELDKGN--I---ENVPAPAIA 300
Nicotiana tabacum       TYLLSPKLAHRIVGYLEEEAIHSYTEFLKELDKGN--I---ENVPAPAIA 244
Zea mays       GYLISPKFAHRVVGYLEEEAIHSYTEYLKDLEAGK--I---ENVPAPAIA 294
Acanthamoeba castellanii       AYLVSPRFCHRFVGYLEEEAVRTYTHLLHDLDAGK--LPEWKDTPAPEIA 326
Gregarina niphandrodes       MYLVSPRLAHRFVGYLEEEAVKTYTHLLEELEAGH--QPELASMKAPLLA 285
Tetrahymena thermophila       LYQFFPRVCHRIVGYLEEEAVKTYTHCIEVINQENSSISHWKTKKAPQIA 269
Paramecium tetraurelia       AYIFWPRVCHRIVGYLEEEAVKTYTHMIHEIEREGSPIHSWTTRKANQNS 217
Trypanosoma brucei       AYVISPRFVHRFVGYLEEEAVITYTGVMRAIDEGR--LRP-TKNDVPEVA 243
       *   *   ** ********   *
Ciona intestinalis       VEYWKLPDDA-MMRDVILAIRADEAHHRSVNHDLGSR---KP-DEQNPYP 366
Strongylocentrotus purpuratus      INYWKLRPDA-DYIDLFRAIRADEAHHREVNHTLSDI---KP-DDRNPFG 286
Crassostrea gigas       IRYWKLPETA-SMKDVVLAIRADEAHHRVVNHTLASM---KE-DEYNPYE 329
Urechis unicinctus       ISYWKLRPGA-AMKDVILAIRADEAHHRVVNHTLSSL---KD-DDYNPYK 345
Nematostella vectensis       SNYWKLKEDA-VMRDVILAIRADEAHHRVVNHTLSSI---HL-DDPNPFF 169
Trichoplax adhaerens       RTYWQLKPDA-KMRDVILAIRADEAHHRLVNHTLASI---NP-EQKNPYK 178
Amphimedon queenslandica       QKYWQLPEGA-MMRDVILAIRADEAHHCEVNHTLSSM---DM-DKQNPFE 305
Penicillium rubens       VKYWQMPEGQRKMKDLLLFIRADEAKHREVNHTLANL---KPTQDPNPYQ 324
Aspergillus flavus       IKYWQMPEGQRSIRSLLLCVRADEANHRDVNHTLGNL---NQDSDPNPFS 299
Arabidopsis thaliana       IDYWRLPADA-TLRDVVMVVRADEAHHRDVNHFASDIHYQGRELKEAPAP 349
Nicotiana tabacum       IDYWRLPKDS-TLRDVVLVVRADEAHHRDVNHFAPDIHYQGQQLKDSPAP 293
Zea mays       IDYWQLPADA-TLKDVVVVVRSDEAHHRDVNHFASDIHFQGMQLKETPAP 343
Acanthamoeba castellanii       RQYWKMGDDA-KWRDVVALIRADEAHHREVNHTFANL---QL-EQDNPFP 371
Gregarina niphandrodes       RQYWSLKNDA-SFTDMIFAIRADESHHRDVNHTFANM---KP-NEENPFE 330
Tetrahymena thermophila       IDYWRLPENA-TMEDVIYAIRKDEEHHRDVNHDLASD---YSQTKVLADT 315
Paramecium tetraurelia       IEYWGLDENA-TLLDVVKAIRKDEEHHKDVNHYFADD---YTQSKPNPFP 263
Trypanosoma brucei       RVYWNLSKNA-TFRDLINVIRADEAEHRVVNHTFADMHEKRLQNSVNPFV 292
        **                * **  *  ***
$QGMHONRYLü HWDO)LJ6SDJH  RI
Ciona intestinalis       ----------PGQ------------------------- 369
Strongylocentrotus purpuratus      ----------PGE------------------------- 289
Crassostrea gigas       ----------PGK------------------------- 332
Urechis unicinctus       ----------PGQ------------------------- 348
Nematostella vectensis       ----------PGQRKL---------------------- 175
Trichoplax adhaerens       ----------PGE------------------------- 181
Amphimedon queenslandica       ----------PGK------------------------- 308
Penicillium rubens       IEYADLSVSHPTKGIDNLRPEGWDRNEIFMGKARTEKS 362
Aspergillus flavus       AKFRNALKE-ASQPLSPVKEHR---------------- 320
Arabidopsis thaliana       ----------IGYH------------------------ 353
Nicotiana tabacum       ----------IGYH------------------------ 297
Zea mays       ----------IEYH------------------------ 347
Acanthamoeba castellanii       ----------PGH------------------------- 374
Gregarina niphandrodes       ----------PGH------------------------- 333
Tetrahymena thermophila       ----------TQDEHYI--------------------- 322
Paramecium tetraurelia       ----------PGK------------------------- 266
Trypanosoma brucei       VLKKNPEEMYSNQPSGKTRTDFGSEGAKTASNVNKHV- 329
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INVESTIGATION
Ligand-Bound GeneSwitch Causes Developmental
Aberrations in Drosophila that Are Alleviated by
the Alternative Oxidase
Ana Andjelkovic,*,† Kia K. Kemppainen,*,† and Howard T. Jacobs*,†,‡,1
*BioMediTech, FI-33520 and †Tampere University Hospital, FI-33014, University of Tampere, Finland and ‡Institute of
Biotechnology, University of Helsinki, FI-00014, Finland
ABSTRACT Culture of Drosophila expressing the steroid-dependent GeneSwitch transcriptional activator
under the control of the ubiquitous a-tubulin promoter was found to produce extensive pupal lethality, as
well as a range of dysmorphic adult phenotypes, in the presence of high concentrations of the inducing
drug RU486. Prominent among these was cleft thorax, seen previously in ﬂies bearing mutant alleles of the
nuclear receptor Ultraspiracle and many other mutants, as well as notched wings, leg malformations, and
bristle abnormalities. Neither the a-tubulin-GeneSwitch driver nor the inducing drug on their own produced
any of these effects. A second GeneSwitch driver, under the control of the daughterless promoter, which
gave much lower and more tissue-restricted transgene expression, exhibited only mild bristle abnormalities
in the presence of high levels of RU486. Coexpression of the alternative oxidase (AOX) from Ciona intestinalis
produced a substantial shift in the developmental outcome toward a wild-type phenotype, which was depen-
dent on the AOX expression level. Neither an enzymatically inactivated variant of AOX, nor GFP, or the
alternative NADH dehydrogenase Ndi1 from yeast gave any such rescue. Users of the GeneSwitch system
should be aware of the potential confounding effects of its application in developmental studies.
KEYWORDS
inducible
transgenes
nuclear receptor
Drosophila
cleft thorax
notched wings
TheGeneSwitch (GS) system is commonlyused toactivate transgenes in
Drosophila in a graded fashion. GS comprises a modiﬁed form of the
yeast transcriptional activator Gal4, which is covalently linked to the
hormone-binding fragment of the progesterone receptor, rendering its
transcriptional activity dependent on an exogenously supplied proges-
terone analog, RU486 or mifepristone (Osterwalder et al. 2001). Any
transgene governed by the UAS promoter element, rendering it Gal4-
responsive, may be induced by the combination of GS and RU486 in a
dose-dependent manner. Depending on the promoter to which GS is
itself combined, plus its insertion site in the ﬂy genome, drug-inducible
transgene expression can be achieved in a wide variety of developmen-
tal patterns, cell-types, and overall strengths. Thus, the widely used
a-tubulin-GS (tubGS) and actin5C-GS drivers confer ubiquitous,
RU486-dependent transgene expression when crossed to lines bearing
a UAS-governed transgene. Tissue-speciﬁc drivers such as the neuron-
speciﬁc elav-GS enable transgene expression in just one tissue, but again
at a level and timing that can bemanipulated over a wide range. The use
of this system is predicated on the assumption that the expression of
GeneSwitch and exposure to RU486 do not themselves produce mea-
surable effects on ﬂy physiology and development, which is supported
by controls in many studies.
Our laboratoryhasmadeuseof this system, for example toexpress, in
Drosophila, foreign transgenes coding for nonproton-motive alterna-
tive respiratory chain enzymes derived from simpler eukaryotes, such
as the alternative oxidase (AOX) from Ciona intestinalis (Fernandez-
Ayala et al. 2009; Kemppainen et al. 2014a). When supplied to adult
Drosophila bearing both tubGS and a UAS-AOX transgene, RU486
produced dose-dependent transgene expression that saturated at drug
concentrations (in ﬂy food) of 100–200mM (Kemppainen et al. 2014a).
However, when supplied throughout development, RU486 concentra-
tions two orders of magnitude lower were sufﬁcient to induce maximal
expression (Fernandez-Ayala et al. 2009). The precise reasons for this
discrepancy in required dose are unclear, although early larvae, which
are very rapidly growing (Church and Robertson 1966; Watts et al.
2006), must absorb larger amounts of drugs added to ﬂy food than
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adults, which do not grow at all and even lose weight during early adult
life (Fernandez-Ayala et al. 2009).
In this study, we addressed the issue of what happens to devel-
opment when larvae expressing GeneSwitch drivers (but no other
transgene) are exposed to RU486 concentrations in excess of those
sufﬁcient to produce maximal transgene expression. We detected a
variety of developmental abnormalities dependent on driver expres-
sion and drug dose. Surprisingly, expression of AOX, but not other
transgenes such as GFP or the yeast alternative NADH dehydroge-
nase Ndi1, mitigated these effects.
MATERIALS AND METHODS
Drosophila stocks and maintenance
Wild-type (Oregon R), standard transgenic host strainsw1118 andwDAH
(Dahomey) and the UAS-GFP (Stinger) line (insertion on chromosome
2) were obtained from stock centers. The tubGS driver line with inser-
tion on chromosome 3 (Sykiotis and Bohmann 2008) was a kind gift
from Dr Scott Pletcher (University of Michigan). The daughterless-GS
(daGS) line (Tricoire et al. 2009) was a kind gift from Dr Alberto Sanz
(Newcastle University, UK). AOX andNdi1 transgenic ﬂies [linesUAS-
AOXF6, UAS-AOXF24, tub-AOX7, tub-AOX35 tub-AOX50, UAS-AOX7.1
(targeted insertion on chromosome 3) UAS-AOXmut (denoted previ-
ously as UAS-AOX4.1, targeted insertion on chromosome 3), and UAS-
Ndi1B20] were as described previously (Fernandez-Ayala et al. 2009;
Sanz et al. 2010b; Kemppainen et al. 2014b; Andjelkovic et al. 2015).
Flies were maintained in standard high-sugar medium (Fernandez-
Ayala et al. 2009) at 25, on a 12 hr light/dark cycle. Where indicated,
medium was supplemented with RU486 (Mifepristone, Sigma) at the
concentrations indicated in ﬁgures and legends.
Eclosion and phenotypic assays
Crosses were conducted in a minimum of three, usually four to ﬁve
replicates, as described previously (Toivonen et al. 2001; Kemppainen
et al. 2009). Either the number of ﬂies eclosing or the percentage of
pupae that successfully eclosed in individual vials were recorded in
different experiments (see ﬁgures and legends). The proportion of
the eclosed progeny falling into different phenotypic classes was scored
by microscopy. Cleft thorax, where subclassiﬁed, was scored as mild or
severe (heminota clearly separated), with the mildest abnormality, mal-
formed scutellum, scored separately in some experiments. Wing phe-
notypes were scored as normal or notched, the latter ranging from
single notches to grossly malformed wings that in some cases did not
inﬂate properly. Flies showing any of the bristle abnormalities as de-
scribed below were generally scored as a single category.
Microscopy
Light microscopy images of eclosed adult ﬂies were taken with a Nikon
Digital DS-Fi1 High-Deﬁnition Color Camera, using the Nikon stereo-
scopic zoom microscope SMZ 745T run by NIS-Elements D 4.20
software. Fluorescence microscopy of ﬂies used a Zeiss Axio Imager
2 microscope (50 ·magniﬁcation). Z projection images were generated
using Carl Zeiss Zen 2012 software.
Protein analysis by western blotting
Total protein was extracted from batches of 20 pupae crushed in
homogenization buffer, and processed as described previously
(Andjelkovic et al. 2015). Primary antibodies used were customized
rabbit anti-AOX (Fernandez-Ayala et al. 2009; 21st Centrury Biochem-
icals, 1:10,000), and mouse anti-ATP5A (Abcam, 1:100,000), with sec-
ondary antibodies as described previously (Andjelkovic et al. 2015).
Data availability
The authors state that all data necessary for conﬁrming the conclusions
presented in the article are represented fully within the article.
RESULTS
tubGS plus high levels of RU486 produce
developmental abnormalities
In initial trials, we noticed that doses of RU486 used routinely to induce
UAS-dependent transgene expression in Drosophila, in combination
with the tubGS driver in adult ﬂies (200–500 mM; Kemppainen et al.
2014a), were lethal when present throughout development. In order to
investigate possible mechanisms of this lethality, we reared ﬂies at
RU486 doses intermediate between this lethal level, and levels sufﬁcient
to induce full dose-dependent transgene expression, which in larvae
was only 1–2 mM. In combination with tubGS, RU486 at 100 mM was
still lethal (Figure 1A), whereas tubGS ﬂies reared without drug,
or wild-type ﬂies reared at this concentration of RU486, developed
normally. At intermediate drug concentrations (5–50 mM, Figure 1,
A and B), we observed dose-dependent semilethality, althoughmany of
the eclosing ﬂies were very weak and died within 1 d. In addition, even
the viable ﬂies displayed a range of dysmorphic phenotypes, illustrated
in Figure 2 and Supplemental Material, Figure S1 and File S1, of which
the commonest andmost striking were cleft thorax (Figure 2, B–D) and
notched wings (Figure 2E). The observed phenotypes were of varying
severity. For example, some ﬂies had single or multiple notches at the
wingmargin (Figure 2E), whereas others had wings that failed to inﬂate
(Figure 2F). Cleft thorax ranged from severe, with the heminota com-
pletely separated (Figure 2, C and D), to very mild, showing only an
abnormal, parted bristle pattern or just a reduced scutellum (Figure
2A). A minority of ﬂies also showed necrotic tissue in the notum area
(Figure 2D), leg abnormalities such as overgrown, reduced, and fused
leg segments (Figure 2G), externalized trachea (Figure 2H), clefted
abdomen (Figure 2I), or a variety of malformations of macrochaetae
(supernumerary, missing, kinked, or short bristles, Figure S1). Clefting
also extended along the abdomen in some cases (Figure 2I). tubGS ﬂies
reared without drug, or cultured in RU486 in the absence of tubGS, did
not exhibit cleft thorax or other developmental abnormalities, indicat-
ing that these teratogenic effects require the combination of the mod-
iﬁed transcription factor plus the inducing steroid.
We quantiﬁed themain classes of abnormality and observed a dose-
dependence on RU486 (Figure 3A). Although the proportion of prog-
eny showing the two major dysmorphic phenotypes of cleft thorax or
notched wings was already substantial at 10mMRU486, increasing the
dose to 30 mM resulted in a signiﬁcant increase in the proportion
exhibiting cleft thorax, whereas a further increase to 50 mM produced
a signiﬁcantly greater proportion with notched wings.
In order to determine whether the induction of these developmental
defects was a general property of GeneSwitch drivers, or a phenome-
non speciﬁc to tubGS, we repeated the experiment using a second
GeneSwitch driver under the control of the daughterless promoter. In
contrast to tubGS, daGS in combination with 10 mM RU486 produced
no clefting and no wing defects. The only developmental abnormality
detected was in regard to bristle morphology and organization which,
while less frequently observed than with the tubGS driver, did show a
tendency to rise in frequency as the concentration of RU486 was in-
creased (Figure 3C). However, neither cleft thorax nor notched wings
were seen at these elevated drug concentrations, nor even at 100 mM.
The difference in the ﬁndings between the two drivers is most likely
attributable to the level and pattern of expression of the GeneSwitch
transcription factor, as reﬂected in its ability to drive transgene
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expression, which we proﬁled quantitatively by western blotting
using a UAS-AOX reporter (Figure S2A) and spatially using a
UAS-GFP reporter (Figure S2B). Expression of UAS-AOX driven
by daGS was quantitatively much less than when driven by tubGS,
even at high RU486 concentrations (Figure S2A). Furthermore, un-
like tubGS, which was able to drive expression ubiquitously in the
developing larva, daGS produced transgene expression only in
a minority of cells (Figure S2B), including salivary glands, parts of
the trachea, some epithelial cells, and segmentally reiterated cell
clusters.
Expression of AOX, but not Ndi1 or GFP, rescues cleft
thorax caused by tubGS/RU486
Wetestedwhetherconcomitantexpressionofother transgenesdrivenby
tubGS in the presence of RU486 was able to modify the developmental
phenotypes resulting from the driver and drug alone (Figure 4). Once
again, neither tubGS nor the drug on its own produced cleft thorax
(Figure 4A) but, when combined, over 50% of the eclosing progeny
manifested severe cleft thorax, and a further 20% showed mild clefting.
Coexpression of Ciona AOX from either of two UAS-AOX transgenic
lines (Fernandez-Ayala et al. 2009) produced a substantial rescue of the
phenotype, with over 50% of the eclosing progeny now showing no
cleft, and less than 20% having severe cleft. UAS-Ndi1 or UAS-GFP
produced no rescue of the phenotype. Nor did a single copy of AOX,
when constitutively expressed under the a-tubulin promoter at a much
lower level than when driven by tubGS (Kemppainen et al. 2015).
However, ﬁve copies of the tub-AOX transgene, when present simul-
taneously, did produce a rescue comparable with that of UAS-AOX.
Coexpression of UAS-AOX with tubGS plus drug, in either of two
backgrounds commonly used in transgenic studies (w1118 and wDAH)
also increased the proportion of pupae eclosing (Figure 4B). The si-
multaneous presence of ﬁve tub-AOX transgenes (Figure 4C) also sub-
stantially rescued the eclosion frequency, as well as the survival of adults
immediately after eclosion.
Figure 1 RU486 in combination with tubGS pro-
duces dose-dependent lethality. (A) Number of
tubGS progeny eclosing at different doses of
RU486 present throughout development, mean 6
SD per vial, in OregonR background. Note that at
100 mM, no ﬂies eclosed.  and # indicate signiﬁ-
cant differences from the next higher concentration
tested in pairwise comparisons (Student’s t-test, P,
0.01 and 0.05, respectively). (B) Proportion (% of
pupae formed) of tubGS progeny at different doses
of RU486 present throughout development; com-
bined data from sets of four vials at a given concen-
tration, set up in parallel, in w1118 background. n =
205 (at 5 M), 193 (at 7.5 mM), 210 (at 10 mM), and
146 (at 12.5 mM). tubGS plus RU486 produced com-
parable amounts of pupal lethality also in the Can-
tonS background. SD, standard deviation; tubGS;
a-tubulin-GeneSwitch.
Figure 2 Examples of dysmorphologies produced by
the tubGS driver in the presence of 10 mM RU486.
(A–D) Thoracic abnormalities: (A) missing scutellar
part, (B) mild cleft, (C) severe cleft, and (D) necrotic
tissue, always localized at the scutellum or notum. (E
and F) Wing abnormalities: (E) notched wings, with
notches localized on the marginal anterior or posterior
side or both, (F) noninﬂated wings. (G) Leg abnormal-
ities, including overgrown, reduced, and fused leg
segments, sometimes present all together. (H) Exter-
nalized trachea, always in the ventral abdomen. (I)
Abdominal clefting: strong midline splits between all
dorsal tergite plates; laterotergites do not fuse at the
dorsal midline and remain as hemitergites, with in-
complete fusion of abdominal epidermis. These phe-
notypes were seen in all genetic backgrounds tested
(OregonR, CantonS, w1118, and wDAH). tubGS;
a-tubulin-GeneSwitch.
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AOX rescues developmental abnormalities in a
dose-dependent manner
We next conducted a large-scale experiment, analyzing almost 2000
individual ﬂies, for each of the major classes of developmental abnor-
mality produced by tubGS in the presence of RU486, in the presence of
different UAS-dependent transgenes (Figure 5). As negative control we
used strain w1118, the background strain for all the transgenic lines that
were crossed in the experiment. To determine whether the failure of
a single copy of tub-AOX to rescue tubGS-induced cleft thorax was
due to low expression, we made use of an additional UAS-AOX line,
Figure 3 Effects of drug con-
centration, driver, and genetic
background on developmental
abnormalities induced by Gen-
eSwitch plus RU486. (A) Propor-
tion of viable adult progeny
exhibiting major phenotypic ab-
normalities as indicated, at dif-
ferent doses of RU486, in the
Oregon R genetic background.
Mean 6 SD for sets of n $ 4 in-
dependent vials. Horizontal bars
denote signiﬁcant differences for
a given phenotypic trait be-
tween the stated drug concen-
trations (Student’s t-test, P ,
0.05). (B) Proportion of progeny
in different phenotypic classes of
tubGS ﬂies in the w1118 and
wDAH backgrounds grown at
10 mM RU486. Note that the
adult phenotypes are scored as
percentages of the viable adult
ﬂies that eclosed. Total numbers of pupae analyzed in each large-scale experiment (n) as indicated. (C) Proportion of adult progeny showing
bristle abnormalities, as illustrated in Figure S1, in ﬂies grown at the indicated doses of RU486, bearing the tubGS or daGS drivers as indicated.
Large-scale experiment using the daGS driver analyzed n = 508 individual adult ﬂies (10 mM), n = 758 (30 mM), and n = 246 (50 mM). The data for
the tubGS driver at 10 mM is the mean6 SD for three independent experiments (n = 89, 284, and 157 adults analyzed). See also Figure S2. daGS,
daughterless-GeneSwitch; SD, standard deviation; tubGS; a-tubulin-GeneSwitch.
Figure 4 AOX partially rescues
cleft thorax and developmental
lethality of tubGS/RU486. Propor-
tion of adult progeny exhibiting
the indicated phenotypes, with
hemizygous transgenes as indi-
cated, cultured with (+) or without
(–) 10 mM RU486. n $ 3 replicate
vials for each genotype studied
(except UAS-Ndi, n = 2, hence
no error bars shown). Transgenic
lines containing tub-AOX trans-
genes (Kemppainen et al. 2014)
had either a single hemizygous
copy or else ﬁve copies (two ho-
mozygous, plus hemizygous copy
on chromosome 3, combined
with tubGS on the same chro-
mosome).  denotes data classes
signiﬁcantly different from the
equivalent class for control lack-
ing any transgene additional to
tubGS (Student’s t-test with Bon-
ferroni correction, P , 0.01). (B) Proportion of pupae from two different genetic backgrounds (bkd), as shown, eclosing after culture in 10 mM
RU486. All pupae carried the tubGS driver and either no other transgene, or either of two different UAS-AOX transgenes, as indicated. # and 
denote data classes signiﬁcantly different from nontransgenic ﬂies in the same genetic background (Student’s t-test, P , 0.05 or 0.01, re-
spectively). (C) Proportion of pupae eclosing as viable or nonviable adults after culture in 10 mM RU486. All pupae carried the tubGS driver
and either no other transgene, or else ﬁve copies of tub-AOX transgenes (see above). Nonviable adults were those that died on the day of
eclosion.  denotes phenotypic classes of transgenic ﬂies signiﬁcantly different from corresponding class of nontransgenic ﬂies (Student’s t-test,
P , 0.01). AOX, alternative oxidase; GFP, green ﬂuorescent protein; tubGS; a-tubulin-GeneSwitch.
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UAS-AOX7.1 (Andjelkovic et al. 2015), showing much lower expression
than either ofUAS-AOXF6 orUAS-AOXF24. Finally, to conﬁrm that the
enzymatic activity of AOX is required for the rescue, we also included a
line (UAS-AOXmut) expressing a catalytically inactive variant of AOX
(Andjelkovic et al. 2015). The proportion of abnormal phenotypes
obtained using UAS-AOXmut was virtually indistinguishable from the
background strain w1118, while the weakly expressing UAS-AOX7.1
transgene produced an intermediate spectrum of phenotypes, with cleft
thorax, leg, and bristle abnormalities signiﬁcantly improved over the
background strain, but to a much lower extent than seen with the
strongly expressing lines UAS-AOXF6 and UAS-AOXF24. UAS-AOX7.1
also produced no rescue of the notched wings phenotype, while UAS-
Ndi1B20 signiﬁcantly exacerbated all of the abnormal phenotypes com-
pared with the background strain, with the exception of leg malformations,
which were decreased in frequency.
DISCUSSION
In this study, we identiﬁed a range of developmental abnormalities
associated with the use of the tubGS driver in combination with RU486.
These were seen at concentrations only slightly above those commonly
used to induce transgene expression inDrosophila during development.
At concentrations of 2.5 mM or above, we observed substantial pupal
lethality, while at 10 mM or above the majority of viable eclosed adults
had visible dysmorphic features, commonly including notched wings
and cleft thorax. Importantly, these phenotypes were dependent on
both the driver and the drug: neither alone produced any evidence of
developmental lethality or abnormality, and the effects did not appear
to be background dependent, since theywere seen inwild-typeOregonR
and Canton-S ﬂies, as well as in two white-eyed lines commonly used in
transgenic studies. A different GeneSwitch driver, with a much lower
and more restricted expression pattern, based on its ability to drive GFP
expression (Figure S2), produced only very subtle abnormalities in bris-
tle organization.
Mechanism of developmental disturbance
by tubGS/RU486
Previous authors have noted that RU486 treatment alone produces no
detectable abnormalphenotypes, althoughexpressionof a smallnumber
of mRNAs is altered in adults treated with the drug (Etter et al. 2005).
Given that we also saw no abnormalities from the use of tubGS or
RU486 on their own, we can exclude the possibility that RU486 binds
to or interferes with the activity of known nuclear receptors in Dro-
sophila (Fahrbach et al. 2012), or that the GeneSwitch transcription
factor is able to interact with any of their physiological ligands. How-
ever, ligand-bound GeneSwitch may be able to interact either with one
or more of these receptors, its targets, or other regulatory factors in-
volved in developmental patterning; for example, by the formation of
nonphysiological heterodimers between ligand-bound GeneSwitch and
bona ﬁde nuclear receptors.
The major dysmorphologies we observed have been reported pre-
viously in a variety ofmutants, often in combinations similar to those
that we observed. Cleft thorax has been reported in mutants of
Ultraspiracle (Henrich et al. 1994), a dimerization partner of the
ecdysone receptor and thus one of the key nuclear receptors regulat-
ing development progression in the ﬂy. It has also been reported in
mutants of the GATA transcription factor pannier (Heitzler et al.
1996) and the zinc-ﬁnger pair-rule transcription factor gene odd
(Tripura et al. 2011). Bristle abnormalities similar to those that we
observed are also characteristic of mutants of the dimerization part-
ner of pannier, u-shaped (Cubadda et al. 1997).
Mutants in the components of the AP-1 transcription factor, jun-
related antigen (homolog of mammalian c-Jun) and kayak (homolog of
mammalian c-Fos), as well as in the JNK signaling pathway that links
AP-1 activity to various upstream developmental signals, cause cleft
thorax (reviewed by Zeitlinger and Bohmann 1999; Kockel et al.
2001). Defects in JNK signaling also underlie wing defects and leg
malformations (Kirchner et al. 2007), and have been implicated in
midline closure defects in mammals (Chi et al. 2005; Zhu et al. 2016).
Cleft-thorax can result both from downregulation of effectors of JNK
signaling, such as the serine protease scarface (Srivastava and Dong
2015), or from mutations in receptor tyrosine kinase Pvr (Garlena
et al. 2015), an upstream JNK pathway activator (Ishimaru et al. 2004;
Igaki 2009). Thoracic closure also depends on downstream targets
such as proteins implicated in cytokinesis and cell adhesion (Sfregola
2014), as well as intracellular protein trafﬁcking (Thomas et al. 2009).
Mutants of blistery, encoding tensin, result in blistered wings, and
interact also with JNK signaling (Lee et al. 2003). Overexpression of
the inhibitor of matrix metalloproteases (Timp) results in pupal le-
thality and cleft thorax (Srivastava et al. 2007). Finally, wing disc-
speciﬁc knockdown of Tap42, a key regulator of protein phosphatases,
Figure 5 AOX rescues diverse
developmental abnormalities
produced by tubGS. Proportion
of progeny hemizygous for
both tubGS and the indicated
transgenes, which exhibited the
indicated developmental ab-
normalities, when reared on
food containing 10 mM RU486.
The total numbers of ﬂies of
each genotype analyzed, in a sin-
gle large-scale experiment (n), is
as shown. See supplemental
material for a detailed descrip-
tion of phenotypic categories.
Asterisks indicate signiﬁcant dif-
ferences (P , 0.001) from the
w1118 background strain hemizy-
gous for tubGS, based on chi-
squared analysis for each phenotypic category or for the four thoracic phenotypes (normal thorax, malformed scutellum, mild cleft, and severe
cleft) considered as a whole. AOX, alternative oxidase; tubGS; a-tubulin-GeneSwitch.
Volume 6 September 2016 | GeneSwitch and Developmental Abnormalities | 2843
gives rise to cleft thorax and to wing abnormalities similar to some
that we observed (Wang et al. 2012).
Notched wings are another previously observed phenotype in many
mutants, including those affecting the highly pleiotropic intercellular
signaling factor Notch (originally discovered by Morgan; Welshons
1958), SNARE-dependent membrane trafﬁcking (Stewart et al. 2001),
protein phosphatase PP2A (Kunttas-Tatli et al. 2009), the RNA-bind-
ing fragile X protein FMR1 (Wan et al. 2000), and histone deacetylation
(Pile et al. 2001).
The exact pattern of developmental abnormalities brought about by
GeneSwitch together with its ligand appears to reﬂect the tissue spec-
iﬁcity of its expression. Thus, whereas the widely expressed tubGS
produces a plethora of abnormal phenotypes, daGS, with much more
restricted larval expression (Figure S2), primarily in segmentally reit-
erated clusters of cells that might represent larval sense organs
(Brewster and Bodmer 1995), has only a single visible phenotype in
the adult, affecting the sensory bristles (Figure 3C). The use of other
GeneSwitch drivers may help to further clarify how its level and pattern
of expression affect the phenotypic outcome.
Finding a common thread through this rather bewildering array of
phenotypes and genetic pathwaysmay not be straightforward. However,
transcriptional cascades are considered to be the main determinants of
developmental processes, and the key system for regulating morpho-
genesis at pupal stage is the steroid hormone 20-hydroxyecdysone
(Riddiford 1993). Thus, an interference with ecdysteroid-dependent
transcription is the most parsimonious explanation for the pleiotropic
effects we observed, even thoughmolecular details remain to be ﬁlled in.
Mechanism of AOX rescue of developmental
disturbance by tubGS/RU486
While the observation that GeneSwitch-plus-RU486 can produce a
range of developmental abnormalities may be unexpected, their rescue
by a mitochondrially localized electron-transfer protein from another
phylum is even more surprising. It is important to note that, while the
abnormal phenotypes were produced by using an engineered (and thus
nonphysiological) transcription factor, andwere rescued by a gene from
a distant phylum, the effects were systematic in both cases, indicating
meaningful underlying biological processes. Thus, the extent of AOX
rescue of pupal lethality, cleft thorax, and other dysmorphologies was
dependenton theAOXexpression level, since strains expressingonlyata
low level (single-copy of constitutive tub-AOX, or low-expressor GAL4-
dependent lineUAS-AOX7.1) produced a less dramatic alleviation of the
phenotypes studied than the corresponding high-expressors (5 · tub-
AOX, UAS-AOXF24, and UAS-AOXF6). Rescue was dependent on the
enzymatic activity of AOX and was not seen with an inert reporter
protein (GFP) or a different mitochondrially localized electron-transfer
protein, yeast Ndi, which appeared to exacerbate some phenotypes.
AOX maintains ATP production, redox homeostasis, and metabolic
ﬂux under physiological conditions where respiratory complexes III
and IV are limiting due to overload, toxins, or genetic damage, and
concomitantly limits mitochondrial ROS production consequent upon
overreduction of the quinone pool (El-Khoury et al. 2014). AOX also
has an unexplained antioxidant effect, decreasing net mitochondrial
ROS output even under conditions where the respiratory chain is func-
tioning normally (Fernandez-Ayala et al. 2009; Sanz et al. 2010a).
How this links to a global alleviation of developmental perturbations
brought about by interference with transcriptional cascades or cell
signaling is far from clear. In a general sense, our ﬁndings hint at
a common metabolic regulation of transcription, such as evidenced
previously byAMPKsirtuins or PARP (Kraus and Lis 2003; Ghosh et al.
2010; Gut and Verdin 2013; Schiewer and Knudsen 2014; Salminen
et al. 2016), although none of these is obviously implicated, so a novel
pathwaymay be involved. Inmice, nuclear receptors are responsive to a
variety ofmetabolic effectors, which can also bemicrobiome-dependent
(Montagner et al. 2016), while cross-talk between nutrient-based sen-
sors and nuclear receptors is dependent on mitochondrial stress signals
and inﬂuences mitochondrial gene expression (Kang et al. 2015).
Many transcription factors, including nuclear receptors such as
LXRa (Serviddio et al. 2013) or NR4A1 (Shimizu et al. 2015) in mam-
mals, are known to be activated in response to oxidative stress
(Lavrovsky et al. 2000), and redox regulation of nuclear receptors such
as the glucocorticoid receptor (Tanaka et al. 1999) is well established.
AOX may therefore act by providing a general dampening of ROS,
normalizing developmental outcomes dependent on such receptors,
with which GeneSwitch plus RU486 interferes. An exhaustive study
using different ROS scavengers may shed further light on this.
Another possibility is based on the observation that synthesis of
20-hydroxyecdysone requires mitochondrial Fe-S cluster-containing
proteins dependent on frataxin (Palandri et al. 2015) and mitoferrin
(Llorens et al. 2015). Because Fe-S proteins are highly susceptible to
ROS damage, a general ROS dampening effect of AOXmay counteract
transcriptional interference from ligand-bound GeneSwitch, simply by
boosting endogenous ecdysteroid synthesis.
Recommendations on use of GeneSwitch drivers
The GeneSwitch system was originally elaborated using other drivers
than tubGS, i.e., those linked to the neuron- and muscle-speciﬁc elav
and Mhc promoters, respectively (Osterwalder et al. 2001), or for spe-
ciﬁc expression in other tissues such as the fat body (Roman et al. 2001).
Subsequently, the “ubiquitous”GS drivers (such as tubGS andActin5C-
GS) have been brought into use for inducing broad expression, both in
adults and larvae (Ford et al. 2007; Waskar et al. 2009; Wigby et al.
2011; Paik et al. 2012; Kuo et al. 2012; Kemppainen et al. 2014a,b; Sun
et al. 2014; Da-Rè et al. 2014).
Our work raises at least two concerns. First, the visible interference
with developmental processes at saturating or near-saturating drug
concentrations, using the tubGS driver, indicates the need for rigorous
controls and cautious interpretation of all data obtained using this
driver during development. Furthermore, we obviously cannot rule
out subtler but also biologically signiﬁcant effects that did not have
visible manifestations, even at lower drug concentrations than those
employed here. Second, other GeneSwitch drivers activated during de-
velopment may also be vulnerable to such effects, since our data indi-
cate that they depend on the drug and the transcription factor in
combination, which applies wherever they are colocated. An exam-
ple would be the recently published use of a GeneSwitch driver to
overexpress malic enzyme (Kim et al. 2015). The driver in this exam-
ple was originally reported to induce expression in the adult abdom-
inal fat body (Hwangbo et al. 2004), although Kim et al. (2015) found
that expression in larvae was instead driven in the salivary glands,
Malpighian tubule, and part of the gut. In this particular paper, the
appropriate controls without the transgene were indeed implemented
for the adult (see Supplementary Table 1C of Kim et al. 2015), but some
questions remain. The driver plus drug alone did not affect the body
weight of L3 larvae (Figure 3A of Kim et al. 2015), but effects on stress
resistance and lifespan in such controls were not documented. The
concentrations of RU486 used by Kim et al. (2015), i.e., 2.5–10 mg/ml,
corresponding with 5.8–23 mM, were within the range in which we saw
major developmental effects using the tubGS driver. Similarly, in
ﬂies expressing GeneSwitch in speciﬁc endocrine cells during
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development, using a customized driver and RU486 at even higher
concentrations from larval L2 stage onwards (Cho et al. 2014), clear
developmental abnormalities were attributed to knockdown of a nu-
clear receptor, although driver-plus-drug controls were not included
in all of the experiments reported. Some phenotypes observed (Figure 3
of Cho et al. 2014) resemble those that we report here (pupal lethality,
uninﬂated wings, abdominal clefting, and leg malformations). While
their interpretation that these are due to disrupted ecdysone signaling
may be correct, an effect of GeneSwitch plus RU486 in the target cells
cannot be excluded. Phenotypic rescue by injected ETH (Table 2 of
Cho et al. 2014) conﬁrmed the involvement of disrupted ecdysis, but
not the underlying causes thereof. A further possible example already
reported in the literature is the effect of the abdominal fat body-
speciﬁc GeneSwitch driver on lifespan, when RU486-containing food
was supplied in the adult to drive the supposedly inert GFP transgene
(Ren andHughes, 2014. RU486-dependent lethality in larvae containing
the Elav-GeneSwitch driver (Shen et al. 2009), and embryonic lethal-
ity produced by either the Elav- or Actin5C-GeneSwitch drivers plus
maternal RU486 (Landis et al. 2015), have been previously reported.
We would recommend that future users of all GeneSwitch drivers
should routinely include otherwise nontransgenic controls bearing the
drivers, plus and minus drug, in all experiments. Based on our ﬁndings
(Figure S2B), the daGS driver is clearly not ubiquitous, despite the fact
that the daughterless gene itself, as well as the “standard” daGAL4
drivers, do show widespread expression.
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ABSTRACT Downregulation of Jun N-terminal kinase (JNK) signaling inhibits cell
migration in diverse model systems. In Drosophila pupal development, attenuated
JNK signaling in the thoracic dorsal epithelium leads to defective midline closure, re-
sulting in cleft thorax. Here we report that concomitant expression of the Ciona in-
testinalis alternative oxidase (AOX) was able to compensate for JNK pathway down-
regulation, substantially correcting the cleft thorax phenotype. AOX expression also
promoted wound-healing behavior and single-cell migration in immortalized mouse
embryonic ﬁbroblasts (iMEFs), counteracting the effect of JNK pathway inhibition.
However, AOX was not able to rescue developmental phenotypes resulting from
knockdown of the AP-1 transcription factor, the canonical target of JNK, nor its tar-
gets and had no effect on AP-1-dependent transcription. The migration of AOX-
expressing iMEFs in the wound-healing assay was differentially stimulated by anti-
mycin A, which redirects respiratory electron ﬂow through AOX, altering the balance
between mitochondrial ATP and heat production. Since other treatments affecting
mitochondrial ATP did not stimulate wound healing, we propose increased mito-
chondrial heat production as the most likely primary mechanism of action of AOX in
promoting cell migration in these various contexts.
KEYWORDS AP-1, Jun N-terminal kinase, alternative oxidase, transcription, wound
healing
Cell migration is an essential process in animal development, as well as in tissuerepair. It has been widely studied in model systems, where the focus has been
largely on mechanosensation and mechanotransduction (1, 2). The transcriptional and
cytoskeletal regulation of cell migration ensures coordination and an ability to respond
to extrinsic and intrinsic cues (2). At the cellular level, the most studied mammalian
model is the scratch or wound-healing assay, in which a linear scratch is made in a
conﬂuent monolayer of cells, which then migrate to close the gap at a measurable rate
(3). In Drosophila development, cell migration has been studied in embryogenesis, in
the process of dorsal closure (4, 5), and later on during metamorphosis, when many of
the same genes are involved in thoracic closure (6). This process involves cells everting
from the wing imaginal discs, which spread over the preexisting larval epidermis (7).
These migrating cell sheets eventually fuse at the midline to create a closed epithelial
layer that gives rise to the cuticular structures of the dorsal thorax.
In an earlier study (8), we reported that the process of dorsal thoracic closure is
disrupted by the expression of a commonly used, inducible driver of transgene expres-
sion, GeneSwitch, in the presence of the inducing steroid RU486. GeneSwitch is a
modiﬁed version of the Saccharomyces cerevisiae transcription factor GAL4 incorporat-
ing the ligand-binding domain of the progesterone receptor so as to place it under
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steroid control (9, 10). Since progesterone or its analogues are not found in Drosophila,
it had been assumed that GeneSwitch plus RU486 would be phenotypically inert in
otherwise wild-type ﬂies, which is indeed the case in adults. Although cleft thorax was
the most dramatic and frequent phenotype observed in GeneSwitch-expressing ﬂies
reared throughout development on RU486-containing medium, other developmental
dysmorphologies were also observed, including wings with apoptotic regions, abnor-
mal or missing bristles, and cleft abdomen.
In the course of these studies, we observed that coexpression of the mitochon-
drial alternative oxidase (AOX) from Ciona intestinalis was able to revert the cleft
thorax and other dysmorphological phenotypes brought about by GeneSwitch plus
RU486 (8). Expression of an otherwise inert transgene, such as green ﬂuorescent
protein (GFP), the alternative NADH dehydrogenase Ndi1 from yeast, or even a
catalytically inactive variant of AOX, was unable to correct GeneSwitch-plus-RU486-
induced cleft thorax (8).
AOX represents an accessory component of the mitochondrial respiratory chain (RC),
which is found in microbes, plants, and some metazoan phyla but not insects or
vertebrates (11). AOX provides a non-proton-motive bypass for complexes III (cIII) and
IV (cIV) of the standard RC. In various contexts, it is able to relieve metabolically
deleterious stresses arising from damage, toxic inhibition, or overload of the RC (11, 12).
Furthermore, when expressed in human cells, ﬂies, or mice, Ciona AOX can alleviate the
damaging phenotypes associated with RC inhibition (13–19). However, the link be-
tween respiratory homeostasis and dysmorphologies resulting from GeneSwitch plus
RU486 is unknown.
These ﬁndings prompted us to test whether AOX could revert the cleft thorax
phenotype brought about by genetic manipulations in the signaling network that
maintains the migratory behavior of the cell sheets everting from the wing discs.
Three such classes of mutants have been studied. First, cleft thorax is manifested by
speciﬁc, recessive alleles of the gene encoding the Drosophila RXR homologue,
ultraspiracle (usp), which acts as a dimerization partner for the ecdysone receptor
(20). Second, compound heterozygotes for another essential transcription factor,
the GATA factor pannier (pnr), also give rise to this phenotype (21). One pnr allele
used in these studies is pnrMD237, a hypomorph created by insertion of GAL4 into
the promoter region for one of the two antagonistic pnr isoforms. This allele was
originally isolated in an enhancer-trap screen and has proven useful as a driver of
transgene expression in the speciﬁc domain of pnr expression in the dorsal epithe-
lium; thus, it is often referred to as pnr-GAL4.
Third, cleft thorax results from mutations in the Jun N-terminal kinase (JNK)
signaling pathway (4) (Fig. 1A). JNK (22) is a member of the mitogen-activated
protein (MAP) kinase family that activates the AP-1 transcription factor by phos-
phorylating its c-Jun subunit (23). AP-1 has a plethora of cellular roles, which
include the regulation of cell migration both in development (24) and in pathology,
e.g., tumor invasion (25). It is also subject to many types of regulation (26). JNK is
itself activated by a variety of stresses through a classic kinase cascade (27, 28). In
the context of thoracic closure, the initiating stimulus appears to be the engage-
ment of receptor tyrosine kinase pvr (29) (PDGF [platelet-derived growth factor] and
VEGF [vascular endothelial growth factor receptor] receptor related). Cleft thorax is
produced by mutant alleles of the JNK kinase (JNKK) hemipterous (hep) (30) or of the
AP-1 subunit kayak (kay; the Drosophila ortholog of mammalian c-Fos) (31). The use
of pnr-GAL4 or other drivers to bring about the local downregulation of JNK targets,
such as scarface (serine protease) (32), or overexpression of the AP-1 target puckered
(puc; a phosphatase regulator of JNK via a negative feedback loop) (33) or the tissue
inhibitor of metalloproteases (Timp) (34) can also produce cleft thorax, while down-
regulation of puc can rescue cleft thorax caused by mutations of hep (30). One key
target of JNK in dorsal closure (35, 36) is the transforming growth factor  family
member decapentaplegic (dpp). In thoracic closure, dpp promotes the migration of
cells at the imaginal leading edge (7), but it acts in a parallel pathway rather than
Andjelkovic´ et al. Molecular and Cellular Biology
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downstream of JNK (30). One key target of dpp in thoracic closure is pnr (37). A dpp
homologue in mammals is similarly involved in palatal closure (38).
We therefore set out to test whether AOX could rescue cleft thorax when induced
by manipulations of the JNK pathway and the associated gene network described
above.
RESULTS
AOX expressionmitigates cleft thorax due to downregulation of JNK signaling.We
ﬁrst conﬁrmed, using RNA interference (RNAi) and the pnr-GAL4 (pnrMD237) driver, that
the downregulation of key components of the JNK signaling cascade (Fig. 1A) (22) in
the mediodorsal region during Drosophila development resulted in a phenotype of cleft
thorax. After verifying the expression pattern conferred by pnr-GAL4, using the GFP
reporter already present in the pnrMD237 stock (Fig. 1B; see Table S1 in the supplemental
material), we combined it with RNAi insertions targeted against basket (bsk; encoding
JNK), hemipterous (hep; encoding JNKK), misshapen (msn; JNKKKK), and PDGF- and
VEGF-receptor related (pvr; encoding the receptor tyrosine kinase at the top of the
cascade [Table S2]). These all produced a cleft thorax phenotype of various severities
(see Fig. 1C for examples), according to the tested construct/insertion and temperature.
The two isolates of the pnr-GAL4 driver gave indistinguishable morphological pheno-
types and were therefore used interchangeably in the remainder of the study. Under
conditions producing the clearest phenotypes, but avoiding substantial lethality (ex-
cept in the case of pvr, where it was unavoidable), we then combined these with
expression constructs for AOX or for a control transgene, the GFP gene (Fig. 2 and 3).
For bsk and hep we tested multiple RNAi lines (Table S1), each producing cleft thorax
when combined with the pnr-GAL4 driver. Although the severity of cleft thorax varied
FIG 1 Cleft thorax produced by downregulation of JNK signaling. (A) Summary of the main steps in the
JNK signaling cascade in Drosophila thoracic development indicating Drosophila genes by their standard
symbols and their functional assignments in red text. The dotted line to dpp represents its activation by
AP-1 in embryonic dorsal closure but not in pupal thoracic closure. pnr is activated by dpp to regulate
the dorsal phenotype. The steps indicated with a green background are the ones that were clearly
inﬂuenced by AOX, based on the data presented later in the paper. TGF-, transforming growth factor
. (B) Live-cell imaging of a 13- to 15-h-old embryo (i), an L3-stage larva (ii), and a pupa (iii) of ﬂies
expressing GFP under the control of the pnr-GAL4 driver (original pnrMD237 strain). (C) Examples of
thoracic phenotypes scored as normal, mild, or severe, with arrows indicating the trend within each class
toward more severe cleft thorax phenotypes.
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slightly between experiments, expression of AOX (Fig. 2A and 3A and B) but not that
of GFP (Fig. 2B) led to a signiﬁcant and substantial shift toward a wild-type phenotype
in the progeny of bsk or hep knockdown ﬂies. Two different RNAi lines for each gene
showed the same effect (Fig. 3E to G). Any contribution to the alleviation of the
phenotype from promoter dilution was excluded by measuring the amount of AOX
RNA driven by pnr-GAL4 in pupae with and without one of the double-stranded RNA
(dsRNA) constructs for hep, which showed no signiﬁcant difference (Fig. 2D).
FIG 2 AOX rescues cleft thorax produced by downregulation of JNK signaling. (A, B) Effects of coex-
pressing AOX (A) or GFP (B) on the proportion of different phenotypic classes resulting from knockdown
of bsk and hep, using the pnr-GAL4 driver and RNAi lines KK 104569 (bsk) and GD 47507 (hep). For details
of the crosses, see Table S2 in the supplemental material. The data represent the means  SEM for
nine replicate vials in each experiment, with n indicating the total number of ﬂies analyzed in each
case. Statistically signiﬁcant differences between the proportions of AOX- or GFP-expressing and
-nonexpressing ﬂies of different phenotypic classes are shown. P values, as indicated, were deter-
mined by paired, two-tailed Student’s t test with Bonferroni correction. (C) Effect of coexpressing AOX or
GFP on pupal semilethality caused by knockdown of pvr (RNAi line KK 105353) using the pnr-GAL4 driver.
For details of the crosses, see Table S2 in the supplemental material. The data represent the means  SEM
for nine replicate vials in each experiment, with n indicating the total number of ﬂies analyzed in each
case. Statistically signiﬁcant differences between classes are indicated, with P values being determined
by analysis of variance with the Tukey post hoc honestly signiﬁcant difference (HSD) test. Note that
conversion to percentages for each vial corrects for differential lethality and for other vial-speciﬁc
anomalies. (D) qRT-PCR analysis of AOX RNA (means  SD; n  3) in hemizygous UAS-AOXF6 transgenic
ﬂies that were also hemizygous for pnrMD237 (pnr-GAL4), with or without the hep RNAi construct of line
GD 47509. Values were normalized against those for RpL32 and then against the mean value for ﬂies
expressing AOX only, to generate the relative values shown. KD, knockdown.
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For msn knockdown, very few ﬂies eclosed using the available RNAi line, and AOX
or GFP expression produced no signiﬁcant change in phenotype, despite a trend
toward the wild type for AOX (Fig. 3C) and increased severity in the case of GFP (Fig.
3F). A pvr knockdown line was pupal semilethal when combined with the pnr-GAL4
driver, even at 18°C. As a result, the number of eclosing progeny was insufﬁcient to
enable a statistically meaningful analysis of the thoracic phenotype according to
severity, but the mean proportion of progeny with cleft thorax was about 80% in this
and parallel pvr knockdown experiments. Coexpression of AOX, but not GFP, gave
substantial rescue of semilethality (Fig. 2C), with 71% (75/105) of the eclosing ﬂies
having a normal thorax.
AOX expression can inﬂuence mammalian cell migration. The failure of thoracic
dorsal closure during Drosophila development indicates a defect in cell migration,
which AOX expression was able to correct. To test the generality of this ﬁnding, we
conducted cell migration assays in mammalian cells. Mouse embryonic ﬁbroblasts
(MEFs) were isolated from AOX hemizygous mice and wild-type littermates and im-
mortalized using a standard retroviral transduction procedure with viruses encoding
human papillomavirus 16 (HPV16) oncoproteins E6 and E7 (39). AOX-endowed immor-
talized MEFs (iMEFs) showed an increased speed of wound closure in the standard
FIG 3 Conﬁrmation of AOX rescue of cleft thorax caused by JNK knockdown. Effects of coexpressing AOX
or GFP on the proportion of different phenotypic classes resulting from knockdown of bsk, hep, and msn,
using the pnr-GAL4 driver. (A, B) Repeats of experiments whose results are shown in Fig. 2A. (C) Results
of assays with RNAi line KK 101517 (msn) with coexpression of AOX. (D, E, G) Repeats of the experiments
whose results are shown in Fig. 2A, using alternate RNAi lines, GD 38138 (bsk) and GD 47509 (hep). (F)
Results of assays with RNAi line KK 101517 (msn) with coexpression of GFP. For details of the crosses, see
Table S2 in the supplemental material. The data represent the means  SEM for nine replicate vials in
each experiment, with n indicating the total number of ﬂies analyzed in each case. Statistically signiﬁcant
differences between the proportions of AOX- or GFP-expressing and -nonexpressing ﬂies of different
phenotypic classes are shown. P values, as indicated, were determined by paired, two-tailed Student’s t
test with Bonferroni correction. Note that conversion to percentages for each vial corrects for differential
lethality and for other vial-speciﬁc anomalies.
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scratch assay (Fig. 4A), which was maintained in the presence of various drugs, notably,
phorbol myristate acetate (PMA), an indirect activator of AP-1-dependent transcription
(acting via protein kinase C), and the JNK inhibitor SP600125. However, JNK inhibitor V
decreased the rate of wound closure of AOX-endowed iMEFs to the same level as
wild-type iMEFs. The scratch assay conducted on primary MEFs (at passage 6) revealed
no difference in migration rate between AOX-endowed and control MEFs (Fig. 4B). All
primary lines migrated much more slowly than iMEFs, with inhibitor V also producing
substantial cell death. The rate of single-cell migration of AOX-endowed iMEFs was also
signiﬁcantly greater than that of control iMEFs (Fig. 4C).
AOX expression has no systematic effect on c-Jun phosphorylation. We next
tested the same set of JNK modulators for their effects on c-Jun phosphorylation at JNK
target sites (40) Ser63 and Ser73, which has been shown to promote wound healing in
the scratch assay (41). This was done in iMEFs (Fig. 5A), as well as in two other cell lines,
the HEK293-derived AP-1 transcriptional reporter line used later in the study (HEK-AP1)
(Fig. 5B) and human ﬁbroblast line BJ-5ta (Fig. 5C). Only SP600125 decreased the
amount of phosphorylated c-Jun, whereas JNK inhibitor V instead increased it, as did
PMA. The presence of AOX did not inﬂuence c-Jun phosphorylation at these sites in
iMEFs (Fig. 5A), although it did appear to potentiate the effect of inhibitor V in an
AOX-expressing BJ-5ta cell clone (Fig. 5C).
AOX does not rescue cleft thorax caused by manipulation of AP-1 expression
or other targets. We reasoned that directly downregulating c-Jun or its dimerization
partner, c-Fos, encoded in Drosophila by Jun-related antigen (Jra) and kayak (kay),
respectively, should produce effects that largely override its regulation by JNK and the
beneﬁcial effects of AOX. Accordingly, coexpression of AOX had only a slight effect on
the severity of cleft thorax induced by knockdown of kay or Jra using the pnr-GAL4
FIG 4 Effects of AOX on mammalian cell migration. (A, B) Rate of wound closure in scratch assay of
cultured wild-type iMEFs (control) and AOX hemizygous iMEFs (A) and primary MEFs (B) at passage 6, as
indicated, either untreated (untr), treated with only 0.2% DMSO, with PMA (20 mM), with SP600125 (20
M in 0.2% DMSO), or with JNK inhibitor V (inh V; 20 M), as shown. Asterisks above the bars indicate
a statistically signiﬁcant difference (determined by one-way analysis of variance with the Tukey post hoc
HSD test) from untreated cells of the given genotype. Asterisks joining the bars indicate statistically
signiﬁcant differences between the genotypes for a given treatment, based on the same statistical
analysis. For clarity, other signiﬁcant differences are not shown. All data points are based on three
biological replicates, each analyzed in triplicate, except for DMSO only, which used only two biological
replicates. For the primary MEFs in panel B, the means  SD are for pooled data from two cell lines of
each genotype analyzed in triplicate at passage 6. (C) Rate of migration of single iMEFs of the indicated
genotypes. Asterisks denote statistical signiﬁcance, as shown (Student’s t test, unpaired; n  31 for
control iMEFs; n  21 for AOX-endowed iMEFs).
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driver (Fig. 6A and B). Similarly, AOX was unable to rescue the lethality caused by overex-
pression of the AP-1 target, puc, which also antagonizes the action of bsk (Fig. 6C). Note,
however, that this result may be trivial, since puc overexpression generates a severe
embryonic phenotype, due to the inhibition of dorsal closure.
As discussed earlier, pnr is considered to act in thoracic closure via a pathway
parallel to the JNK pathway. Since the pnr-GAL4 line pnrMD237 is also a pnr hypomorph,
we combined it with the pnrD1 mutant as a compound heterozygote, producing, as
expected, a phenotype of severe cleft thorax (Fig. 6D). This was not alleviated by AOX,
whether it was supplied using a constitutive or a GAL4-dependent transgene (Fig. 6D).
Our ﬁndings are consistent with the inference that AOX acts on JNK signaling upstream
of AP-1 but cannot compensate for a deﬁciency of AP-1 itself nor of a parallel pathway
also required for thoracic closure.
FIG 5 Phosphorylation status of JNK target residues in c-Jun. Western blots of whole-cell protein extracts
from control and AOX-expressing iMEFs (A), HEK-AP1 cells (B), and AOX-expressing or control human
BJ-5ta ﬁbroblasts (C) untreated (untr) or treated with JNK modulators, as shown: 0.2% DMSO, 20 M
SP600125 (SP) in 0.2% DMSO, 20 M JNK inhibitor V (V or inh V), or 8 nM PMA. The molecular weights
of the major bands detected by each antibody, inferred from size markers run on all gels, were as
expected (100 kDa for -actinin [-act], 47 kDa for c-Jun phosphorylated at residue Ser73 [pSer73] or
Ser63 [pSer63]). Separate blots were initially probed for pSer73 or pSer63, and then in both cases the
blots were reprobed for -actinin as a loading control. Drug concentrations were based either on
dose-response curves obtained using the HEK-AP1 cell transcriptional reporter system (for PMA and JNK
inhibitor V; see Table S3 in the supplemental material) or on trials to determine the highest concentration
at which there was no evidence of substantial cell death (for SP600125). Blot images were optimized for
brightness and contrast, rotated, and cropped with the addition of white frames or dividers for clarity,
but with no other manipulations.
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AOX does not inﬂuence AP1-dependent transcription in cultured cells. To
investigate the mechanism by which AOX impacts the outcome of JNK signaling, we
tested whether it inﬂuences transcription directed by AP-1. Using a well-established
luciferase-based AP-1 reporter system (42) and a variety of different expression con-
FIG 6 AOX does not rescue cleft thorax produced by altered expression of AP-1 or other targets. (A, B)
Effects of coexpressing AOX on the proportion of different phenotypic classes resulting from knockdown
of kay (at 25°C) and Jra (at 18°C), using the pnr-GAL4 driver and RNAi lines GD 6212 (kay) and KK 107997
(Jra) (A) and alternate RNAi lines GD 19512 (kay) and GD 10835 (Jra) (B). For details of the crosses, see
Table S2 in the supplemental material. Because the GD 10835 (Jra) construct is carried on chromosome
X, two parallel crosses were required to test the effects of AOX expression in each sex, and statistical
analysis was not meaningful in this case. The data represent the means  SEM for nine replicate vials in
each experiment, with n indicating the total number of ﬂies analyzed in each case. Statistically signiﬁcant
differences between the proportions of AOX-expressing and -nonexpressing ﬂies of different phenotypic
classes are shown. P values, as indicated, were determined by paired, two-tailed Student’s t test with
Bonferroni correction. Note that Jra knockdown using RNAi line KK 107997 (Jra) was lethal at 25°C and
that AOX did not rescue this lethality. (C) Effect of coexpressing AOX or GFP on pupal lethality caused
by overexpression of puc under the control of the pnr-GAL4 driver. Progeny classes are as indicated, and
all contained, in addition, the UAS-puc overexpression construct. For details of the crosses, see Table S2
in the supplemental material. The data represent the means  SEM for nine replicate vials in each
experiment, with n indicating the total number of ﬂies analyzed in each case. Note that conversion to
percentages for each vial corrects for differential lethality and other vial-speciﬁc anomalies. (D) Pheno-
types of pnrMD237/pnrD1 compound heterozygotes with and without the presence of AOX transgenes, as
indicated. Neither the GAL4-driven UAS-AOXF6 transgene nor homozygosity for the tub-AOX transgenes
on chromosomes 2 and X produced the rescue of the strong cleft thorax phenotype. Note that because
progeny phenotypes were essentially uniform for a given genotype, no meaningful variances could be
calculated.
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structs for AOX, we tested whether AOX expression in Drosophila S2 cells was able to
alter AP-1-dependent transcription under different conditions of JNK pathway activa-
tion. First, we compared the transcriptional readout in cells cotransfected with the
reporter plasmids and with AOX cloned into the copper-inducible expression vector
pMT/V5-His B, with its natural stop codon, with that in cells transfected with the empty
vector. JNK pathway activation was achieved using the pUAST-Hepact plasmid, included
in all transfections in combination with pAct-Gal4, which promotes pUAST-Hepact
transcription by constitutive expression of Gal4. Transfection efﬁciency was controlled
by the inclusion of a constitutively expressed plasmid encoding renilla luciferase, which
can be experimentally distinguished from the ﬁreﬂy luciferase of the reporter construct.
Finally, to measure background transcription independently of AP-1, the system in-
cludes a mutated version of the reporter (which was used as an alternative in trans-
fections), to which AP-1 does not bind.
Despite the complexity of this system, it gave clear-cut results. AOX produced no
signiﬁcant change in AP-1-dependent luciferase expression under both basal and
JNK-activated conditions (Fig. 7A; Table S4). Next, we tested reporter cells cotransfected
with a plasmid (pAC/AOX) (43) directing constitutive AOX expression under the control
of a -actin promoter versus cells cotransfected with the empty vector. Again, AOX
expression had no effect on the transcriptional readout (Fig. 7B; Table S4). Using a
system in which JNK pathway activation and AOX induction were brought about
simultaneously by expression of the exogenous transcription factor Gal4, but this time
using a control plasmid harboring a catalytically inactive, mutated AOX, we again found
no effect of AOX (Fig. 7C: see also the results of a parallel experiment in Table S4). AOX
also produced no signiﬁcant difference in AP-1-dependent transcription in cells where
hep had been knocked down (Fig. 7D; Table S4).
We conducted a similar exercise in mammalian cells, using an HEK293 cell-derived
reporter cell line (here designated HEK-AP1), stably transduced with lentiviral con-
structs expressing AOX or, as a control, the mutated, catalytically inactive variant
(mutAOX). Successful transduction and cell cloning at limiting dilution were veriﬁed via
the ﬂuorescence conferred by the cotransduced marker GFP, and AOX functionality was
veriﬁed by respirometry (Table S5). Although individual HEK-AP1 cell-derived clones
showed a variable degree of AP-1-dependent transcriptional activity, AOX-expressing
and control cell clones showed a similar susceptibility to the effects of the JNK
antagonists SP600125 and inhibitor V (Fig. 7E). Surprisingly, SP600125 increased rather
than decreased the transcriptional readout, despite the fact that it inhibited c-Jun
phosphorylation (Fig. 5B), although it did modestly suppress PMA-activated transcrip-
tion in the reporter line (Fig. 7E).
Antimycin A differentially stimulates the migration of AOX-expressing cells. To
gain insight into the intracellular process(es) underlying the enhanced migratory
behavior of AOX-expressing cells, we tested the effects of sublethal doses of various
metabolic effectors on the relative rates of migration of AOX-expressing versus control
iMEFs. In an initial experiment (Fig. 8A), we tested various oxidative phosphorylation
inhibitors, antioxidants, and protease inhibitors in the wound-healing assay for a
differential effect on AOX-expressing cells. For further study, we selected three treat-
ments that appeared to give a differential effect (antimycin A, oligomycin, and mito-
quinone mesylate [MitoQ]), together with two that did not (rotenone and carbonyl
cyanide p-triﬂuoromethoxyphenylhydrazone [FCCP]), and measured wound closure in
four independent experiments. Antimycin A had a signiﬁcantly different effect on the
migration of AOX-expressing MEFs versus wild-type MEFs (Fig. 8B), stimulating the
migration of the former but suppressing that of the latter, whereas MitoQ, rotenone,
oligomycin, and FCCP had no signiﬁcant effects. To understand the implications of
these ﬁndings for the mechanism by which AOX promotes cell migration, we checked
the effects of AOX expression on respiration in the cell lines tested (Fig. 8C). AOX had
no signiﬁcant effect on whole-cell respiration or on permeabilized cell respiration on cI-,
cII-, and cIV-linked substrates. However, in the presence of antimycin A, it enabled
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almost 80% of the uninhibited respiration rate in permeabilized cells, driven by
succinate. This capacity actually exceeded the measured rate of whole-cell respiration
under uninhibited conditions, implying that the capacity for AOX-mediated respiration
was sufﬁcient to maintain normal respiratory electron ﬂow in iMEFs in the presence of
antimycin A.
FIG 7 Effects of AOX on AP-1-dependent transcription. (A to D) Fireﬂy luciferase activity in extracts of S2
cells cotransfected with pMT-AOX (or empty vector) (A), pAC/AOX (or empty vector) (B), or pUASTattB-
AOX (or pUASTattB-mutAOX) (C), with pUAST-Hepact together with pAct-Gal4 (or not) to activate it (A to
C) or following 5 days of dsRNA treatment (knockdown) for hep (D), and with reporter constructs
containing intact (TRE-ﬂuc) or mutated (mRE-ﬂuc) phorbol ester-response elements (RE), as indicated,
and pAct-RL for normalization. All data were ﬁrst normalized for transfection efﬁciency, based on renilla
luciferase activity, followed by renormalization against basal activity for the relevant control cells, i.e., the
empty vector (A, B, D) or pUASTattB-mutAOX (C). The results for AOX-expressing and AOX-nonexpressing
cells in any category were not signiﬁcantly different from each other (Student’s t test, two-tailed,
unpaired), apart from one case in panel D, as indicated. Statistically signiﬁcant differences between data
classes were determined by one-way analysis of variance with the Tukey post hoc HSD test; for
clarity, only comparisons between the pairs which were coherent are shown, except in panel D,
where some signiﬁcance values differed, as shown. See also Table S4 in the supplemental material
for the results of repeat and parallel experiments. act, activated. (E) Fireﬂy luciferase activity in
extracts of HEK-AP1 reporter cells and clones derived from them transduced with AOX- or mutAOX-
expressing lentiviral constructs (see Table S5 for clone characterization) and treated with the
indicated drugs: 0.2% DMSO, 20 M SP600125 in 0.2% DMSO, or 20 M JNK inhibitor V. Data were
normalized against the values for the corresponding untreated cells (unstimulated) or for the
corresponding cells stimulated with 8 nM PMA, as shown. Box plots indicate the means and the 95%
conﬁdence intervals for each data set.
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DISCUSSION
In this study, we showed that the expression of AOX is able to promote cell
migratory behavior in two different models: in Drosophila, AOX expression corrected
thoracic closure defects produced by impaired signaling at several steps in the JNK
pathway (summarized in Fig. 1A), while AOX-expressing iMEFs (but not primary MEFs)
showed enhanced migration, which was abolished by JNK inhibitor V. In contrast, AOX
was unable to correct cell migration defects resulting from downregulation of the main
JNK substrate, the c-Jun subunit of AP-1, or by manipulation of other factors, such as
the AP-1 downstream target puc or the pnr transcription factor. Using a luciferase
reporter system, AOX also had no effect on AP-1-dependent transcription in prolifer-
ating Drosophila (S2) or mammalian (HEK293-derived) cells. The migration of AOX-
expressing iMEFs compared with that of control iMEFs was differentially stimulated by
antimycin A but not by other drugs that affect mitochondrial electron ﬂow, ATP
production, reactive oxygen species (ROS), or membrane potential. We thus propose
increased mitochondrial heat production as the most likely mechanism by which AOX
promotes cell migration.
Conditions for AOX activation. Clearly, to affect cell motility or any other pheno-
type, AOX needs to be enzymatically active, modifying the cellular metabolic state.
Previous studies in model systems (13–19) found that AOX expression has only minimal
effects on phenotype under standard physiological conditions. Its activation requires
that its substrate, ubiquinol, accumulate to substantial levels in the reduced form (44,
45), due to respiratory chain inhibition or overload. Other aspects of metazoan AOX
FIG 8 Modulation of iMEF migration by metabolic inhibitors. (A, B) Relative rate of wound closure for
wild-type iMEFs (control) and AOX-hemizygous iMEFs treated either with DMSO only (—) or with the
indicated drugs (see Materials and Methods). Data are normalized against the closure rate for the given
cell line treated only with DMSO. (A) Preliminary experiment with 9 different drugs. (B) For the 5 drugs
indicated, the data represent the means  SD from 4 independent experiments. Asterisks indicate
statistically signiﬁcant differences (Student’s t test, P 0.01) between drug-treated and untreated (DMSO
only) cells of the given genotype. (C) Respiratory oxygen consumption of control and AOX-expressing
iMEFs is indicated as follows: endo, endogenous whole-cell respiration; cI, cII, cIV, and AOX, respiration
of permeabilized cells driven by cI-, cII-, or cIV-linked substrate mixes or by cII-linked substrate mix in the
presence of antimycin A (denoted AOX), respectively.
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regulation remain largely unknown. In plants, AOX is activated by pyruvate (44, 46),
although this regulation has not been demonstrated in the metazoan enzyme (47).
Nevertheless, AOX rescue of cleft thorax and promotion of iMEF motility imply that it
can become activated at the margin of a migrating cell sheet. Cell movement is an
energy-requiring process, and AMP-activated protein kinase (AMPK), one of the cell’s
key regulators of energy homeostasis (48), is locally activated at the leading edge of a
migrating cell sheet (49), where it promotes the movement of mitochondria into this
subcellular domain. This metabolic microenvironment may also favor AOX activation, if
the extra demand exceeds the capacity of respiratory complex III. In addition to AMPK,
the mitochondrial unfolded protein response (mtUPR), which has previously been
linked with JNK signaling (50), may be elicited. Treatment with antimycin A, which was
shown here to differentially stimulate the migratory behavior of AOX-expressing iMEFs,
should lead to the further activation of AOX, since blockade of cIII increases the ratio
of ubiquinol to ubiquinone, diverting electron ﬂow through AOX.
The proteins used for immortalization of MEFs, namely, the HPV16 E6 and E7
oncoproteins, may also synergize with activated AOX. Among other effects (51), E7
switches energy supply from respiration to glycolysis by activating pyruvate kinase (52).
Switching to the high-capacity glycolytic pathway may underlie the increased migra-
tory capacity of immortalized MEFs, as inferred previously for cancer cells (53, 54). AOX
may enhance this by increasing pyruvate clearance via the tricarboxylic acid cycle,
promoting glycolytic ﬂux. Similarly, E6 promotes glucose transport (55–57) and facili-
tates the degradation of p53 (58), providing a possible link to AP-1 and JNK (59–62). E6
also upregulates hypoxia-inducible transcription factor 1 (HIF-1) (63) and mTORC1
(64).
Is AP-1 the target of AOX? Reporter assays indicate that AP-1 and its transcriptional
activity are not a direct target of AOX, although the Drosophila ﬁndings and the effects
of inhibitor V leave open a possible direct involvement of JNK, acting through other
targets.
The transcriptional reporter cell assays were conducted in proliferating cells, where
AP-1 may act differently than in a migrating cell sheet. It plays diverse physiological
roles, and each of its subunits is encoded by a gene family (65). Although its canonical
members, c-Fos and c-Jun, drive cell proliferation (66), others are functionally diverse
and are regulated by a host of mechanisms (67), including subunit composition (68),
other MAP kinases (69), and mitochondrial ATP depletion (70).
The interpretation of experiments using JNK inhibitors rests upon assumptions
regarding their speciﬁcity, but the effects of SP600125 and JNK inhibitor V do not ﬁt
previous assumptions regarding their mode of action. Inhibitor V was the only drug
tested which blocked the migration-promoting effects of AOX in iMEFs, indicating that
it acts at a step different from that inﬂuenced by AOX. These drugs have previously
been studied almost exclusively in highly artiﬁcial in vitro systems (49, 71), taking little
account of their demonstrated activity against other kinases (71–73). The alternative
approach of using genetic ablation of JNK to elucidate the AOX-responsive step cannot
easily be applied in mammalian cells, since JNK has diverse isoforms created by
alternative splicing and is encoded by a multigene family, some of whose members
have undoubtedly been functionally redeployed during evolution (74).
AP-1 is subject to oxidative inactivation (65, 75), from which it is protected in
Drosophila by the coactivator MBF1 (76), and the loss of MBF1 sensitizes animals to cleft
thorax, if also exposed to H2O2. AOX decreases net ROS production from mitochondria
(15, 77), which could compensate for the impaired upstream activation of AP-1, but, as
discussed below, its effects on mammalian cell migration were not inﬂuenced by drugs
that alter ROS (MitoQ, N-acetyl cysteine; Fig. 8).
AOX and other signaling pathways. AOX may also act through other pathways
independently of or in conjunction with AP-1. For example, immortalized ﬁbroblasts
show an enhanced induction of HIF-1 under hypoxia (78), while AOX also blunts the
hypoxia response (79). In cancer cells, mitochondrial ROS activates many transcription
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factors (80), and interactions between AMPK and AP-1 have been reported in cardio-
myocytes (81) and Jurkat T cells (82). Mitochondrial energy status also governs calcium
transport into mitochondria, which has major effects on cell migration (83).
Other transcription factors mediate mitochondrial responses to stress, notably, Nrf2
(84), ATF4 (85), and other AP-1 paralogs. Although stressors that activate AP-1 via JNK
have only minimal effects on Nrf2- or ATF4-induced transcription (86), this does not
exclude the possibility of the converse. JNK can be activated by mitochondrial ROS in
ischemia-reperfusion (87) or by the mtUPR (50). JNK itself has also been reported to
interact directly with mitochondria, triggering downstream effects (88).
AOX stimulates migratory behavior by a mechanism connected to metabolism.
Of the metabolic inhibitors tested, only antimycin A preferentially stimulated the
migratory behavior of AOX-expressing cells compared with control cells in the wound-
healing assay. This result provides a strong clue as to the mechanism of action of AOX.
The ineffective treatments included agents that should increase mitochondrial mem-
brane potential (oligomycin [89]) or decrease it (FCCP [90], rotenone [91]), other
treatments that inhibit mitochondrial ATP production (oligomycin, FCCP, and rotenone)
or drugs that increase ROS production (oligomycin [92], rotenone [91, 93]) or dampen
it (N-acetyl cysteine [94], MitoQ [95]) or that can have effects in either direction,
depending on the dose (FCCP [96–98]). Agents that limit proteolytic turnover of cellular
components in lysosomes (chloroquine [99]; E64d [100]) or by caspases [carbobenzoxy-
valyl-alanyl-aspartyl-(O-methyl)-ﬂuoromethylketone (Z-VAD-FMK) (101)] also appeared
to have no differential effect on the migration of AOX-expressing cells. Not only did
these other treatments fail to inﬂuence control and AOX-expressing cells differentially,
but none of them produced substantial alterations to the rate of migration of control
cells.
Since AOX-expressing iMEFs continue to respire when treated with antimycin A,
most metabolites should be only minimally affected. The biggest difference should be
in the rate of mitochondrial ATP production, when respiratory complexes III and IV are
replaced by the non-proton-motive AOX. However, as indicated above, mitochondrial
ATP production as such cannot be the crucial factor determining the rate of migration.
In the presence of antimycin A, the energy released by AOX in catalyzing quinol
oxidation is instead converted to heat. We earlier showed that AOX-driven respiration
in human cells was able to maintain the same mitochondrial temperature with less than
half the amount of respiratory ﬂux (102). In the iMEFs tested, the capacity for AOX-
mediated respiration was sufﬁcient to maintain respiratory electron ﬂow in the pres-
ence of antimycin A at the same rate as in untreated cells (Fig. 8C). This implies that the
cells should be able to maintain normal redox homeostasis in the presence of the drug
with only a minimal metabolic disturbance, arising from the need to make more ATP
through nonmitochondrial pathways. Maintenance of respiratory ﬂux but in which ﬂux
is driven through AOX rather than cIII implies a pronounced thermogenic effect. Thus,
we propose increased mitochondrial heat production as the most likely mechanism
whereby AOX stimulates cell migration.
Fibroblast motility has long been known to be temperature dependent (103), and
actin polymerization itself is highly affected by changes in temperature (104). The
migration of mesenchymal stem cells is stimulated by increased expression of heat
shock protein 90 (105), which impinges on various signaling pathways, possibly un-
derlying the different effects of JNK inhibitors with poor selectivity. Heat shock protein
70 has also been shown to promote cell migration, by acting as a chaperone for the
delivery of proteins needed by migrating cells to the leading edge (106). Even a
transient heat shock can promote cell migration in cancer cell lines (107), which may
(108) or may not (107) depend on heat shock transcription factor 1 (HSF1).
Together, these data strongly suggest that AOX activation is able to promote cell
migration by raising the intracellular temperature, most likely in speciﬁc subcellular
compartments. The compensatory effects on JNK signaling are thus implied to be
indirect, accounting also for the fact that AOX was able to correct cleft thorax in a
completely different model generated by deranged nuclear receptor signaling (8).
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Further validation of this hypothesis will require the development of quantitatively
reliable methods to measure the intracellular temperature in speciﬁc cell compartments
in situ. It will require even more sophisticated technology to make such measurements
in vivo in the Drosophila pupa. Alternatively, if some other metabolic effect of AOX-
driven respiration is responsible, we would need to wait for metabolomic technologies
to advance to the single-cell level (109) to identify plausible candidates, although novel
in situ methods would be needed to take this to the subcellular level.
Developmental context of mitochondrial effects on cell migration. Insect meta-
morphosis is fuelled by stored nutrients accumulated during larval growth, principally,
lipid which is metabolized in mitochondria (110). A drop in the ATP level due to
nutritional limitations should activate AMPK, so as to refocus resources onto ATP
production. However, because all protein kinases depend on ATP as a substrate, ATP
deﬁciency should restrain other regulatory kinases and limit ATP-consuming develop-
mental processes, such as cell migration. Assuming that JNK operates as one such
pathway, its inappropriate downregulation in the dorsal thoracic epithelium under
conditions where the ATP supply is adequate could restrict cell migration while other
developmental processes are energized normally, resulting in the speciﬁc failure of
midline closure.
Rapid wound healing is also important for limiting pathogen invasion. Pathogens
may deplete the nutritional environment of a wound, potentially jeopardizing the
processes that support tissue repair. Rapid and efﬁcient wound closure in a nutritionally
limited environment may therefore depend on metabolic remodeling to support
motility (111).
A full elucidation of the processes that link mitochondrial perturbations with cell
migration should be of considerable medical importance and might even enable the
design of new and more effective treatments, e.g., for metastatic tumors, tissue injuries,
and congenital midline closure defects. Conﬁrmation of a role in these processes for
mitochondrial heat production may open up entirely new avenues for therapy.
MATERIALS AND METHODS
Drosophila strains and culture. The Drosophila strains used in the study and their sources are
summarized in Table S1 in the supplemental material. Flies were maintained in standard high-sugar
medium (15) on a 12-h light/12-h dark cycle at 25°C, except where indicated in the ﬁgure legends.
Crosses were generally implemented in triplicate, with ﬂies being tipped into new vials on three
successive days after mating.
Cell culture. Drosophila strain S2 cells were maintained as described previously (112). AOX-positive
and -negative mouse embryonic ﬁbroblasts (MEFs) (113), sourced either from embryos transgenic for C.
intestinalis AOX, inserted at the Rosa26 locus (18), or from their nontransgenic littermates, were studied
at passage 6. MEFs were immortalized (iMEFs) by retroviral transduction with HPV16 oncoproteins E6 and
E7 (39) and maintained at 37°C in 5% CO2 in Dulbecco modiﬁed Eagle medium (DMEM; Sigma-Aldrich)
supplemented with 20% (primary MEFs) or 10% (iMEFs) heat-inactivated fetal bovine serum (FBS;
Sigma-Aldrich), 1% penicillin-streptomycin (Lonza), and 4 mM L-glutamine (Sigma-Aldrich). An AP-1
reporter HEK293 recombinant cell line (JNK signaling pathway; BPS Bioscience), here abbreviated
HEK-AP1, was maintained at 37°C in 5% CO2 in minimal essential medium (HyClone) supplemented with
10% heat-inactivated FBS (Sigma-Aldrich), 1% nonessential amino acids (HyClone), 1 mM sodium
pyruvate (Sigma-Aldrich), 1% penicillin-streptomycin (Lonza), and 400 g/ml Geneticin (Gibco, Life
Technologies). Geneticin was freshly distributed to each plate when cells were passaged. BJ-5ta human
ﬁbroblasts (ATCC CRL-4001) were grown at 37°C in 5% CO2 in DMEM (Sigma-Aldrich) supplemented with
10% heat-inactivated FBS (Sigma-Aldrich), 20% medium 199 (Sigma-Aldrich), 1% penicillin-streptomycin
(Lonza), and 4 mM L-glutamine (Sigma-Aldrich). HEK-AP1 and BJ-5ta cells expressing C. intestinalis AOX
or the mutated, catalytically inactive variant mutAOX (43) were obtained by pWPI-based lentiviral
transduction as described previously (114). Transduced cell populations were sorted according to GFP
ﬂuorescence using a BD FACSAria II cell sorter equipped with an 85-m nozzle and operated at a sheath
pressure of 45 lb/in2 and then cloned at limiting dilution. Clones were reveriﬁed for GFP ﬂuorescence by
ﬂuorescence-activated cell sorting and for AOX functionality by respirometry, as described previously
(43).
Wound-healing and single-cell migration assays. Samples of 90,000 cells were plated on 24-well
plates (CellStar; Greiner Bio-One) as technical triplicates (3 wells per sample). After 24 h, cells were treated
with one of the following reagents: 0.2% dimethyl sulfoxide (DMSO; Hybri-Max; Sigma-Aldrich), 20 M
SP600125 (Sigma-Aldrich) in 0.2% DMSO, 20 M JNK inhibitor V (Merck), or 20 nM phorbol myristate
acetate (PMA; Sigma-Aldrich) in fresh medium. After 2 h, a linear scratch was made in the center of each
well with a p10 (1- to 10-l) pipette tip. The cells were then washed three times with medium to remove
detached cells, and fresh medium containing the appropriate reagent was added to each well. For testing
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the effects of metabolic inhibitors in this assay, cells were seeded at 45,000 to 90,000 cells per well on
24-well plates until a monolayer was formed (24 to 48 h), before the scratch was made. After rinsing once
with normal medium, medium was replaced with 1 ml of fresh medium containing one of the following
drugs: oligomycin (1 ng/ml), antimycin A (60 ng/ml), rotenone (150 nM), FCCP (10 M), N-acetyl cysteine
(5 mM), chloroquine (20 M), E64d (10 g/ml), MitoQ (250 nM; a kind gift of Mike Murphy, MRC
Mitochondrial Biology Unit, Cambridge, UK), valinomycin (10 M), Z-VAD-FMK (20 M), or just 4 l DMSO
as a solvent control. All chemicals were from Sigma-Aldrich, except where stated otherwise. To measure
single-cell migration, samples of 15,000 cells were plated on 6-well plates (CellStar; Greiner Bio-One) as
technical triplicates (3 wells per sample). To minimize plate-speciﬁc effects, each plate contained both
AOX-positive and -negative iMEFs in all assays. Cells were imaged as described below.
Microscopy. Imaging of ﬂy thoraxes used a Nikon digital DS-Fi1 high-deﬁnition color camera with a
Nikon SMZ 745T stereoscopic zoom microscope operated by NIS-Elements D (version 4.20) software. For
live imaging of Drosophila embryos, eggs were collected from grape juice-agar plates after adult ﬂies
were placed in a mating chamber for 1 h, covered by a dark box, dechorionated using double-sided tape
(115), placed into 35-mm glass-bottom microwell dishes (MatTek Corporation) ﬁlled with Halocarbon Oil
700 (Sigma-Aldrich), and imaged for GFP ﬂuorescence using an Andor spinning disc confocal microscope
equipped with an Andor Neo 5.5 sCMOS vacuum-cooled camera at 20 magniﬁcation. The larvae were
cleaned of adherent food using a soft paintbrush, dried on a precision wipe, placed on an ice-cold
microscope slide (Menzel Gläser), and covered with a few drops of 50% ice-cold glycerol and then with
a cover glass (thickness number, 11⁄2; Zeiss). Samples were placed in a 20°C freezer for 15 min to
immobilize the larvae. Live imaging used a Zeiss Axio Imager M2 upright microscope with a Zeiss EC
Plan-Neoﬂuar 5/0.16, WD 18.5-mm air objective and ZEN software without the ApoTome function.
Pupae were gently detached from the vial, placed with the dorsal side down into 35-mm glass-bottom
microwell dishes (MatTek Corporation), and imaged as described above for embryos. Wound closure
time-lapse images were taken with a ChipMan Technologies Cell-IQ observation incubator equipped with
a Retiga EXi 1392 charge-coupled-device camera, using a Nikon CFI Plan Fluorescence DL objective
(magniﬁcation, 10) until the wound closed (approximately 48 h) or for just 24 h when metabolic
inhibitor drugs were applied. Images were taken every 30 min. The incubator environment was held at
a temperature of 37°C and had an atmosphere of 5% CO2, 19% O2, and 76% N2. Wound-healing analysis
was performed using a Cell-IQ analyzer (version 4.3) by manually tracking the gap area, based on lines
drawn along the wounded area of an image taken every second hour. The speed of the collective motion
of the cells was measured in the most linear part of the wound area over time. In the experiment using
metabolic inhibitors, the most linear time interval for closure was also analyzed and applied across all
treatments and plates. To generate images for measuring single-cell migration, cells were transferred 24
h after plating to a Nikon BioStation CT instrument equipped with a Nikon DS-1QM camera and imaged
at 4 magniﬁcation. The environment in the incubator was held at a temperature of 37°C with a relative
humidity of 85% and a 5% CO2 atmosphere, as described above for the wound-healing assay. Images
were taken every 6 min, and movies were made using CL Quant (version 3.10) software. Movement was
analyzed using CellTracker image-processing software with semiautomated migration detection (116),
ignoring cells that were dying or dividing.
qRT-PCR. RNA was extracted from S2 cells (117), and quantitative reverse transcription-PCR (qRT-
PCR) was performed (16) as described previously, using RpL32 mRNA as an internal standard. Primers for
RpL32 and AOX were those used previously (16), and those for hep mRNA were TTGGTTTCTTGGGGTC
GATG and TGGACTCCAAGGCCAACACT, the sequences of both of which are shown 5= to 3=.
Transfections and luciferase reporter assays in S2 cells. Fireﬂy/renilla luciferase dual-reporter
assays in S2 cells used a cotransfection protocol (42), based on plasmids TRE-ﬂuc, mRE-ﬂuc, pAct-RL,
pAct-Gal4, and pUAST-Hepact, kindly supplied by Dirk Bohmann, University of Rochester. Transfections
used either TRE-ﬂuc (a ﬁreﬂy luciferase reporter with the intact phorbol-ester response element) or
mRE-ﬂuc (with the mutated response element) plus pAct-RL (renilla luciferase for transfection normal-
ization) with or without pAct-Gal4 together with pUAST-Hepact for activated transcription and with the
following plasmids or controls harboring AOX, as indicated in the ﬁgure legends: pMT-AOX (a kind gift
of Filippo Scialó, Newcastle University), containing the C. intestinalis AOX-coding sequence recloned with
its natural stop codon from the original vector, pCDNA5/FRT/TO (13), as an EcoRI fragment into the
copper-inducible vector pMT/V5-His B (Thermo Fisher Scientiﬁc); pAC/AOX and pAC/mutAOX (43, 112),
containing, respectively, the wild-type C. intestinalis AOX-coding sequence and the mutated, catalytically
inactive variant under the control of the constitutive actin-5C promoter plus the corresponding empty
vector pAc5.1/V5-His B (Invitrogen); and pUASTattB-AOX and pUASTattB-mutAOX (43), containing the
same transgenes cloned into the pUASTattB vector under the control of a Gal4-dependent promoter.
Expression and induction of AOX were veriﬁed for each plasmid by transfection and Western blotting as
described previously (43), prior to use in luciferase reporter assays. Transfections used the FuGENE HD
transfection reagent (Promega), according to the manufacturer’s instructions, at a ratio of 3 l FuGENE
per g of DNA. For each transfection, 3  105 cells/ml were plated on 6- or 12-well plates. To each well
was added a transfection mix consisting of FuGENE, 1 g of each plasmid to be used (per ml of culture
medium), and sterile water up to a ﬁnal volume of 100 l (6-well plates) or 50 l (12-well plates).
Transfections were carried out 1 h after plating (24 h in the case of pMT-AOX or the corresponding empty
vector, with addition of 500 M CuSO4 after a further 24 h), and luciferase assays were performed 72 h
after transfection. In transfection mixtures to which mitochondrial inhibitors were added, 6 105 cells/ml
were plated on 6-well plates, and drugs were added 24 h after transfection at the concentrations shown
in the ﬁgure legends. For luciferase reporter experiments in which hep expression was knocked down by
RNAi, cells were also transfected with a dsRNA against the hep coding sequence, prepared by a
AOX and Cell Migration Molecular and Cellular Biology
December 2018 Volume 38 Issue 24 e00110-18 mcb.asm.org 15
two-round PCR-based procedure essentially as described previously (112), but using hep-speciﬁc primers
(shown 5= to 3=) TGGAGGCAAAGCTCCAGGC and CGCGAACGAAGCAGCCAAGG for the ﬁrst round and
GAATTAATACGACTCACTATAGGGGAGACATCCGCCACCCACGCACCTTC and GAATTAATACGACTCACTATA
GGGGAGATCCCATTGCCCAGGTCGCCCAG for the second round, followed by transcription using a
MEGAscript T7 transcription kit (Life Technologies). Knockdown at the RNA level (to 85%) was
veriﬁed in transfected cells (112) by qRT-PCR. For combined dsRNA/reporter plasmid transfections, 1 
105 cells were plated per well in 24-well plates. After 30 min, cells were transfected with 300 ng of each
relevant plasmid and 4 g of hep-speciﬁc dsRNA per well in a total volume of 100 l. A further 4 g of
the dsRNA was added 72 h later, and luciferase assays were conducted 110 h after the initial transfection.
For luciferase assays, 75 l of suspended cells from each well was transferred in triplicate to the wells of
a 96-well microplate (Lab Systems) and analyzed using a Dual-Glo luciferase assay system (Promega),
according to the manufacturer’s protocol. Luminescence was measured using a Thermo Labsystems
Luminoskan Ascent plate reader.
Luciferase reporter assays in mammalian cells. Fireﬂy luciferase reporter assays were carried out
in HEK-AP1 cells and in AOX/mutAOX-expressing clones derived from them, as follows: 30,000 cells were
plated in technical duplicate (2 wells per sample) in luminometer-compatible Nunc MicroWell 96-well
plates with lids (Thermo Fisher Scientiﬁc). After 24 h, the medium was replaced with medium containing
either 0.2% DMSO, 20 M SP600125 in 0.2% DMSO, 20 M JNK inhibitor V, or no added drug. Cells were
incubated for 2 h at 37°C. For PMA treatment, a second replacement medium contained 8 nM PMA plus
20 M SP600125 in 0.2% DMSO, 20 M JNK inhibitor V, or no other added drug, as appropriate, and the
cells were incubated for a further 6 h. Luciferase assays were carried out using the Dual-Glo luciferase
assay system (Promega), according to the manufacturer’s protocol, and luminescence was measured
using a PerkinElmer UV/visible plate reader.
Protein analysis by Western blotting. Batches of 300,000 MEFs or HEK-AP1 cells or 250,000 BJ-5ta
cells were plated on 6-well plates (CellStar; Greiner Bio-One). After 24 h, the medium was replaced with
medium containing either 0.2% DMSO, 20 M SP600125 in 0.2% DMSO, 20 M JNK inhibitor V, 8 nM
PMA, or no added drug and the plate was incubated for 2 h (or 40 min, in the case of PMA). Cells were
carefully rinsed in ice-cold phosphate-buffered saline (PBS) and then scraped free on ice using a CytOne
cell scraper (220 mm long, 11-mm blade) in 75 l of resuspension buffer containing 100 mM NaCl, 10 mM
Tris-HCl, and 1 mM EDTA, pH 7.8, supplemented with cOmplete, Mini, EDTA-free protease inhibitor and
phosphatase inhibitor cocktails (at the manufacturer’s recommended amount; Roche) and 1 mM phen-
ylmethylsulfonyl ﬂuoride. Protein concentrations were determined using the Bradford assay. After lysis by
the addition of an equal volume of SDS sample buffer (Laemmli 2 concentrate; Sigma-Aldrich), samples
were heated for 5 min at 100°C and brieﬂy centrifuged to remove particulates, and 20 g of each extract
was loaded onto 18-well precast Any kD Criterion TGX Stain-Free protein gels (Bio-Rad), which were run
and blotted as described previously (43). Blots were processed as described previously (15), but with
blocking in 5% bovine serum albumin (BSA) in PBS-Tween for 1 h on a shaker and using the primary
antibody phospho-c-Jun (Ser 73) rabbit monoclonal no. 3270 (1:1,000; Cell Signaling Technology) or
phospho-c-Jun (Ser63) II rabbit polyclonal 9261 (1:1,000; Cell Signaling Technology), with reprobing
using anti--actinin rabbit polyclonal C-20 (1:7,000; sc-7454-R; Santa Cruz Biotechnology). Secondary
antibody was peroxidase-labeled goat anti-rabbit IgG (1:10,000; PI-1000; Vector Laboratories). The
chemiluminescence of all blots was documented both with ﬁlm and by using a Bio-Rad ChemiDoc
imager.
Respirometry. Whole-cell and permeabilized cell respiration was measured essentially as described
previously (118). iMEFs were seeded 24 h before the experiment and grown in DMEM containing 4.5
g/liter glucose, 10% fetal bovine serum (Thermo Fisher Scientiﬁc), 2 mM GlutaMAX (Gibco), and 100 U/ml
penicillin plus 100 g/ml streptomycin (Lonza). To activate cell respiration, the growth medium was
replaced 1 h before the assay. Cells were detached with 0.05% trypsin and counted by trypan blue
exclusion. Mitochondrial respiration in permeabilized cells was assayed using an Oroboros oxygraph-2K
oxygraph (Oroboros, Innsbruck, Austria), with 2  106 iMEFs being directly suspended in the oxygraph
chamber containing 2 ml of respiration buffer B (10 mM KH2PO4, 20 mM HEPES-KOH, 20 mM taurine, 0.5
mM EGTA, 3 mM MgCl2, 1 mg/ml essentially fatty acid-free BSA, 60 mM potassium-lactobionate, 110 mM
mannitol, 0.3 mM dithiothreitol, pH 7.1). After measuring endogenous whole-cell respiration, substrates
and inhibitors were added in the following order: (i) digitonin (30 g), to permeabilize the cells; (ii)
sodium pyruvate (to 5 mM), sodium glutamate (to 5 mM), and sodium malate (to 2 mM) as a cI-linked
substrate mix, followed by ADP (to 2 mM); (iii) rotenone (to 150 nM) followed by succinate (to 10 mM)
as a cII-linked substrate mix; (iv) antimycin A (to 30 ng/ml), to reveal AOX-mediated respiration; (v)
n-propyl gallate (nPG; to 200 M), to reveal any residual non-AOX-mediated oxygen consumption to be
subtracted; (vi) N,N,N=,N=-tetramethyl-p-phenylenediamine (TMPD; to 1 mM) plus sodium L-ascorbate (to
2 mM) as a cIV-linked substrate mix; and (vii) sodium azide (to 40 mM), to reveal any non-cIV-mediated
oxygen consumption to be subtracted. O2 consumption (in picomoles · second1 · milliliter1) was
normalized to the amount of total proteins extracted from 1  106 cells and assayed by the Bradford
method (119). All chemicals were purchased from Sigma-Aldrich.
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